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Abstract 
3-Acyltetramic acids, such as reutericyclin, belong to a group of natural products which 
contain a 5-membered pyrrolidine-2,4-dione heterocycle with an acyl group at the 3-
position.  Molecules containing this motif have been shown to contain a wealth of desirable 
bio-activity such as antibiotic, antitumor, antiviral, antiulcerative, fungicidal and cytotoxic 
properties.1,2  The motivation for synthetic efforts towards reutericyclin and analogues is 
that it has been shown to have potential as an antibiotic treatment against superbug C. 
difficile.3   
Our synthetic approach used a pyrroloisoxazole bicyclic system as a ‘masked’ form of the 
acyltetramic acid core structure, which enables us to make selective modifications towards 
these bio-active products and produce more analogues suitable for biological testing.  We 
report the synthesis of several novel compounds closely related to a masked reutericyclin as 
well as elaborations at the C-3 methyl group through aldol chemistry.   
The route began with a naturally occurring amino acid that underwent N-protection, 
carboxyl reduction and conversion to an oxime.  This oxime is precursor to a nitrile oxide 
used in a 1,3-dipolar cycloaddition to achieve a substituted isoxazole that was deprotected 
and, through an intramolecular peptide coupling reaction, provided the pyrroloisoxazole 
core as the masked acyltetramic acid.  Acylation reactions were completed upon this 
pyrroloisoxazole using butyllithium as a base and a range of acyl chlorides (Scheme 1). 
 
Scheme 1. Synthesis overview  
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Other developments made in this synthesis were the isolation of the chlorinated oxime and its use 
in a solvent study and significant improvements in the peptide coupling reaction.  Also, synthetic 
efforts were made to produce an analogue of the natural product laccarin A using this 
methodology.  
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Abbreviations 
Ar Aryl 
Boc tert-Butoxycarbonyl 
br. 
Brine 
n-BuLi 
Broad  
Saturated aqueous Sodium Chloride solution 
n-Butyllithium 
DCC  1,3-Dicyclohexylcarbodiimide 
DCM  Dichloromethane 
DIBAH Diisobutylaluminium hydride 
DMF N,N-Dimethylformamide 
DMSO  
DIPA 
Dimethyl sulfoxide 
Diisopropylamine 
EDCI 1-Ethyl-3-(3-dimethylaminopropyl) carbodiimide 
hydrochloride 
Eq 
FMO 
Equivalent 
Frontier Molecular Orbital 
g Gram 
h 
HOMO 
Hour 
Highest Occupied Molecular Orbital 
HOSu N-Hydroxysuccinimide 
IR 
LDA 
LUMO 
Infrared 
Lithium Diisopropylamide 
Lowest Unoccupied Molecular Orbital 
M Molar or mol dm-3 
mp Melting point 
mL Millilitre 
MRSA Methicillin-Resistant Staphylococcus aureus  
MS Mass Spectrometry 
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NCS  N-Chlorosuccinimide 
NMR 
NRPS 
Nuclear Magnetic Resonance 
Non-ribosomal Peptide Synthase 
Phth 
PKS 
PPA 
Phthaloyl 
Polyketide Synthase 
Polyphosphoric acid 
PS Polystyrene 
PS-CDI Polystyrene carbodiimide 
PTSA 
rt 
p-Toluenesulfonic acid 
Room Temperature 
Et3N 
T3P 
TBAF 
Triethylamine 
Propylphosphonic anhydride  
Tetra-n-butylammonium fluoride 
TFA Trifluoroacetic acid 
THF Tetrahydrofuran 
TLC 
TMSCl 
Thin Layer Chromatography 
Chlorotrimethylsilane 
UV Ultraviolet 
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1.0 – Introduction 
1.1 - 3-Acyltetramic Acids 
Tetramic acids are a family of naturally occurring metabolites consisting of a 5-membered 
heterocycle with the general structure of a pyrrolidine-2,4-dione.  Discovered in the early 
twentieth century, it was not until the mid-1960’s that their true advantages became 
known.4,1,2 The beneficial properties of the class were investigated upon the realisation that 
several naturally occurring compounds contain this heterocyclic moiety, which is most 
common with the addition of an acyl group at the 3-position in the ring (1), giving rise to the 
popularity of 3-acyltetramic acids. 
 
Figure 1. The 3-acyltetramic acid motif  
There is a wealth of desirable activities that these compounds have been shown to possess 
which include antibiotic, antitumor, antiviral, antiulcerative, fungicidal, mycotoxic and 
cytotoxic properties1,2.  What is most compelling is that all these potential health benefits 
can arise from relatively simple modifications to the R3, C-5 and N-substituted groups, 
providing the assumption that most biological activity originates from the tricarbonyl 
structure at the centre.  This ability to continue to produce slightly different compounds still 
containing the biological activities, as seen in penicillin, is massively desirable in drug 
development due to risks associated with resistance.  This high variety of biological activity 
and challenging structural complexity makes the acyltetramic acids ideal targets for 
synthetic organic chemists.  
Although this chemical moiety was found to be beneficial in the mid-1960’s, the first 
synthetic example was produced in 19145, synthesised due to its occurrence in some in 
natural products and its (at the time) synthetically challenging  structure. The 3-acyltetramic 
acids have been shown to possess a pKa in the range of 3.0-3.56, which is thought to be due 
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to the methine carbon at C-3 which is at the centre of the three carbonyl groups and, 
therefore, holds a very acidic proton.  The charge left behind on removal of this proton can 
be delocalised by three separate oxyanion forms seen in Figure 2, which leads to this highly 
acidic proton. 
 
Figure 2. An explanation of the acidity of the methine proton  
Also related to the tricarbonyl structure is, as with most enolisable ketones, keto-enol 
tautomerism.  Along with this, the addition of the nitrogen in the heterocycle also allows the 
projection of over nine possible tautomers, see Figure 3.   
 
Figure 3. Some theoretical tautomers of the 3-acyltetramic acid motif  
 
1a 1b 1c 1d 
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Research has shown that only four of these nine are observed in solution (2a-d).  As with 
most compounds, behaviour is determined by the structure of these tautomers as well as 
any subsequent intramolecular forces that may arise.  The conversion between the 
tautomers shown has been observed and it was identified that the exchange between the 
internal tautomers (2a 2b, 2c 2d) is too rapid to detect on an NMR spectroscopy 
timescale because it relies simply upon a proton transfer along the shown intramolecular 
hydrogen bond, see Figure 4 for the 5-sec-butyl compounds. 
 
Figure 4.  The most common tautomers and their relative rate of interchange  
The interconversion between the internal and external tautomers of the 5-sec-butyl 
compounds (3a,3b 3c,3d) has been shown to occur at a much slower rate, which can be 
understood as it relies upon the rotation of the 3-acyl chain7.  The major tautomer at room 
temperature in the solid state has been identified as the 2,4-diketo external-enol (3d)8.  This 
was extensively researched and led to conflicting views in the contradictory paper by 
Yamaguchi9, who concluded the major tautomers to be both internal (3a and 3b) from his 
studies involving electron density and CNDO/2 calculations.  The true major tautomer (3d) 
was confirmed by the production of more 13C and 1H NMR experiments10, in which it was 
shown that the ratio between 3a:b:c:d is 5:15:0:80 respectively in deuterated chloroform, as 
2a 2b 
2c 2d 
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well as crystal structures11 proving 3d as the major tautomer in the solid state. 
1.2 - 3-Acyltetramic Acids Present in Natural Products 
As previously discussed the most common form of tetramic acids in natural products is the 
3-acyltetramic acid derivative.  These arise in the form of simple lactam compounds, with 
only very minor variations to the general structure 1, and can include large aliphatic or 
aromatic side chains and compounds that integrate the 3-acyltetramic acid into a larger 
macrocycle, but several of these minor variations give rise to a large library of compounds.  
Examples of these will now be discussed as reasons for the on-going research into the 
synthesis of 3-acyltetramic acids. 
The first, and simplest in terms of structural complexity, naturally occurring 3-acyltetramic 
acid derivative to be discussed is tenuazonic acid (3), Figure 5. 
 
Figure 5. Tenuazonic acid 
This compound was isolated in 1957 from a culture of Alternaria tenuis, which is a fungus 
that causes brown spots in leaves, although this particular strain was grown in a laboratory 
on a glucose medium12,13.  Tenuazonic acid is a secondary metabolite and inhibits protein 
synthesis machinery, which is seen in its mycotoxic properties, the ability to inhibit viruses 
such as herpes and poliovirus12. It is important to note that it can be toxic to mammals and 
this high toxicity limits its potential in human patients.  More recently the compound was 
shown to inhibit tumour growth in mice14, which could lead to more attempts at the 
synthesis of non-toxic derivatives of this 3-acyltetramic acid. 
The next naturally occurring 3-acyltetramic acid derivative is a group known as melophlins 
(Figure 6, Table 1).  Melophlins C-O, differing mainly in the length of the 3-acyl group, were 
isolated in 2003 by Wang et al. from a marine sponge, Melophlus sarassinoru.  It is 
3 
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interesting to note that one-third of all natural products are isolated from sponges, leading 
them to be the most abundant providers of natural products in the sea15.   
 
 
Figure 6. Melophlins C-O 
Table 1. Different possible substituents of Melophlins C-O 
Melophlin R1 R2 R3 n 
C (4) - - - - 
D (5) H H H 11 
E (6) H H CH3 11 
F (7) H CH3 H 11 
G (8) H H H 10 
H (9) H H CH3 10 
I (10) H CH3 H 10 
J (11) CH3 H H 10 
K (12) H H CH3 9 
L (13) CH3 H H 9 
M (14) CH3 H H 8 
N (15) CH3 H CH3 8 
O (16) CH3 CH3 H 8 
4 
5 - 16 
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Melophlins (4-16) have all been shown to demonstrate advanced antibacterial activity 
against Bacillus subtilis and Staphylococcus aureus, a strain of which is methicillin-resistant 
Staphylococcus aureus (MRSA).  Melophlin C (4) has also revealed antifungal activity in that 
it can inhibit Candida albicans15.  These applications and small chain differences around a 
single central structure make another intriguing target for synthetic chemists based on the 
tetramic acid motif. 
Another medicinal compound containing this versatile acyltetramic acid is a molecule 
known as equisetin (17), Figure 7,  discovered in the mid-1970’s upon isolation from the 
white mould Fusarium equiseti16.  Equisetin is an N-methyl 3-enolised-acyltetramic acid that 
contains a bicyclic system as the acyl group.  It has also been shown to display a range of 
biological activity such as antibiotic and HIV integrase inhibition, cytotoxicity and ability to 
bind to mammalian DNA17. 
 
 
Figure 7. Equisetin 
The desirable biological activity and structural complexity of equisetin make it a suitable 
target for multiple synthetic attempts; more details will be given later18. 
An additional biological property seen in compounds containing this pyrrolidine-2,4-dione is 
commercially desirable nematocidal activity.  Nematodes are organisms that have been 
described as hard to distinguish, yet 28,000 different examples have been found, with 
16,000 being parasitic19.  A compound possessing this desirable feature is geodin A (18, 
Figure 8) (characterised as a magnesium salt) that was able to be isolated by Capon et al. in 
1999.  Along with this potent nematocidal activity, this example was also chosen as it 
contains a macrocyclic polyketide ring, linking the 3-acyl and C-5 chains.  The structure was 
17 
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assigned on the basis of detailed spectroscopic analysis20. 
 
Figure 8. Geodin A Magnesium Salt 
These natural products are only some of the over 150 examples found since 19601,2 and the 
possibilities of thousands more can be easily imagined by simple changes to this small 3-
acyltetramic acid centrepiece.  The huge range of diversity in these biological activities is 
also fascinating and can be assumed to have a strong basis in this intriguing pyrrolidine-2,4-
dione core. 
 
 
 
 
 
 
 
 
18 
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1.3 – Specific Naturally Occurring Examples Relevant to the Research 
Undertaken and their Previous Synthesis 
1.3.1 – Reutericyclin and Analogues 
When discussing naturally occurring 3-acyltetramic acid targets, reutericyclin (19, Figure 9) 
was a clear candidate.  Reutericyclin and analogues possess a wealth of biological activity, 
including potential for use in an antibiotic treatment against hospital superbug Clostridium 
difficile 21,3,22,23,2, which is currently very critical as antibiotic resistance by this bacterium is 
causing it to be spread “fast and easy” leading to fatalities in older patients and people with 
a compromised immune system24.  The structure of the acyltetramic was also deemed an 
appropriate target for this research due to its relative lack of chiral complexity, as compared 
with equisetin (17), coupled with this highly desirable biological activity.   
 
Figure 9. Reutericyclin 
Reutericyclin was discovered in 2000 by Jung and co-workers as the first low molecular 
weight antibiotic from a bacterium found in cereals fermented in lactic acid.  In this 
particular case the lead compound was identified from Lactobacillius reuteri LTH258421, 
found in sourdough which is used as a baking aid.  This initial discovery was of importance as 
it was able to inhibit Gram-positive bacteria, the category of bacteria in which Clostridium 
difficile resides. 
The first published synthesis of reutericyclin was very quickly provided by its discoverers, 
Jung and co-workers, in the same year as the publication of its discovery, 200025.  This was a 
racemic synthesis providing the only chiral centre as both enantiomers in 7 steps with an 
overall yield of 5%.  The synthetic product was confirmed by direct comparison of the 
spectral analysis with the data obtained from the natural product, which was found to occur 
only in one enantiomer, R.  The synthesis began with the formation of 2-decenoic acid in 
19
?? 
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65% yield by the condensation of octanal with malonic acid, followed by chlorination of this 
acid using thionyl chloride in a quantitative yield.  The acyl chloride was then used to acylate 
tert-butyl O-protected L-leucine and, after acidic ester cleavage with TFA the N-acylated 
amino acid was isolated in a 63% yield from the acyl chloride.  This amino acid was then 
converted to the N-acylated tetramic acid in a 75% yield by coupling with Meldrum’s acid 
and subsequent thermal cyclisation with racemisation, losing the introduced chirality.  
Racemic reutericyclin was produced and isolated in a 17% yield after HPLC purification from 
the non-acylated tetramic acid derivative by C-acylation using excess acetyl chloride and 
titanium tetrachloride (Scheme 2). 
 
Scheme 2. Racemic synthesis of reutericyclin  
Reagents and conditions: (a) CH2(COOH)2, -CO2, (b) SOCl2, (c) L-Leu-OtBu, (d) 50% TFA in 
CH2Cl2, -isobutene, (e) Meldrum’s acid, DCC, DMAP, (f) Heat, -acetone, -CO2, (g) AcCl, TiCl4. 
R and S-Reutericyclin 
21 
23 
75% 
17% 
20 
22 
24 
25 
19
?? 
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The synthesis requires a strong Lewis acid, TiCl4, and also requires a highly controlled step to 
thermolyse the Meldrum’s acid, which the authors state needs a specific temperature 
requirement to be reproducible at the yields they report.  
This was a successful first synthesis but biological studies showed the racemic mixture 
exhibited slightly lower antibiotic activity than the naturally occurring enantiomerically pure 
reutericyclin25.  Therefore an enantiospecific total synthesis was required, and was provided 
by Jung and his team again in 200526. 
This new synthesis produces R-reutericyclin in 3 steps with an overall yield of 24% using 
chiral pool chemistry.  Starting by coupling the R-leucine ethyl ester with N-
hydroxysuccinimidoyl acetoacetate in dichloromethane, Jung et al. were able to add an 
activated ketoester to the amine.  This modified amino acid could then be cyclised to the 
acyltetramic acid using an amended Dieckmann cyclisation with sodium ethoxide in ethanol, 
which was developed as standard conditions were unsuccessful.  This acyltetramic structure 
then needed to be N-acylated to add the crucial dec-2-enoyl group, which was finally 
completed using n-butyllithium in a 38% yield after the lower effectiveness of other 
methods attempted, Scheme 3. 
 
Scheme 3. Total synthesis of R-reutericyclin  
a)CH2Cl2, r.t., 3 h. b) EtONa/EtOH, 3 h. c) 1. THF, BuLi (2.2. equiv.), -70oC; 2. (E)-dec-2-enoyl 
chloride; 3. H3O+ 
26 27 28 
29 
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This synthesis was successful in producing enantiomerically pure R-reutericyclin from R-
leucine in 3 steps, without requirement for chiral separation.  This chiral pool chemistry 
retained the chirality from the starting amino acid, which was lost in the previous synthesis. 
It is suggested by the authors that the NMR data for reutericyclin failed to identify a major 
tautomer as a crystal could not be produced and an oil was repeatedly produced after slow 
evaporation.  Jung and co-workers also suggested his method might be suitable for mass 
production of the target. 
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1.3.2 –Laccarin A 
In the search for possible targets and applications for the synthetic route being developed it 
became apparent that, although not specifically an acyltetramic acid, an analogue (18) of 
laccarin A (30) could be targeted, see Figure 10.  The synthetic plan towards this interesting 
molecule is described later in this report. 
 
Figure 10. Laccarin (30) and a synthetically feasible analogue (31)  
The widely growing but inedible mushroom fungus Lactarius subplinthogalus, found in 
China, has been extensively researched for its production of biologically active alkaloids27,28.  
In 1996, Matsuda et al. discovered laccarin and determined its structure based on 
spectroscopic evidence29. Further evidence was found confirming this structure and several 
similar compounds in 2003 by Wang et al. using more accurate spectroscopic methods30. 
Upon its first discovery, laccarin was shown to exhibit potent biological activity which 
allowed interest to grow in its synthesis and potential medical uses.  The activity displayed 
was similar to that of tenuazonic acid (3) in its ability to moderately inhibit 
phosphodiesterase activity.  It was also shown to contain phytotoxic and antineoplastic 
characteristics29.     
This biological activity displayed by this molecule and its small molecular weight caused it to 
be of interest to synthetic chemists, with  a total synthesis of laccarin being reported in 2007 
by Gallagher31, see Scheme 4. 
 This first total synthesis, which is also an asymmetric synthesis, was developed by Gallaher 
et al. and remains the only published synthesis to date, obtaining the correct enantiomeric 
product in 13 steps with an overall yield of 18.4%.  This is an impressive yield over 13 steps 
and the chemistry used is notable.  Firstly, (3R)-hydroxybutyrate (32) had its ethyl ester 
converted into N-benzyl amide (33) which was subsequently reduced and the amino alcohol 
30 31 
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formed protected as a cyclic sulfamidate (34).  Ring opening was then achieved by addition 
of the sodium enolate of diethyl malonate and subsequent protection of the now free 
amine was completed (35) to ensure there would be no early formation of a lactam ring.  An 
amino group was added using monochloroamine under basic conditions and this free amine 
was then acylated using diketene.  Cyclisation of the pyrrolo unit by base was followed by 
decarboxylation using aqueous acid.  TFA removal of the remaining Boc group led to the 
cyclisation of the second ring system which was shown to form the target (trans) and also its 
cis diastereoisomer in a 7:2 ratio (40:39).  The two were separated and the trans 
diastereoisomer identified based on a detailed spectroscopic analysis and X-ray 
crystallography.  Debenzylation of the product was then achieved to yield the target 
compound laccarin, whose structure was confirmed by detailed spectroscopic analysis, X-ray 
crystallography and direct comparison with the natural product. 
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Scheme 4. Synthesis of Laccarin  
 
Reagents and conditions: i, AlMe3, BnNH2, PhMe, 0 0C; ii, LiAlH4, THF, reflux; iii, SOCl2, Et3N,  
imidazole, CH2Cl2, -20 0C to 0 0C; iv, RuCl3 (0.25 mol%), NaIO4, MeCN–H2O, 0 0C; v, diethyl 
malonate, NaH, DMF, 110 0C; then 5 M HCl; vi, Boc2O, NaHCO3, MeCN; vii, NH2Cl (Et2O), t-
BuOK, THF, 0 0C; viii, diketene, cat. DMAP, THF, 60 0C; ix, NaOEt, EtOH, 60 0C; x, H2O, then 5 
M HCl; xi, TFA, CH2Cl2 then Et3N; xii, PhMe, 80 0C; xiii, 10% Pd/C (65 wt%), H2 (5.5 bar), TFA. 
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1.4 – Suggested Biosynthesis of 3-Acyltetramic Acids in Natural Products 
Some consideration must be given to the natural production of this diverse and interesting 
group of metabolites.  The biosynthesis of such molecules has been investigated thoroughly 
due to their production in a multitude of different species including sponges, cyanobacteria, 
bacteria and fungi as well as their discussed biological activity, although it is still unknown 
what the genetic determinants for the biosynthesis of these compounds are in fungi and 
bacteria32.   
It has been proposed that 3-acyltetramic acids can be formed in biological systems via two 
main reactions, one involves the combination of an amino acid and an acetyl group followed 
by subsequent acylation at C-3 (route 1).  The other notion comprises the cyclisation of an 
amidated polyketide chain, fashioned by polyketide synthases (PKS),  forming the lactam 
ring in the presence of non-ribosomal peptide synthase (NRPS) in the cytoplasm 
spontaneously or enzymatically (route 2)33–35, Scheme 5.  It is worth noting that any N-
acylation, as seen in reutericyclin and other examples, is assumed to occur before the 
lactam ring closure by the enzymatic addition of the relevant acyl substituent. 
 
 
Scheme 5. Biosynthetic routes to the 3-acyltetramic acids 
41 42 43 44 
45 
46 
47 
48 
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It was concluded by 14C labelling of the substrates provided to a fungal broth in a feeding 
study that the intermediate 43 (route 1) was not observed, yet all intermediate substrates 
involved in route 2 (45-48), were seen in an individual example which was the biosynthesis 
of tenuazonic acid1,36,37, Scheme 6.  
 
Scheme 6. Biosynthetic route to 3-acyltetramic acids 
Numerous further studies have been conducted on this biosynthetic process, including that 
of Cox38, in which he recently isolated a fungus, Beauveria bassiana, grown on spiders, that 
contain new tetramic acid derivatives.  These genetic studies support route 2 of Scheme 5. 
Other known biosynthetic pathways to popular tetramic acids include the assembly of 
trichosetin (49), equisetin (17) and phomasetin (50)39.  It was found that these compounds, 
due to the similarity of large portions of the structure, are all made correspondingly from 
two separate reactants which can be abundantly produced by the organism.  These units 
include an amino acid (in the case of trichosetin it was found to be L-serine (51) which can 
also be assumed to be used in the biosynthesis of the other two) and a series of eight 
acetate groups, known as an octaketide (52), joined in a linear manner, Scheme 7.  It is 
assumed that upon the addition of these two units the (reduced) polyacetate tail undergoes 
an intramolecular Diels–Alder reaction to produce the modified bicyclic ring system. 
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Scheme 7. A proposed biosynthetic origin of Trichosetin (49), Equisetin (17) and 
Phomasetin (50) 
The intramolecular Diels-Alder reaction proposed in this suggested biosynthesis is common 
to natural products containing this ring structure40. 
 
 
 
 
 
 
 
 
Table 2. Different substituents in suggested Equisetin 
Biosynthesis 
Number R1 R2 R3 
49 H H CH3 
17 CH3 H CH3 
50 CH3 CH3 CHCHCH3 
 
52 
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1.5 – Selected General Synthetic Routes to 3-Acyltetramic Acids 
Due to the large applications and challenging structural features of these tetramic acid 
analogues there has been substantial research into their synthesis.  Both racemic and (later) 
enantioselective syntheses have been developed, with stereoselective syntheses being 
sought because only some enantiomers and diastereoisomers are biologically active.  These 
routes will now be discussed. 
The first synthesis of a 3-acyltetramic acid was achieved by Gabriel in 191441,5 causing the 
ring closure by forming a new C(2)-N carbon-nitrogen bond.  This was accomplished by 
reaction of phthalimidoisobutyryl chloride (53) with diethyl sodiomalonate to yield the 
addition-elimination product 54.  This, in turn, was subjected to strong sulfuric acid 
conditions which produced the novel tetramic acid 55, Scheme 8. 
 
Scheme 8. The first published synthesis of a 3-acyltetramic acid derivative 
This method was successfully implemented in the 1984 racemic synthesis of natural product 
dysidin (56) by Willard and Laszlo42.  Note that dysidin is not a 3-acyltetramic acid but does 
show some structural similarities, demonstrating the diversity in the uses of these synthetic 
strategies. 
53 54 55 
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Figure 11. Dysidin, which was successfully produced using this early synthetic technique 
A second racemic synthesis, derived after the original 1914 work by Gabriel5, was developed 
by means of a Dieckmann cyclisation which in effect is an intramolecular Claisen 
condensation, by King et al.43,44 in 1950.  This involved the use of an N-acyl--amino ester 
(57) in the basic conditions caused by sodium ethoxide and it was shown that a tetramic 
acid could be afforded but this method lacked the ability to add a 3-acyl group, although 
manipulation at C-5 was possible, Scheme 9. 
 
 
Scheme 9. An example of the ring closure reaction to produce tetramic acids 
This method was advanced by Lacey in 195445 to produce a 3-acetyltetramic acid from 
readily available amino acids.  This was a major advance in the synthesis of racemic tetramic 
acids and is still the most prominent method used today.  This widely popular method 
56 
57 
58 59 
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involves the addition of diketene to the N-terminus of any readily available amino acid (60) 
followed by Dieckmann cyclisation to give the corresponding 3-acetyltetramic acid (62).  The 
diketene restricts variation at C-3 but the amino acid used provides a variety of possibilities 
at the C-5 substituent, Scheme 10. 
 
Scheme 10. 3-Acetyltetramic acid synthesis by diketene addition and ring closure 
This method has been developed further to integrate new asymmetric synthetic discoveries, 
such as using chiral naturally occurring compounds to produce single diastereoisomers46,47 
that have been shown to exhibit desirable biological activity.  These prepared compounds 
include (-)-dysidin (56) and (-)-tirandamycin A (62).  In the early 1990’s, this synthetic 
method was improved upon by Ley and others in order to introduce more enantiocontrol at 
the C-5 position, in Scheme 10 where R1 is not hydrogen.48,49   This control was assessed by 
using a variety of different bases in the base mediated ring closure of the final lactam ring, 
concluding that Lacey’s original method of refluxing in methanol with sodium methoxide 
overnight was too harsh and led to further racemisation.  The studies identified two 
conditions that were found to be more efficient in controlling the enantioselectivity, these 
were potassium t-butoxide in t-butanol for 5 minutes at room temperature and tetra-n-
butylammonium fluoride (TBAF) in THF for 5 minutes at room temperature.  Both provided 
excellent yields for the cyclisation product and retained the chirality in the starting material. 
This base mediated technique to close the ring, along with an intramolecular Diels-Alder 
reaction, was also built upon recently in a synthesis by Ley50 in which a long conjugated 
chain closed thermally to form equisetin (17) from the thioester. 
60 61 62 
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Figure 12. (-)-Dysidin (56), (-)-Tirandamycin A (63) and Equisetin (17) 
Another milestone in the synthesis of 3-acyltetramic acids was a technique first exploited by 
Kohl in 1974.51 This involved forming the lactam ring through the Lacey–Dieckmann 
cyclisation seen above with an alkene in the R1 position, without the 3-acyl substituent.  This 
group was added later via a C-3 acylation using an acyl chloride and boron trifluoride-
etherate, Scheme 14. 
 
a) RCOCl, BF3.OEt2; b) Ac2O, NaOAc, MgCl2 
Scheme 11. Kohl method of 3-Acylation on pyrrolidine-2,4-dione 
This strategy was later developed by Jones and colleagues in an attempt to produce 
complex naturally occurring products.52   The preliminary results were not encouraging 
when using TiCl4 as the Lewis acid, but using boron trifluoride with alterations to the work 
up the 3-acyltetramic acid products were able to be identified as their boron difluoride 
complexes and then isolated pure after liberation with methanol, Scheme 1253,54   
56 63 17 
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Scheme 12. Jones method of 3-Acylation on pyrrolidine-2,4-dione 
More recently, Yoda and colleagues have used a procedure involving the synthesis of the   
pyrrolidine-2,4-dione species and a 3-acylation was accomplished by an O- to C-acyl 
rearrangement.55  This was developed in the synthesis of the antibacterial agent 
epicoccarine A and the key rearrangement step involved firstly, the coupling of the C-4 
oxygen with an acid to form an ester which was then rearranged using 4-
dimethylaminopyridine (DMAP) and calcium chloride, Scheme 13. 
 
Scheme 13. Yoda method for O- to C-acyl rearrangement, where R is a long alkene with 
multiple double bonds and branched substitution  
Due to the wide use of these previously discussed methods and their variants there has 
been a lack of new developments until Jones et al. devised a method where the tricarbonyl 
tetramic acid structure is masked as a pyrroloisoxazole to allow elaboration at the C-3 
66 67 
68 69 
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position56,57.  This method has moved into its second generation and involves the 1,3-dipolar 
cycloaddition of a nitrile oxide, that originates from an amino acid ester hydrochloride, and 
an enamine.  This produces an isoxazole that can then be deprotected via the use of an acid 
and subsequently, by using a peptide coupling reaction, the pyrrolo-ring can be closed.  This 
now provides an acidic proton on the methyl group that is directly bound to the 
pyrroloisoxazole core and will become, after nitrogen-oxygen bond reduction to the 3-
acyltetramic acid, the 3-acyl group.  This method therefore allows flexible manipulation of 
the C-3 acyl groups, Scheme 14. 
 
Scheme 14. A synthesis of 3-acyltetramic acids involving masking the core as a 
pyrroloisoxazole 
The research work undertaken in this thesis follows on directly from this methodology. 
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1.6 – Isoxazoles 
An isoxazole (or 1,2-oxazole) is an azole, or 5-membered ring including an integrated 
nitrogen, with an oxygen atom directly bonded to the nitrogen atom and formally 
containing one double carbon-carbon bond and one double nitrogen-carbon bond (77), see 
Figure 13. 
 
Figure 13. Isoxazole 
Isoxazoles are important due to their aromaticity, their presence in biologically active 
products and simple synthesis.  Although the targets chosen in this research do not include 
the isoxazole unit, as it is used as an intermediate in the route, it is important to understand 
the uses of such compounds and their possible syntheses.  
The occurrence of isoxazoles in medicinal drugs is very widely known as they have been 
demonstrated as being used to treat psychological conditions, obesity, migraines, general 
anti-inflammatory and specific illness or disease states.  Some examples of these commonly 
used drugs are Valdecoxib58 (58), Zonisamide59 (59) and Leflunomide (60)60, see Figure 14. 
  
Figure 14. Examples of isoxazoles in medicinal drugs: Valdecoxib (78), Zonisamide (79) and 
Leflunomide (80). 
Due to these biological applications, the general interest in isoxazoles and their physical 
aromatic properties, there are traditionally two routes known towards isoxazole systems.  
77 
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The first isoxazole was developed in 1888 by Claisen using hydroxylamine to cyclise -keto 
esters and yield 3-hydroxyisoxazoles61.  This route can be used with various 1,3-dicarbonyl 
compounds.  The more common method of making isoxazoles is now to implement a 1,3-
dipolar cycloaddition, which was to be the selected method for the production of the 
isoxazole required in this research.  The 1,3-dipolar cycloaddition will now be discussed in 
more detail.  
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1.7 - 1,3-Dipolar Cycloaddition 
As previously discussed, isoxazoles can be formed by a 1,3-dipolar cycloaddition, but the 
scope of a 1,3-dipolar cycloaddition goes much further than just the synthesis of these 
useful molecules.  The 1,3-dipolar cycloaddition (or [3+2]-cycloaddition) can be used to 
accomplish a large variety of reactions in which 5-membered heterocycles are formed.  The 
general scheme is that 1,3-dipolar compounds are added across double bonds causing the 
formation of two new  bonds and a new ring, which has been demonstrated to be very 
efficient in general alkaloid and asymmetric synthetic pathways44,45.  The next chapter has in 
depth discussion of the uses of just one of these possible 1,3-dipoles, a nitrile oxide (81).  
Another interesting feature is that the 1,3-dipolar cycloaddition can occur intermolecularly 
and intramolecularly, with the only requirements being a 1,3-dipole (typically represented 
a-b-c) being sterically able to approach a multipule bond (typically represented d=e), see 
Scheme 15. 
 
Scheme 15. 1,3-dipolar cycloaddition, where i) intermolecular and ii) intramolecular 
A 1,3-dipole is an extremely polarised system, also called a zwitterion, that contains charge 
separated across three bonded atoms with four  electrons distributed between them, 
shown above as a-b-c.  Some commonly used 1,3-dipoles are shown in Scheme 16 and 
Scheme 17; note that there are type 1 and 2 dipoles.  Both dipoles have a sequence of a-b-c, 
where c has a sextet of electrons available in its outer-shell and a has an octet of electrons 
but vitally, b must contain at least one unshared pair of electrons to stabilise the sextet 
terminus.  Type 1 dipoles possess a double bond in their sextet canonical forms and a triple 
bond in other canonical forms, see Scheme 16.  Type 2 dipoles possess a single bond in their 
sextet canonical forms and a double bond in other canonical forms, see Scheme 1764.   
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Scheme 16. Some examples of Type 1 1,3-dipoles in both the sextet and octet forms 
 
 
Scheme 17. Some examples of Type 2 1,3-dipoles in both the sextet and octet forms 
Dipolarophile is the name given to the other species required for this kind of cycloaddition 
to occur. Dipolarophiles contain two electrons and are commonly carbon-carbon -
systems, such as alkenes and alkynes.  Examples of heteronuclear diatomic molecules in a 
bond are carbonyls, nitriles and thials. 
It should be noted that some systems shown require formation in situ due to their 
instability; reactions are still possible with the above examples yet, not all with carbon-
carbon dipolarophiles65.  It is also known that not all dipolarophiles, or even alkenes, are 
successful in a 1,3-cycloaddition.  For a successful cycloaddition it is usual that the 
dipolarophile must be considered a good dienophile in the Diels-Alder reaction.  The 1,3-
cycloaddition has been found to be stereospecific and syn or suprafacial, meaning both 
Nitrile Oxides 
Nitrile Ylides 
Azides 
Sextet Octet 
Nitrones 
Carbonyl 
Oxides 
Ozone 
Sextet Octet 
81 
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bonds of  the new ring form on the same face of the double bond66.  The orientation of the 
dipolarophile and the 1,3-dipole is deduced by considering the Frontier Molecular Orbitals67, 
which will be discussed later in more detail. 
In order to produce the 1,3-dipolar cycloaddition required to obtain the desired isoxazole 
product, it was decided the 1,3-dipole needed was a nitrile oxide, which had to be formed in 
situ.  Nitrile oxides will now be discussed in more depth. 
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1.8 – Nitrile Oxides 
The chemistry of the nitrile oxide species (81, Scheme 16) has been extremely well 
documented and is well appreciated in the synthetic chemistry community with reactions 
dated back to 1896 and through to the present68,69.  The nitrile oxide species is traditionally 
used to prepare several different other functionalities including its ability to dimerise to 
furoxans (82), 1,2,4-oxadiazole-4-oxides (83), 1,4,2,5-dioxadiazines (84) and isomerise to 
isocyanates (85)70, see Scheme 18. 
 
Scheme 18. Reaction of and forming nitrile oxides, where i) Et3N, ii) PhNCO, iii) heat, iv) 
NCS, v) base, vi) dimerisation 
The synthesis of nitrile oxides has therefore been extensively researched and there are a 
number of different commonly used techniques for forming them in situ.  For example, they 
can be formed from aliphatic nitro compounds (86) in a process known as the Mukaiyama 
procedure71, formed by cycloreversion from (82)72, or from an aldoxime (87) in 
fundamentally an overall dehydrogenation (oxidation) process, which was the chosen 
method for this research, see Scheme 1870. 
86 
82 
87 
61 
82 85 83 84 
New Routes to Acyltetramic Acids and Analogues – James Bullous 
 
38 
1.9 – Frontier Molecular Orbital Theory 
As previously stated, the orientation and stereoselectivity of 1,3-dipolar cycloadditions can 
be explained using Frontier Molecular Orbital (FMO) theory.  FMO theory, first suggested by 
Fukui in 195473, takes into consideration the state of the electrons in the orbitals that wil 
undergo bonding, which for a dipole and a dipolarophile is sigma () and pi () bonding, see 
Figure 15. 
 
Figure 15. Sp3 and p Orbitals 
Using the shading shown it is possible to see different phases, where the shaded area can be 
considered as + and the lighter area as -.  The coming together of these can differ depending 
on their orientation, for example if a + and a – area align (where + and – represent the sign 
of the wave function), the energy requirement is higher and it is known as anti-bonding.  If, 
oppositely, a + and +, or – and -, align the energy requirement is lower and it is known as 
bonding74.  This information can be used to predict or explain regiochemistry in 1,3-dipolar 
cycloaddition products, see Figure 16 and Figure 17. 
  
Figure 16. Bonding and anti-bonding in  and  orbitals 
 
Sp3 p 
Bonding Bonding 
Anti-bonding Anti-bonding 
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Figure 17. Energy difference in  and  Orbitals 
In terms of electrons in these orbitals, there are two energy levels to be considered.  The 
highest occupied molecular orbital (HOMO) contains the electrons to be donated in the 
formation of new covalent bonds.  The orbital into which these electrons are to go would be 
the lowest unoccupied molecular orbital (LUMO) of the other component.  The interactions 
of these orbitals are dominant in determining the orientations observed in standard 1,3-
dipolar cycloadditions, but all filled and empty combinations contribute to the bonding.  It 
has been deduced that there are three different types of FMO combination for 
cycloadditions, each describing which orbital determines the regiochemistry in the product 
based on the energy differences.  It is known that electrophilic dipolarophiles have a lower 
energy LUMO whilst nucleophilic dipolarophiles have a higher energy HOMO74. This 
relationship has been shown in Figure 18, where type 1 is HOMO-determined with HOMO of 
dipole and LUMO of dienophile as dominant interaction, type 2 is either HOMO- or LUMO- 
determined with both interactions significant, and type 3 is LUMO-determined with LUMO 
of dipole and HOMO of dienophile as dominant interaction. 
 
E E E 
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 Figure 18. Illustration of different energy levels required depicting which orbital 
determines stereoselectivity75 
Using the methodology we had selected, which involved using a nitrile oxide, an electron 
rich dipole, coupled with an enaminoester, an electron deficient dipolarophile, we could 
propose that we have a high energy HOMO and a low energy LUMO74, lending itself to a 
type 1 reaction. 
However, it is important to note that FMO theory can predict incorrect regiochemistry76.  
This can arise when electrostatic or steric effects occur.  For example in an intramolecular 
system the hindrance caused could lead to another regiochemistry being adopted.  This is 
often planned into the experimental methodologies for these reactions.  In respect of what 
is planned for this research, it is intended to use an enamine with a substituted carboxyl 
group (electron withdrawing) and pyrrolidine group (electron donating).  This way the FMO 
theory and electrostatic effects can combine to give a better reaction yield.  This 
information was used in the synthetic plan for the research undertaken, which will now be 
discussed in more detail. 
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1.10 - Synthetic Aim 
1.10.1 – Pyrroloisoxazole Formation and Elaboration   
The research undertaken in this project was prompted by the second generation of the 
scheme developed by Jones et al.57 which included the formation of an isoxazole via 1,3-
cycloaddition77 of a nitrile oxide and an enamine.  This is then subsequently converted to 
the pyrroloisoxazole and thus, allowing manipulation of the potential C-3 tetramic acyl unit 
as well as the nitrogen in the lactam ring.  A general aim was to construct natural and 
unnatural examples of acyltetramic acids using a methodology revolving around a 1,3-
dipolar cycloaddition and have them tested for biological activity. 
An initial aim of this research was to successfully construct the pyrroloisoxazole ring system 
from a selection of readily available amino acids and prepared enamines.  Primarily, these 
pyrroloisoxazoles were then to be treated with strong base in excess, deprotonating at N-1 
and at the C-3 methyl position, then utilising aldol reactions at C-3 to add a range of 
enolisable aliphatic aldehydes with a range of structural features including long and short 
chain lengths, -substitution and unsaturation.  The alcohol adducts would then be 
subjected to acid leading to the dehydrated unsaturated product, (Scheme 19).  This project 
leads on from earlier work that successfully utilised non-enolisable aldehydes, such as 
benzaldehydes to these same pyrroloisoxazole systems under thermodynamic enolate 
generation57.  These reactions are more well-known56 and therefore an investigation into 
the less known reactions of enolisable aldehydes was required. 
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(Reagents: (a) Pentanal, (b) Decanal, (c) Isobutyraldehyde, (d) Cyclohexanecarboxylaldehyde, 
(e) Crotonaldehyde) 
Scheme 19. The initial aims of this research 
These elaborations at the C-3 position are investigations towards the possibility of adding 
long chain unsaturated aldehydes that could later undergo intramolecular Diels-Alder 
cyclisation and produce tetramic acids that contain a bicyclic system in the 3-acyl group such 
as seen in trichosetin (49), equisetin (17) and phomasetin (50)39, Scheme 20. 
 
93 – R2 – CH2CH2CH2CH3 
94 – R2 – CH2(CH2)7CH3  
95 – R2 – CH2[CH3]2 
96 – R2 – C6H11 
97 – R2 – CHCHCH3 
 
88 – R1 – CH2CH2CH2CH3 
89 – R1 – CH2(CH2)7CH3  
90 – R1 – CH2[CH3]2 
91 – R1 – C6H11 
92 – R1 – CHCHCH3 
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Scheme 20. The proposed synthesis of a compound structurally similar to equisetin (17) 
The second form of elaboration to be attempted on these pyrroloisoxazole systems was to 
use one equivalent of strong base, which would deprotonate at the amide of the lactam 
ring.  This could then be used in N-acylation reactions to add functionality here as seen in 
tetramic acids such as the previously discussed reutericyclin, among other examples.  After 
the acylation using a range of substrates (including long and short chained aliphatic, 
aromatic and sterically hindered acyl derivatives), see Scheme 21, the later discussed 
pyrroloisoxazole reduction will be implemented to achieve the N-substituted 3-acyltetramic 
acids. 
 
 
 
Scheme 21. N-Acylation of the pyrroloisoxazole 
a – R1 – CH(CH3)2 
b – R1 – CH2CH(CH3)2  
c – R1 – C6H5  
 
98 – R2 – CH2CH2CH3 
99 – R2 – CH2(CH2)7CH3  
100 – R2 – C(CH3)3 
101 – R2 – CHCHCH3 
102 – R2 – Ph 
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1.10.2 – Pyrroloisoxazole Reduction to 3-Acyltetramic Acid  
The reduction of the isoxazole could present some issues as the unmasking of the 1,3-
dicarbonyl moiety occurs in two stages, (i) the reduction of the nitrogen-oxygen bond 
yielding the enaminoketone, (ii) hydrolysis leading to the substitution of the amine group to 
give an enolised 1,3-diketone, Scheme 22.  Two reductive methods have been developed for 
the formation of the enaminoketone (103) involving hydrogenation, for use in the case of no 
unsaturation in the added side chains, or using molybdenum hexacarbonyl where there are 
other reducible groups.78,57,75  A potential issue in the hydrolysis step is deacylation where 
N-acyl derivatives are concerned.  
.  
R1 = H, CH3, CH(CH3)2 
R2 = CH2CH2C6H5, CHCHC6H5 
R3 = H, C(O)CH2CH2CH3 
Scheme 22. Unmasking the pyrroloisoxazole 
 
1.10.4 – Laccarin Synthesis by Means of Dipolar Cycloaddition Route   
As previously stated, laccarin and possible analogues became of interest as research targets 
when it was confirmed the pyrroloisoxazole could be synthesised effectively.  The proposal 
was to start with commercially available L-ornithine, bis-Boc protect and react through to 
the pyrroloisoxazole with the above described methodology.  The idea was then to reduce 
the isoxazole to the corresponding enaminoketone and allow the terminal amine to perform 
an intramolecular nucleophilic substitution reaction to form the second ring in the bicyclic 
product (31), see Scheme 23. 
103 
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Scheme 23. Scheme for potential synthesis of a laccarin analogue  
 
31 
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2.0 – Results and Discussion 
2.1 – Pyrroloisoxazole Formation using tert-Butyl 3-(pyrrolidin-1-yl)but-2-
enoate and L-Valine or L-Leucine 
2.1.1 – Preparation of a Cycloaddition Reactant, the Dipolarophile  
In order for the planned 1,3-dipolar cycloaddition reactions, we needed to produce a 
dipolarophile with a suitable leaving group substituted on the double bond as it would need 
to be readily eliminated after the cycloaddition driven by the aromaticity gained in the 
isoxazole.    It was deduced that the best group to use as a dipolarophile was an enamine 
containing a pyrrolidine group that would self-eliminate after cycloaddition.  The other 
characteristic that this enamine required was a protected acid group that could, eventually, 
close the pyrrolidine ring in a peptide bonding fashion with an amine group derived from an 
amino acid.  It was therefore reasoned that a reactant containing these characteristics could 
be easily made by the addition of pyrrolidine to tert-butyl acetoacetate or ethyl 
acetoacetate under Dean-Stark conditions, Scheme 24. 
 
Scheme 24. The production of an enamine for the 1,3-dipolar cycloaddition 
The reaction involved heating the reactants with toluene in a Dean-Stark apparatus and a 
condenser.  The solution was heated to reflux for 4 hours and confirmation of completion of 
the reaction was determined by the condensation of the calculated amount of water.  This 
solution then required no washings and was simply evaporated under reduced pressure to 
yield the product, either tert-butyl 3-(pyrrolidin-1-yl)but-2-enoate (72a) or ethyl 3-
(pyrrolidin-1-yl)but-2-enoate (72b), both as yellow powders in excellent yields, 97-99%. 
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The tert-butyl 3-(pyrrolidin-1-yl)but-2-enoate (72a) and  ethyl 3-(pyrrolidin-1-yl)but-2-
enoate (72b) were identified by clear corresponding signals in  the IR spectra, the 
appearance of a singlet at  = 4.5 ppm for the alkene proton and 85.0 ppm for the methine 
carbon in the 1H and 13C NMR spectra, respectively, and mass spectrometric identification of 
the molecular ions.   These reactants were produced as a stock intermediate, under the 
assumption that they would not degrade if stored away from moisture and therefore would 
be available on demand as and when the oxime (and hence dipole) was produced.  A 
suggested mechanism for production of the enamine via dehydration is shown in Scheme 25 
using producing tert-butyl 3-(pyrrolidin-1-yl)but-2-enoate. 
 
Scheme 25. A proposed mechanism for the enamine production. 
Also important to note is that the scale of the reaction did not affect the yield produced as is 
commonly seen in some synthetic procedures.  99% Yield was achieved when reacting 10 g 
of pyrrolidine and 20 g of tert-butyl acetoacetate to give 26.4 g of enamine product as well 
as when using 1.0 g of pyrrolidine and 2.0 g of tert-butyl acetoacetate producing 2.60 g of 
product. 
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2.1.2 – Preparation of a Cycloaddition Reactant, the Dipole via an Oxime 
The assembly of this oxime, to be used in the 1,3-dipolar cycloaddition as precursor to a 1,3-
dipole, requires 3 individual steps.  The oxime was chosen as a suitable precursor as it could 
be oxidised to a nitrile oxide by chlorination – dehydrochlorination, in Scheme 18. 
The oxime synthesis began with a commercially available amino ester, initially L-valine 
methyl ester hydrochloride but later L-leucine methyl ester hydrochloride.79,75  The aim of 
this project was not only to develop the cycloaddition step but to utilise it as a means of 
providing a masked tetramic acid permitting manipulation at C-3 and other elaborations 
including N-acylations.   
The S-valine and S-leucine amino esters were obtained from a commercial provider (Sigma-
Aldrich) as the methyl ester hydrochloride salts (106a/b, respectively), which enabled us to 
directly protect the amino group.  The protecting group used was tert-butyloxycarbonyl 
(Boc) because its removal is relatively simple under acidic conditions, a characteristic that 
will be exploited later in this synthesis when removed in tandem with another t-butyl based 
protecting group.  This protection was initiated by the addition of triethylamine, which was 
required to deprotonate the hydrochloride salts, at 0 0C over 30 minutes.  To this chilled 
solution was added di-tert-butyl dicarbonate [(Boc)2O] suspended in dichloromethane 
(DCM) dropwise, to avoid localised heating, after which the reaction was stirred at 0 0C for 
an hour and then at room temperature for a further 17 hours.  It was found by repeat 
experiments that the addition could be done either dropwise or in one portion with no 
effect on the yield, also that a longer reaction time (17 or 48 hours) similarly did not affect 
the yield, showing the reaction was complete after 17 hours.  However, when up to 20.0 g 
of amino ester hydrochloride salt was used a reaction time of up to 48 hours was required 
for completion otherwise unreacted di-tert-butyl dicarbonate required separation from the 
product by column purification, laborious due to large sample size. 
 
Excess basic contaminants (triethylamine) were removed by an acidic wash with 1 M citric 
acid solution, followed by a saturated brine wash.  The solution was then dried and 
concentrated under reduced pressure to yield both tert-butyl (2-methyl-4-oxohexan-3-
yl)carbamate (107a) and tert-butyl (2-methyl-4-oxoheptan-3-yl)carbamate (107b) as 
colourless oil in 99% yields, Scheme 26. 
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Scheme 26. Boc protection of an amino acid methyl ester hydrochloride 
This reaction yield was also unaffected by a large scale, achieving the best yield of 99% in 
the production of 27.0 g of the valine based product 107a.  Another encouraging aspect of 
this reaction is that no purification was necessary; the pure product was confirmed by IR, 1H 
and 13C NMR spectroscopy, and mass spectrometric identification of molecular ion.  A 
suggested mechanism for this reaction is shown below, Scheme 27. 
 
Scheme 27. A suggested mechanism for a Boc protection of an amino acid methyl ester 
hydrochloride  
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The next step was to reduce the methyl ester to an aldehyde, ready for the ensuing 
transformation to an oxime.  This was achieved by cooling a suspension of the tert-butyl (2-
methyl-4-oxohexan-3-yl)carbamate (107a) or tert-butyl (2-methyl-4-oxoheptan-3-
yl)carbamate (107b) in dry toluene to -78 0C followed by the addition of a 1.0 M solution of 
diisobutylaluminium hydride (DIBAL) in toluene, completed dropwise with the aid of a 
syringe pump over 4 hours.  Again, the addition was dropwise to avoid any localised heating 
in the flask as temperatures above -70 0C could lead to either the further reduction of the 
aldehyde to an alcohol, or to racemise.  The reaction was quenched whilst at -78 0C by 
slowly adding methanol, which led to the production of large amounts of hydrogen gas as 
the reactions were done on a large scale.  Once satisfactorily quenched, the reaction 
mixture was added to a solution of sodium potassium tartrate (Rochelle salt) in water and 
stirred vigorously for 2 hours.  The Rochelle salt is a separation agent to enable emulsions to 
successfully disperse; in this case it causes the organic reaction mixture, containing 
aluminium residues, to interact with the water and enable successful separation, which is 
notably more difficult when no Rochelle salt is used.  After extraction with ethyl acetate the 
product solution was dried and concentrated under a reduced pressure to yield tert-butyl 
(3-methyl-1-oxobutan-2-yl)carbamate (108a) and tert-butyl (4-methyl-1-oxopentan-2-
yl)carbamate (108b) as clear and colourless oils in a highest yield of 91%, Scheme 28. 
 
 
Scheme 28. Reduction of a methyl ester to an aldehyde 
 
 
A mechanism for this reaction has been suggested, Scheme 29.  It Is important to note that 
these aldehydes were then immediately used in the synthesis of the oxime to avoid any 
racemisation at the chiral centre as this chirality needs to be retained to the final product.   
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Scheme 29. A suggested mechanism for the interaction of DIBAL and an ester to give an 
aldehyde 
The crude aldehydes (108a/b) were dissolved in the least amount of ethanol and added to 
an aqueous solution containing hydroxylamine hydrochloride and sodium acetate.  This 
method of oxime formation from aldoximes by condensation of the aldehyde with 
hydroxylamine hydrochloride and sodium acetate has been previously used in our labs and 
shown to be reliable80. Immediately it was noted that a white precipitate formed, which had 
to be redissolved with the minimum amount of ethanol.  The solution was heated to 70 0C 
on a heating mantle for 30 minutes, during which time a watchglass was placed over the 
neck of the round bottomed reaction flask to restrict solvent loss, and after this time the 
flask was cooled to room temperature and placed in the refrigerator (2-5 0C) for 18 hours.  
After this time a white precipitate had formed which was removed by filtration and was 
identified as the product oximes, tert-butyl [1-(hydroxyimino)-3-methylbutan-2-
yl]carbamate (109a) and tert-butyl [1-(hydroxyimino)-4-methylpentan-2-yl]carbamate 
(109b), by NMR spectroscopy in d6-DMSO and by mass spectrometric identification of the 
molecular ion.  In some cases it was noted that no precipitate formed and therefore the 
reaction mixture was extracted with ethyl acetate followed by a single wash with a sodium 
bicarbonate solution to remove the remaining acetic acid.  Successive drying and 
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concentration under vacuum led to the desired product, tert-butyl [1-(hydroxyimino)-3-
methylbutan-2-yl]carbamate (109a) and tert-butyl [1-(hydroxyimino)-4-methylpentan-2-
yl]carbamate (109b) with a yield maximum of 86% sometimes as a clear oil or a sticky white 
solid or a dry white powder, all of which were confirmed as the oxime by IR and NMR 
spectroscopy and mass spectrometry of the molecular ion, Scheme 30.  Although this 
reaction is common practice the mechanism has been included for completeness, Scheme 
31. 
 
 
Scheme 30. The conversion of an aldehyde to an oxime 
 
Scheme 31. Mechanism for the conversion of an aldehyde to an oxime 
This provided the oxime in good yields on all small-scale reactions, larger scales were not 
attempted.  The highest yield recorded from both series was 86% and this was achieved 
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when producing 2.2g of product but it is essential to note the yield fluctuated significantly 
when following the exact same reaction procedure with the range of yield achieved being 
15%-86% with all reactions producing between 1g and 4g. 
The oximes could be stored and they were recorded as being stable for at least 4 weeks 
when kept at 2-5 0C under a nitrogen atmosphere.  Usually, however, the oximes were 
reacted in the 1,3-dipolar cycloaddition sequence within 24 hours of their preparation.    
 
2.1.3 – 1,3-Dipolar Cycloaddition Reactions 
Following the original synthesis, this work utilised initial C-chlorination using N-
chlorosuccinimide (NCS) followed by the addition of a base to form the nitrile oxide in situ 
by eliminating the chloro-substituent.  This would then allow the 1,3-dipolar cycloaddition 
to occur upon the addition of the dipolarophile (the enamine tert-butyl (2Z)-3-(pyrrolidin-1-
yl)but-2-enoate, 72). 
The first protocol involved the oximes, tert-butyl [1-(hydroxyimino)-3-methylbutan-2-
yl]carbamate (109a) and tert-butyl [1-(hydroxyimino)-4-methylpentan-2-yl]carbamate 
(109b),  being suspended in chloroform at 0 0C.  To them was added N-chlorosuccinimide 
dropwise over 30 minutes at this constant temperature to ensure a controlled reaction, 
although introducing the NCS in one portion was later found not to affect the results.  This 
mixture was then returned to room temperature and heated to reflux with stirring for a 
further 18 hours.  When quantities of less than 2.0g of the oximes tert-butyl [1-
(hydroxyimino)-3-methylbutan-2-yl]carbamate (109a) and tert-butyl [1-(hydroxyimino)-4-
methylpentan-2-yl]carbamate (109b) were used it was noted that after 18 hours at reflux 
the mixture had turned a blue green, but when using more than 2.0g of oxime 85a and 85b 
the solution became dark orange/brown.  Through thin layer chromatographic (TLC) analysis 
it was found that both different coloured samples were the same chlorinated product.   
These chlorinated oximes were then immediately dehydrochlorinated using triethylamine, 
added directly through the reflux condenser, to form the unstable nitrile oxide intermediate 
110 in situ. To this intermediate was immediately added 2.2 equivalents of the enamine 
tert-butyl 3-(pyrrolidin-1-yl)but-2-enoate (72) in one portion and this reaction mixture was 
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heated at reflux for a further 3 hours, after which time it was added to water and the 
organic layer separated and removed, Scheme 32.  This was followed by multiple washings 
with 1 M citric acid, to remove any excess basic amines, 5 % w/v sodium hydroxide, to 
remove any acid remaining from chloro-elimination, and finally with saturated brine 
solution.  This yielded the organic fraction that, after drying and concentrating under 
reduced pressure, contained the crude product isoxazole as a thick brown oil.  This was then 
subjected to separation via column chromatography eluting with light petroleum and ethyl 
acetate (3:1 v/v) which provided the isoxazoles, tert-butyl 3-[(1-tert-butoxycarbonylamino-
2-methylpropyl)]-5-methylisoxazole-4-carboxylate (111a) and (S)-tert-butyl [(1-chloro-1-
(hydroxyimino)-4-methylpentan-2-yl)]carbamate (111b), as mobile yellow oils in 44% and 
50% maximum yields, respectively.    
 
 
Scheme 32. The formation of the 1,3-dipole in solution and subsequent production of the 
isoxazole 
The dipole formation is presumably initiated by the electrophilic addition of a chlorine atom 
to the carbon adjacent to the oxime nitrogen and simultaneous injection of the oxygen lone 
pair into nitrogen-oxygen bond to give a protonated -chloronitroso intermediate, as 
illustrated in the valine series, 112.  This oxygen charge is then quenched by the elimination 
of a proton and formation of a carbon-nitrogen double bond, producing the C-chlorinated 
oxime (113) (Scheme 33). 
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The suggested mechanism for the production of the isoxazole via the 1,3-dipolar 
cycloaddition is shown in Scheme 33.  Deprotonation of the hydroxyl group of the 
hydroximoyl choride, 113, by triethylamine is accompanied by chloride expulsion to provide 
the reactive intermediate dipole 110, to which is immediately added the dipolarophile 
(enamine 72) to partake in the 1,3-dipolar cycloaddition, the initial product of which is 
presumed to be the isoxazoline 114.  Due to the potential leaving ability of the pyrrolidine 
and driving force to achieve aromaticity, the pyrrolidine is directly eliminated from the ring 
forming the isoxazole 111.  
 
Scheme 33. The proposed mechanism for the 1,3-dipolar cycloaddition 
The yield obtained with this reaction was acceptable, 44% and 50% for the valine and 
leucine based series respectively, at its highest over the two steps.  The main by-product is 
the -ketoester 115a, which it is assumed is formed by the hydrolysis of the excess enamine 
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post-reaction.  This has been observed before and, with optimisation, it had been 
determined that 2.0 equivalents of the enamine relative to the oxime was the most 
effective.75  This issue is complicated by the fact that the -ketoester by-product is very 
difficult to separate from the isoxazole product due to very similar RF values in all solvent 
systems explored.  This led occasionally to inability to isolate the pure isoxazole, therefore a 
study was launched to investigate if this yield could be improved. 
The first adaption made to the original procedure for the attempted synthesis of the 
isoxazole was made on the assumption that extended high temperature (18 hours at 60 oC) 
could be causing decomposition of the chloro-oxime and limiting the yield of the reaction.  
We attempted to avoid this by adding NCS to the oxime tert-butyl [1-(hydroxyimino)-3-
methylbutan-2-yl]carbamate (109a), suspended in chloroform as before, at 0 0C in one 
portion, but then heating at 40 0C for 4 hours.  During this process the reaction solution did 
not change colour as seen before but it was still reacted further with triethylamine and the 
enamine.  This reaction, unfortunately, gave none of the desired product and only starting 
materials were collected, showing these milder conditions did not lead to a successful 
chlorination, Scheme 34. 
 
 
Scheme 34. An attempted alternative isoxazole synthesis 
Our next investigation was to isolate the chloro-oxime to determine the yields for each 
individual step.  The chlorinated products that we were able to isolate were the (S)-tert-
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butyl [1-chloro-1-(hydroxyimino)-3-methylbutan-2-yl]carbamate from the (S)-valine series 
and (S)-tert-butyl [1-chloro-1-(hydroxyimino)-4-methylpentan-2-yl]carbamate, which is from 
the (S)-leucine series.  After following the protocol as before, addition of NCS at 00C and 
heating at reflux for 18 hours, the work up included washing the cooled solution with water 
and saturated brine, to remove excess NCS, before drying the organic layers with MgSO4, 
filtration and concentration under reduced pressure to yield the chlorinated oxime as an 
orange oil in a good 75% and 82% yield, respectively.  This was surprising as it had been 
assumed that this simple step was yielding close to a quantitative yield, but did provide an 
anticipation that the subsequent 1,3-dipolar cycloaddition reaction was higher yielding than 
previously assumed. 
The cycloaddition reaction was completed by directly following the procedure described 
before, with the chloro-oxime being suspended in chloroform and heated at reflux before 
the addition of the triethylamine and dipolarophile enamine.  This cycloaddition reaction, 
following work up and purification by column chromatography, yielded the isoxazole in 60% 
yield from the chloro-oxime, which agrees with the average 44% overall achieved in the ‘one 
pot’ methodology.  This developed reaction scheme is shown in Scheme 35. 
 
Scheme 35. Isolation of chloro-oxime followed by isoxazole synthesis 
Searching for new methods for a 1,3-dipolar cycloaddition reaction yielded a procedure 
utilising microwave radiation as a source of energy for the reaction.  It was shown by Touaux 
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et al. in 1998 that aldoximes reacted in a one-pot reaction with NCS and alkenes to form 
isoxazoles under microwave radiation in yields of up to 75% over both stages.81  Therefore, 
the conditions attempted following these new protocols were to absorb (S)-tert-butyl [1-
(hydroxyimino)-3-methylbutan-2-yl]carbamate (2.5 mmol), tert-butyl 3-(pyrrolidin-1-yl)but-
2-enoate (5.0 mmol), and NCS (2.5 mmol) on Al2O3 (5 g).  These reactants were sealed in a 
closed Teflon tube and irradiated to 30 W for 4 minutes in a microwave (Biotage Eight).  This 
reaction was unsuccessful and, after work up by extraction with CH2Cl2, drying with MgSO4, 
filtration and concentration under a reduced pressure, no isoxazole product was identified 
with only starting materials being recovered. 
The final variation to be explored was the solvent in which the cycloaddition reaction is 
performed, which can be polar, non-polar or a median between the two. Isolation of the 
chloro-oxime provided this opportunity as due to insolubility of the oxime, only CHCl3 was 
used for the chlorination, whereas the chloro-oxime was soluble in a range of solvents.  
The solvents attempted in the study were ethanol, 2-propanol, toluene and chloroform as a 
standard to compare the results of the reaction.  The specific reaction studied was (S)-tert-
butyl [1-chloro-1-(hydroxyimino)-3-methylbutan-2-yl]carbamate (2.0 mmol) with tert-butyl 
3-(pyrrolidin-1-yl)but-2-enoate (4.0 mmol) and triethylamine (2.2 mmol), which was 
repeated four times identically, following the initial protocol above (Scheme 36).  The 
relative solvent polarities are shown in Table 3 below as well as the yields achieved which 
were calculated after separate work-ups and isolation of the pure isoxazole by preparative 
TLC, confirmed by comparison with previously synthesised samples. 
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a) EtOH, iPrOH, PhMe, CHCl3 
Scheme 36. Reaction of the chloro-oxime in the isoxazole synthesis 
Table 3.  Table showing the results and relative polarities82 of solvent used  
Solvent  Polarity*82  Yield 
Ethanol 0.654 41% 
2-Propanol 0.546 36% 
Chloroform 0.259 54% 
Toluene 0.099 9% 
*The values for relative polarity are normalized from measurements of solvent shifts of 
absorption spectra 
The results showed that the reaction completed in CHCl3 achieved the highest yield after 
isolation and therefore it was deduced that this is after all the best solvent to use under 
these reaction conditions. 
The next stage was to form the bicyclic pyrroloisoxazole, which was intended to be achieved 
by the deprotection of the isoxazoles and subsequent ring closure by a peptide coupling 
reaction forming the lactam ring. 
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2.1.4 – Formation of the Masked Acyltetramic acid, a Pyrroloisoxazole   
In the formation of the pyrroloisoxazole moiety, there needs to first be a removal of the 
tert-butyloxycarbonyl (Boc) protection group on the amine as well as cleavage of the tert-
butyl ester group to give an acid.  This free acid and amine could then be reacted in a 
peptide-like coupling reaction. 
Careful selection of the protecting groups used, meant that both protecting groups could be 
removed in a single step using an acid-mediated cleavage (and decarboxylation in the Boc 
removal).  The chosen acid, trifluoroacetic acid (TFA), successfully cleaved the groups but 
left them extremely sensitive to moisture due to the trifluoroacetate salts formed.  This was 
overcome by concentration of the salt under reduced pressure to remove any excess TFA 
and subsequent addition of hydrochloric acid producing the hydrochloride salt, which is less 
moisture sensitive and therefore allows for storage, Scheme 37.  This protocol was found to 
give better results than direct hydrochloric acid cleavage. 
 
 
Scheme 37. Deprotection of the isoxazole with acid 
TFA was added to the isoxazoles (111a and 111b) and stirred at room temperature for 4.5 
hours; note that 30 equivalents were used to ensure the TFA in large excess, to guarantee a 
successful deprotection.  Excess TFA was then removed under reduced pressure and 2M 
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hydrochloric acid added, followed by 30 minutes stirring and successive washings with ethyl 
acetate where the aqueous layer was retained, because the product was a salt and 
therefore water soluble.  This was then evaporated under reduced pressure and any 
remaining water was removed under a high vacuum, yielding 1-(4-carboxy-5-methyl-1,2-
oxazol-3-yl)-2-methylpropan-1-aminium hydrochloride (118a) and 1-(4-carboxy-5-methyl-
1,2-oxazol-3-yl)-3-methylbutan-1-aminium hydrochloride (118b) as dark brown sticky oils in 
quantitative yields.  The product was identified by 1H NMR spectroscopy, with loss of two 
tert-butyl groups, and mass spectrometric identification of molecular ion.  The deprotected 
isoxazole amine hydrochloride salts were ready for the peptide coupling reaction.  
Peptide coupling reactions are a method of efficiently combining an acid and an amine to 
form a new amide bond and are immensely useful to synthetic organic chemists and thus 
have been the subject of a number of reviews and much interest83.  There are a large 
number of potential coupling agents available, each with their own applications, advantages 
and disadvantages, and include compounds possessing carbodiimides, phosphonium and 
imidazolium salt functionalities.  The most commonly used peptide coupling reagents are 
carbodiimides, as they are readily available and easily handled, but disadvantages include 
the potential for side reactions to occur including the formation of N-acylureas which are 
notoriously difficult to remove from the product.  This issue has been shown to be 
overcome by adding an activator which promotes a successful reaction.  A selection of the 
commercially available coupling reagents and activators is provided in Figure 19. 
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Figure 19. Common peptide coupling reagents and activators 
 
The most popular of the carbodiimides used in peptide bond synthesis is 1,3-
dicyclohexylcarbodiimide (DCC, 119), first used in 195584, making it the obvious choice.  
However, disadvantages associated with DCC include the fact that the by-product of peptide 
coupling reactions (dicyclohexylurea) is hard to separate from the reaction mixture which 
causes problems in obtaining pure material.  
Therefore, it was decided to use another, less common, peptide coupling reagent, 
polystyrene-bound carbodiimide (PS-CDI, 124) which possesses the DCC functionality whilst 
being permanently bound to a polystyrene bead.  Although less frequently used, possibly 
due to the high price (approx. £60 per gram), this carbodiimide source has excellent 
119 
DCC84 
1,3-dicyclohexylcarbodiimide 
 
120 
HOSu 
Hydroxysuccinimide 
122 
HOBt 
1-hydroxybenzotriazole 
121 
CDI 
Carbonyldiimidazole 
123 
EDCI 
1-ethyl-3-(3’-dimethylaminopropyl)carbodiimide hydrochloride 
 
124 
PS-CDI 
Polystyrene-carbodiimide 
New Routes to Acyltetramic Acids and Analogues – James Bullous 
 
63 
potential as the urea by-product remains bound to the polystyrene after the reaction has 
occurred and therefore is very easily removed by filtration.  Polystyrene-bound 
carbodiimide was also shown to be effective by an earlier group member75. 
In this reaction it was necessary to ensure all glassware was thoroughly dry and this was 
confirmed by heating glassware in an oven overnight and cooling under a nitrogen flow 
before the reaction and also by leaving reactants in a sealed desiccator containing 
phosphorus pentoxide.   
The deprotected isoxazoles, 1-(4-carboxy-5-methyl-1,2-oxazol-3-yl)-2-methylpropan-1-
aminium hydrochloride (118a) and 1-(4-carboxy-5-methyl-1,2-oxazol-3-yl)-3-methylbutan-1-
aminium hydrochloride (118b), were suspended in a mixture of dry dichloromethane (DCM) 
and dry N,N-dimethylformamide (DMF) (9:1 v/v).  To this solution was charged 
triethylamine, required to remove the extra proton at the ammonium group and allow it to 
undergo the peptide coupling reaction upon the subsequent addition of the polystyrene-
bound carbodiimide (124).  After all reactants were added, the reaction was stirred at room 
temperature for between 17 and 48 hours, although no difference was observed in the yield 
over longer reaction times, before removing the polystyrene-bound by-products by 
filtration.  The filtrate was washed with saturated potassium carbonate solution, to remove 
the triethylamine hydrochloride, and also with saturated brine.  The crude amide product 
was confirmed by 1H NMR spectroscopy, seen by the removal of an amine proton and the 
acidic proton,  and was separated from the impurities and unreacted starting materials by 
flash column chromatography eluting with ethyl acetate and light petroleum (5:1 v/v).  This 
process yielded 3-methyl-6-(propan-2-yl)-5,6-dihydro-4H-pyrrolo[3,4-c][1,2]oxazol-4-one 
(125a) and 3-methyl-6-(2-methylpropan1-yl)-5,6-dihydro-4H-pyrrolo[3,4-c][1,2]oxazol-4-one 
(125b), both confirmed by IR, 1H and 13C NMR spectroscopic, and mass spectrometric  
identification of the molecular ion, as white solids in a range of yields, 30-59%, Scheme 38. 
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Scheme 38. The formation of a pyrroloisoxazole from a deprotected isoxazole using PS-CDI 
To add to the array of evidence spectroscopic methods, it was decided to define the 
structure completely with X–ray crystallography, which confirmed the correct structure for 
the valine-derived pyrroloisoxazole (125a), Figure 20. 
 
Figure 20. X-ray structure of 3-methyl-6-(propan-2-yl)-5,6-dihydro-4H-pyrrolo[3,4-
c][1,2]oxazol-4-one (125a) 
Due to some moderate yields achieved (between 30% and 59%) it was decided that another 
method would be attempted in parallel to deduce if it was more advantageous.  The other 
selected method involved the use of 1-ethyl-3-(3’-dimethylaminopropyl)carbodiimide 
hydrochloride (EDCI, 123) in the presence of a hydroxysuccinimide (HOSu, 120) activator.  
The main advantage of EDCI is that the urea products remain water soluble while the 
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product is kept in the organic layer, allowing for an easy separation. A suggested mechanism 
for the carbodiimide reaction is shown in Scheme 39. 
 
Scheme 39. Mechanism for the reaction of the isoxazole with a general carbodiimide 
giving the pyrroloisoxazole 
In this reaction the glassware was dried as before and the reactants also left to dry in a 
desiccator.  EDCI (98) was added to the suspension of deprotected isoxazoles and HOSu 
(120) in DMF dropwise over 30 minutes at 0 0C and the mixture was then stirred at room 
temperature for a further 17 hours before the addition of triethylamine, followed by 17 
hours of stirring at room temperature, Scheme 40.  After an acidic work-up, drying and 
evaporation under reduced pressure, the beige solid was subjected to separation via flash 
column chromatography eluting with an ethyl acetate and light petroleum (5:1 v/v).  This 
yielded the product pyrroloisoxazoles 3-methyl-6-(propan-2-yl)-5,6-dihydro-4H-pyrrolo[3,4-
118a 
125a 
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c][1,2]oxazol-4-one (125a) and 3-methyl-6-(2-methylpropan-1-yl)-5,6-dihydro-4H-
pyrrolo[3,4-c][1,2]oxazol-4-one (125b), as a white solids in a maximum 40% yield. 
 
Scheme 40. The formation of a pyrroloisoxazole from a deprotected isoxazole using 
EDCI/HOSu 
The yields achieved were less than hoped for and as this was stage 7; the amount of 
material was limited with a maximum of 600mg being produced in this step. 
The yields routinely achieved ranged from moderate to good but it was felt these could be 
improved upon.  When cost of starting materials is considered, the higher yielding PS-CDI 
reaction was deemed less practical.  This left the 40% yielding EDCI reaction as the choice 
reaction, for which the yield was undesirable this late in the synthesis.  This issue was 
resolved by the discovery of a new peptide coupling and water scavenging reagent, 
propylphosphonic anhydride, marketed as T3P by Archimica in Germany85, Figure 21  
 
Figure 21. Propylphosphonic anhydride or T3P 
Not only did using T3P provide the products in a shorter reaction time but also as pure white 
solids with no requirement for any further purification.  Figure 22 and Figure 23 show NMR 
spectra for the S-valine and S-leucine pyrroloisoxazoles after washings and removal of 
solvent provided them in 59% and 68% yields, respectively, Scheme 41.  This was the highest 
yield achieved for this reaction, showing a successful development of the methodology. 
118 125 
 
a b 
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Figure 22. NMR of S-valine pyrroloisoxazole (125a) straight after washings and reduction 
of excess solvent 
 
 
 
Figure 23. NMR spectrum of crude S-leucine pyrroloisoxazole (125b) (straight after 
washings and removal of excess solvent) 
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Scheme 41. The formation of a pyrroloisoxazole from a deprotected isoxazole using T3P 
A mechanism for this reaction has been suggested below, Scheme 42, and involves the 
opening of the phosphonic heterocycle by a nucleophilic attack of the carboxylate oxygen 
on a phosphorus atom due to its partial positive charge and the affinity of oxygen for 
phosphorus.  This then allows the nitrogen to attack the acid and provide the phosphorus-
containing by-product as a dianion, soluble in the aqueous layer. 
 
Scheme 42. Peptide coupling mechanism using T3P 
118 125 
 
a b 
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125 
126 
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This method using T3P provided the S-valine and S-leucine pyrroloisoxazole; from the latter 
a crystal was grown suitable for X-ray crystallography which provided the structure seen in 
Figure 24. 
 
Figure 24. X-ray structure of S-leucine pyrroloisoxazole (125b) 
Now the pyrroloisoxazoles had been successfully produced, elaborations on the methyl 
group could be undertaken, trialled on the L-valine series only, as well as other interesting 
extensions.  For example, both pyrroloisoxazoles were used in the synthesis of reutericyclin 
and analogues, which will be discussed later. 
The ability of these pyrroloisoxazole units to undergo hydrogenation and hydrolysis to form 
the 3-acyltetramic acids has previously been shown by the group so it was deemed 
unnecessary to repeat and discard valuable material.75,57 
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2.2 - Elaboration at C-3 Position of the L-Valine Pyrroloisoxazole 
2.2.1 – Aldol Reaction at C-3 Position of the L-Valine Pyrroloisoxazole  
This stage was key to one of the initial aims of the project and involved an anion 
condensation on to an aldehyde to provide a new carbon-carbon bond and allowing chain 
extension.  This can typically be done by an aldol-type reaction, using the C-3 position 
methyl group via its anion, which is accessed via basic conditions and subsequent addition 
to an aldehyde, followed by acidification to yield the alcohol adduct, Scheme 43.   
 
Scheme 43. A general mechanism for an aldol-type reaction under basic conditions 
It has also been previously demonstrated, both by our group and very recently by Wells et 
al., that the C-3 methyl position can be selectively deprotonated with lithium 
diisopropylamide (LDA) or n-butyllithium (n-BuLi), and subsequently added to an aldehyde 
to allow a chain extension using non-enolisable aldehydes in low yields (typically up to 
30%).79,75,86  The basic condition selected was deprotonation via nBuLi based on previous 
work finding this to be more effective than LDA.  It should be noticed that the acidic proton 
that was removed was the second most acidic, with the most acidic being on the lactam 
nitrogen.  This meant a minimum of 2.2 equivalents of base was required, which was 
modified to 3.2 equivalents and even 5 equivalents in some cases providing the best yields, 
Scheme 44.  Although it is thought the first deprotonation will occur at the amide, it is 
assumed that the product from this attack is reversible under the acidic conditions of work 
up. 
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Scheme 44. Some possible resonance structures for the pyrroloisoxazole dianion 
The first attempt made on the chain extension was the addition of pentanal.  n-Butyllithium 
was added dropwise to a solution of the pyrroloisoxazole 3-methyl-6-(propan-2-yl)-5,6-
dihydro-4H-pyrrolo[3,4-c][1,2]oxazol-4-one (125a) suspended in anhydrous tetrahydrofuran 
(THF) at -78 0C and kept under a nitrogen atmosphere to allow a controlled and selective 
deprotonation.  The reaction mixture was stirred at this temperature for 2 hours, after 
which a large excess of freshly distilled (bp 103 0C) pentanal was added in one portion, 
typically 1 mL.  After a further 2 hours of stirring the reaction mixture was quenched by the 
addition of water and acidified with hydrochloric acid, Scheme 45.  The reaction mixture 
was then concentrated under vacuum and the resulting yellow oil was suspended in water 
and ethyl acetate.  The aqueous phase was extracted by using ethyl acetate which was dried 
under vacuum to yield a yellow solid.  This material was then purified using flash column 
chromatography eluting with ethyl acetate and light petroleum (5:1 v/v) to yield the product 
3-(2-hydroxyhexyl)-6-(propan-2-yl)-5,6-dihydro-4H-pyrrolo[3,4-c][1,2]oxazol-4-one (127) as 
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a white solid (≤1 mg, 6 %). The product was confirmed only by 1H NMR spectroscopy with 
the disappearance of the methyl group at 2.5-2.6 ppm, 13C NMR spectroscopy and 
identification of the molecular ion by mass spectrometry due to a lack of available sample. 
 
Scheme 45. Aldol addition of pentanal to pyrroloisoxazole 
This yield was poor when compared with the non-enolisable aldehydes and surprising 
considering the aldol reaction is well established and typically high yielding87.  This low yield 
required analysis to identify the issue, which will be discussed later.  The equivalence of 
base used in the attempt was 3.2, which was established by previous research showing it to 
be the most productive.75 
It was also identified that there would be diastereomers formed because of the introduction 
of a new chiral centre at the hydroxyl group carbon.  This stereochemistry was not 
investigated since this chirality was intended to be immediately removed in the next stage 
via dehydration.  It can be suggested that a roughly equal mixture of diastereomers would 
be obtained as the existing chiral centre is too remote to have any significant effect. 
The next attempted chain extension was to add decanal, which was chosen as an alternative 
saturated analogue due to its longer chain length.  The boiling point of this aldehyde was 
considerably higher than pentanal (207-209 0C88) and therefore required another form of 
purification.  The aldehyde was suspended in diethyl ether and the solution washed several 
times with saturated potassium carbonate solution to remove any acidic impurities.  The 
organic fraction was then dried and concentrated under a reduced pressure to achieve the 
pure aldehyde, confirmed by a clean NMR spectrum with the expected signals.   
In this preparation, 3.2 equivalents of nBuLi was added dropwise to a solution of the 
pyrroloisoxazole 3-methyl-6-(propan-2-yl)-5,6-dihydro-4H-pyrrolo[3,4-c][1,2]oxazol-4-one 
(125a)  in THF at -78 0C, under a nitrogen atmosphere.  The solution was stirred at this 
125a 127 
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temperature for 2 hours, after which the excess purified decanal was added in one portion 
and stirring continued for at -78 0C for 2 hours.  The reaction solution was then quenched by 
the addition of water and acidified with hydrochloric acid.  The reaction mixture was 
concentrated under vacuum and the resulting yellow oil was partitioned between water and 
ethyl acetate.  The aqueous phase was then extracted using ethyl acetate, which was dried 
and concentrated under vacuum to yield a crude yellow solid (900 mg, >100%).  This was 
purified by flash chromatography eluting with ethyl acetate and light petroleum (5:1 v/v) to 
yield a mixture of products, which was chromatographed again under the same conditions 
to give the desired product 3-(2-hydroxyundecyl)-6-(propan-2-yl)-5,6-dihydro-4H-
pyrrolo[3,4-c][1,2]oxazol-4-one (128) as a white solid (27 mg, 28 %), Scheme 46.  The 
product was confirmed only by 1H NMR spectroscopy with the disappearance of the methyl 
group at 2.5-2.6 ppm and identification of the molecular ion by mass spectrometry. 
 
Scheme 46. Aldol addition of decanal to pyrroloisoxazole 
This yield of 28% was more promising, but it is notable that this reaction was attempted 
more than 15 times and only yielded the desired compound once.  This unreliability and 
recurring low yields led to the conclusion that the anion formation is not as dependable as 
first assumed. 
The next aldehyde reaction was to add an -substituted aldehyde, the simplest being 2-
methylpropanal.  This aldehyde was also purified by washing with saturated potassium 
carbonate solution to remove any acid by-product that could interfere with the reaction 
conditions.  These precautions for purifying the reactants were taken even in cases where 
the commercial aldehyde was supplied freshly and were all confirmed by a clean 1H NMR 
spectrum. 
In the addition of 2-methylpropanal, nBuLi was added dropwise to a solution of the 
125a 128 
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pyrroloisoxazole 3-methyl-6-(propan-2-yl)-5,6-dihydro-4H-pyrrolo[3,4-c][1,2]oxazol-4-one 
(125a) in THF at -78 0C under a nitrogen atmosphere.  The solution was stirred at this 
temperature for 2 hours, after such time the purified 2-methylpropanal was added in one 
portion and stirring continued for at -78 0C for a further 2 hours.  The reaction was 
quenched as before, the mixture evaporated under a reduced pressure and suspended in 
water and ethyl acetate.  Extraction with ethyl acetate and washings as before yielded crude 
yellow oil (845 mg, >100%), which was purified by flash chromatography eluting with ethyl 
acetate and light petroleum (5:1 v/v) to yield 3-(2-hydroxy-3-methylbutyl)-6-(propan-2-yl)-
5,6-dihydro-4H-pyrrolo[3,4-c][1,2]oxazol-4-one (129) as a light yellow oil (30 mg, 32%), 
Scheme 47.  The product was again confirmed only by 1H NMR spectroscopy with the 
disappearance of the methyl group at 2.5-2.6 ppm and identification of the molecular ion by 
mass spectrometry. 
  
Scheme 47. Aldol addition of 2-methylpropanal to pyrroloisoxazole 
The yield of 32% was the highest observed yield to date of this type of reaction in the group 
and provided promise, but this reaction was, also, only successful once in multiple attempts. 
Progressing through our library of aldehydes the next to be tried was 
cyclohexanecarboxylaldehyde, another -disubstituted aldehyde, also containing a ring. 
Again, due to a high boiling point, this aldehyde was purified by washing with saturated 
potassium carbonate solution. 
The reaction was completed as seen before and was shown to yield the crude 3-(2-
cyclohexyl-2-hydroxyethyl)-6-(propan-2-yl)-5,6-dihydro-4H-pyrrolo[3,4-c][1,2]oxazol-4-one 
(130) as a yellow oil (800 mg, >100%),%), which was purified by flash chromatography 
eluting with ethyl acetate and light petroleum (5:1 v/v) to yield 3-(2-cyclohexyl-2-
hydroxyethyl)-6-(propan-2-yl)-5,6-dihydro-4H-pyrrolo[3,4-c][1,2]oxazol-4-one (130)  as a 
125a 129 
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light yellow oil (45 mg, 28%), Scheme 48.  Products were confirmed only by 1H NMR 
spectroscopy, with the disappearance of the methyl group at 2.5-2.6 ppm, and identification 
of the molecular ion by mass spectrometry. 
 
Scheme 48. Aldol addition of cyclohexanecarboxaldehyde to pyrroloisoxazole 
This yield of 28% was another successful result, but unfortunately this result could not be 
reproduced under similar conditions in several attempts. 
The last aldehyde analogue utilised in this stage of the project was unsaturated at the 2,3-
position, namely but-2-enal, Scheme 49.  This was chosen as there may be the need to add 
unsaturated chain extensions en route to naturally occurring 3-acyltetramic acids in the 
future, and also for completeness of the study. Again, this aldehyde was purified by 
washings which saturated potassium carbonate solution. 
The reaction was completed as above and was shown to yield the crude 3-[(3E)-2-
hydroxypent-3-en-1-yl]-6-(propan-2-yl)-5,6-dihydro-4H-pyrrolo[3,4-c][1,2]oxazol-4-one 
(131) as a yellow oil (500 mg, >100%).  This was purified by flash chromatography eluting 
with ethyl acetate and light petroleum (5:1 v/v) to yield 3-[(3E)-2-hydroxypent-3-en-1-yl]-6-
(propan-2-yl)-5,6-dihydro-4H-pyrrolo[3,4-c][1,2]oxazol-4-one (131)  as a light yellow oil (10 
mg, 30%).  This compound was confirmed by 1H NMR spectroscopy, with the disappearance 
of the methyl group at 2.5-2.6 ppm, 13C NMR spectroscopy, identification of the molecular 
ion by mass spectrometry and IR analysis.  The full analysis was able to be acquired on this 
molecule when the reaction was reproduced a further one time.  This was a breakthrough in 
that this specific aldol addition was reproduced, although it was only twice in over 15 
attempts. A 30% yield was a relatively good yield for this reaction based on previous 
attempts. 
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Scheme 49. Aldol addition of crotonaldehyde to pyrroloisoxazole 
These five aldehydes were all successfully added to the C-3 methyl group at least once and 
the adduct structures were suggested by mass spectrometry, IR analysis in one case and 
NMR analysis.  These aldol adduct pyrroloisoxazoles were then required to undergo a 
condensation elimination of the hydroxyl group to form the double carbon-carbon bond in 
the product. 
These studies and further investigations seen later in this thesis have however shown that 
the anion formation is unreliable and its ability to reproducibly attack any appropriate 
carbonyl moiety is questionable.  This issue will be discussed in further detail later. 
 
2.2.2 – Extended Pyrroloisoxazole Dehydration 
A dehydration step was required to show the enolisable aldehyde addition product was able 
to be converted into an unsaturated compound.  This was desirable as many 3-acyltetramic 
acid natural products exhibit this unsaturated functionality at the C-3 acyl substituent.   
The dehydration appears simple and involves using an organic soluble acid, such as p-
toluenesulfonic acid (PTSA) in toluene, to protonate the hydroxyl group and make a good 
leaving group.  The potential conjugation in the system will then drive elimination of water 
forming a new carbon-carbon double bond.  Due to the possible reverse reaction, the water 
produced must be removed via a Dean-Stark apparatus set-up. All of the attempted 
dehydrations of alcohols 127-131 failed to afford any isolated alkene products, Scheme 50.   
125a 131 
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Scheme 50. General synthetic attempts at dehydrating the aldol adducts 
It was unknown why they should fail based on successful, high yielding, reactions being 
performed on the non-enolisable aldehyde derivatives in the past.  Possible explanations 
include the fact the reactions were attempted on small scale, around 20mg-30mg, which 
could have led to detection errors.  Also, a separation was required and although crude 
NMR spectra were obtained, separations were not completed successfully as RF values were 
too similar and the products contained too many impurities.  It is also thought that a 
condensation under acidic conditions could be destructive to the molecule, so therefore 
further work on this reaction would be needed to investigate the substitution of other 
leaving groups (such as mesylates) into this position. 
An attempt was made to produce the aldol adducts as acetyl adducts by quenching with 
freshly distilled acetyl chloride.  Due to the unreliability of the aldol reaction, this did not 
prove possible and therefore it was not determined if this leaving group would have 
eliminated to yield the unsaturated target. 
 
 
 
127 – R1 –CH2CH2CH2CH3 
128 – R1 –CH2(CH2)7CH3  
129 – R1 –CH2[CH3]2 
130 – R1 –C6H11 
131 – R1 –CHCHCH3 
 
132 – R2 –CH2CH2CH2CH3 
133 – R2 –CH2(CH2)7CH3  
134 – R2 –CH2[CH3]2 
135 – R2 –C6H11 
136 – R2 –CHCHCH3 
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2.3 – Reutericyclin and Analogue Synthesis from a Variety of 
Pyrroloisoxazoles, Elaboration via N-Acylation and Alkylation.  
2.3.1 – N-Acylation Reactions of Pyrroloisoxazoles 
As previously discussed, reutericyclin and analogues have been shown to have potent 
biological activity against Gram-positive bacteria, such as hospital superbug C. difficile, so it 
was decided to synthesise a library of structurally similar compounds, all with different N-
substitutions.  N-Acylpyrroloisoxazoles could be regarded as masked reutericyclin 
analogues. 
Once a method had been investigated for the aldol reactions at the C-3 methyl group of our 
pyrroloisoxazoles, our attention was diverted to the potential of N-acyl and -alkyl 
derivatisation.  As we recognised from the aldol studies, n-butyllithium was a sufficiently 
strong base to remove the amide proton and so was chosen as the base in these acylation 
reactions.  The concept was an N-acylation reaction coupling an amide anion and an ester 
(as esters are cheap and easy to store), but preliminary results showed the ester was not 
reactive enough to undergo the acylation, only yielding quantitative amounts of the starting 
materials indicating no reaction occurred.  The valine-derived pyrroloisoxazole (125a) was 
suspended in dry THF and cooled to -780C before adding ethyl butyrate followed by stirring 
the reaction mixture for 1 hour at this temperature.  This solution was quenched with 
saturated ammonium chloride solution to pH 7, extracted with ethyl acetate, dried over 
magnesium sulfate and filtered.  The filtrate was evaporated under reduced pressure and 
only starting material was identified using 1H NMR spectroscopy. 
 
 
Scheme 51. Attempted N-acylation using an ester, ethyl butyrate 
125a 137a 
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The next attempts were made using a selection of acyl chlorides to provide variety in the 
library of compounds produced.  This diversity was also accomplished by using both of the 
pyrroloisoxazoles synthesised, the leucine- and valine-derived pyrroloisoxazoles, and also 
one prepared by another member of the group from phenylglycine.75  
We opted to work with pyrroloisoxazoles derived from the (S)-amino acids, although this is 
enantiomeric to reutericyclin, based on availability and cost.  We reasoned that our studies 
would be transferable to the other enantiomeric series.  
The prototype reaction was completed using the valine-based pyrroloisoxazole (125a) with 
readily available butanoyl chloride.  This reaction was undertaken following a developed 
procedure using standard acylation conditions and a base validated in the aldol reactions, 
but is similar to the methodology reported by Schobert et al. in 200635.  The valine-derived 
pyrroloisoxazole was suspended in dry THF and cooled to -78 oC before the addition of 1.1 
equiv of n-butyllithium to deprotonate the amide.  This was allowed to stir at -78oC for 10 
minutes, to form the anion, followed by the addition of 1.1 equiv of butyrl chloride, after 
which the reaction was left to stir for a further 2 hours at -78 oC and subsequently quenched 
with saturated ammonium chloride solution.  The aqueous layer was extracted with ethyl 
acetate and the organic fraction dried over magnesium sulfate before being concentrated 
under a reduced pressure to yield pure (S)-5-butyryl-6-(propan-2-yl)-3-methyl-5,6-dihydro-
4H-pyrrolo[3,4-c]isoxazol-4-one (137a) in 89% yield (Scheme 52).   
 
Scheme 52. N-Acylation of valine pyrroloisoxazole using butyryl chloride  
The next example attempted was to couple the leucine-derived pyrroloisoxazole (125b) with 
a sterically bulky acyl chloride, benzoyl chloride.  In this reaction the leucine-derived 
pyrroloisoxazole was suspended in dry THF and cooled to -78oC before the addition of 1.1 
equiv of n-butyl-lithium to deprotonate the amide, as seen above.  This was allowed to stir 
at -78oC for 10 minutes, to form the anion, followed by the addition of 1.1 equiv of benzoyl 
125a 137a 
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chloride, after which the reaction was left to stir for a further 2 hours at -78oC and 
subsequently quenched with saturated ammonium chloride solution.  The aqueous layer 
was extracted with ethyl acetate and the organic fraction dried over magnesium sulfate 
before being concentrated under a reduced pressure to yield crude (S)-5-benzoyl-6-(2-
methylpropyl)-3-methyl-5,6-dihydro-4H-pyrrolo[3,4-c]isoxazol-4-one (137b), which was 
could not be isolated pure in a quantifiable yield after prep-TLC.  This lead to an increase in 
reaction time from 2 hours to 3 hours and, when the reaction was completed under these 
new time conditions pure benzoyl N-substituted product (137b) was isolated after 
purification by prep-TLC eluting with light petroleum:ethyl acetate (3:1 v/v) in a yield of 
43%, Scheme 53.  
 
Scheme 53. N-Acylation of leucine pyrroloisoxazole using benzoyl chloride  
Another illustration of this chemistry was using the phenylglycine-derived pyrroloisoxazole 
(125c) to couple to a conjugated acyl chloride, 2-butenoyl chloride, which was produced by 
an earlier student75 and used in this synthesis after 1H NMR confirmation.  In this reaction 
the phenylglycine-derived pyrroloisoxazole was suspended in dry THF and cooled to -78 oC 
before the addition of 1.1 equiv of n-butyllithium to deprotonate the amide, as seen above.  
This was allowed to stir at -78 oC for 10 minutes, to form the anion, followed by the addition 
of 1.1 equiv of benzoyl chloride, after which the reaction was left to stir for a further 3 hours 
at -78 oC and subsequently quenched with saturated ammonium chloride solution.  The 
aqueous layer was extracted with ethyl acetate and the organic fraction dried over 
magnesium sulfate before being concentrated under a reduced pressure to yield crude (S,E)-
5-(but-2-enoyl)-6-(propan-2-yl)-3-methyl-5,6-dihydro-4H-pyrrolo[3,4-c]isoxazol-4-one 
(138c), which could be isolated pure in a 50 % yield after prep-TLC, Scheme 54.  
125b 138b 
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Scheme 54. N-Acylation of phenylglycine pyrroloisoxazole using crotonyl chloride  
Based on the success of these reactions, it was decided to create a collection of compounds 
that would all be ‘masked’ analogues of reutericyclin, all with potential for biological 
activity.  
The library of compounds that was devised had to show structural diversity and this was 
accomplished by using a selection of acyl chlorides including long and short aliphatic chains, 
an unsaturated substituent, a bulky sterically hindered group and an aromatic moiety.  This 
was achieved by successfully coupling 2-butanoyl chloride, decanoyl chloride, 2-butenyl 
chloride, trimethylacetyl chloride and benzoyl chloride.  The diversity, as previously 
mentioned, was also built upon by not only using one example of a pyrroloisoxazole but 
three (Scheme 55), all accomplished in yields of 33% to 97% producing 12 novel compounds.  
A full illustration of the compounds synthesised in this research is shown in Table 4 and 
Scheme 58 with individual yields.   
 
 
 
 
Scheme 55. N-Acylation reactions summary  
 
a – R1 –(CH3)2CH,  
b – R1 – (CH3)2CHCH2 
c – R1 – CH(C6H5) 
137 – R2– C3H7          139 – R2– CHCHCH3 
140 – R2– C9H17        141 – R2– C(CH3)3 
138 – R2– C6H5 
 
125c 139c 
New Routes to Acyltetramic Acids and Analogues – James Bullous 
 
82 
There were some important alternations made to the synthesis protocol when using 
different acyl chlorides, with the initial alteration required being a purification step.  But-2-
enoyl chloride was able to be removed by evaporation under a reduced pressure, as was 
crotonyl chloride, but the other three acyl chloride starting materials required removal via 
preparative thin layer chromatography (Prep-TLC) eluting with light petroleum:ethyl acetate 
(3:1 v/v).  It was deduced that the increase in residual starting material, as these reactions 
were lower yielding, meant they were unable to be removed completely simply under a 
reduced pressure.  This led to the adoption of an increased reaction time from the initial 2 
hours to an improved 3 hours, which ultimately increased yields of all the acylations, 
especially the more sterically bulky examples.  Even after this extended reaction time, prep-
TLC was required to provide the pure N-acyl products.  
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Table 4.  Library of N-acyl masked reutericyclin analogues (with respective yields) 
   
   
  
 
   
 
Confirmation of all the products was obtained by accurate mass spectrometric identification 
of the molecular ion, infra-red analysis, 13C and 1H NMR spectroscopy.  The latter often 
showed a characteristic splitting in the protons alpha to the carbonyl group on the added 
substituent as well as disappearance of the amide proton on the pyrroloisoxazole.  In 
addition, a crystal was able to be produced suitable for X-ray crystallography from the valine 
based pyrroloisoxazole and crotonyl chloride, with the product characterised as (S,E)-5-(but-
2-enoyl)-6-isopropyl-3-methyl-5,6-dihydro-4H-pyrrolo[3,4-c]isoxazol-4-one (139a, Figure 
25).  This structure also confirmed that the N-acylation had occurred rather than the 
possible lactam O-acylation. 
137a 140a 139a 
141a 138a 137b 
140b 139b 141b 
138b 137c 138c 
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Figure 25. X-ray structure of (S,E)-5-(But-2-enoyl)-6-isopropyl-3-methyl-5,6-dihydro-4H-
pyrrolo[3,4-c]isoxazol-4-one (139a) 
In an attempt to add the N-acyl substituent found in reutericyclin, we tried to prepare the 
appropriate acyl chloride, (E)-dec-2-enoyl chloride (142), was produced from the 
commercially available ethyl ester, ethyl (E)-2-decenoate (143), Scheme 56. 
To ethyl (E)-2-decanoate (143) was added aqueous sodium hydroxide and the mixture was 
heated to reflux for 4 hours.  After cooling, the solution was washed with chloroform to 
remove any starting material and the aqueous layer was acidified to pH 2-3 using 
concentrated hydrochloric acid.  The resultant white precipitate was collected by filtration, 
dissolved in chloroform, which was then dried over magnesium sulfate, filtered and reduced 
under a reduced pressure to yield (E)-2-decenoic acid (144) as a white solid.  After 
characterisation this carboxylic acid was chlorinated by being suspended solventless in 
thionyl chloride and stirred for 2 h to reflux.  Removal of the excess thionyl chloride was 
attempted under a reduced pressure to yield (E)-dec-2-enoyl chloride (142). 
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Scheme 56. Formation of acyl chloride precursor for reutericyclin analogue synthesis  
This reaction was successful, with characterisation of the desired product but TLC analysis 
continually showed remaining thionyl chloride, which was evident by repeated failed 
attempts at the N-acylation reaction.  Several different attempts were made to remove this 
excess thionyl chloride.  Standard methods involving column chromatography would lead to 
the degradation of the desired acyl chloride so alternatives were required.  These included 
extended periods of heating under a reduced pressure, 7 hours at 600C, as well as adding 
formic acid in an attempt to decompose the thionyl chloride to carbon dioxide and sulfur 
dioxide, but all were unsuccessful.  
Another attempt was made to access the acyl chloride using oxalyl chloride.89  This was 
completed by adding oxalyl chloride to dropwise to the (E)-2-decanoic acid in toluene at 0oC 
which, after concentration under a reduced pressure yielded the desired product, yet still 
with impurities which were identified by 13C NMR spectroscopy as the oxalyl chloride, 
Scheme 57.  This was disappointing but due to the collection of 12 compounds already 
synthesised as part of the studies towards reutericyclin analogues, it was decided to leave 
the synthesis at this point. 
 
Scheme 57. Formation of acyl chloride precursor for reutericyclin analogue synthesis with 
oxalyl chloride  
 
143 144 142 
144 142 
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2.3.2 – N-Alkylation Reactions of Pyrroloisoxazoles 
After the success of the acylations, and some examples of N-alkyl reutericyclin derivative 
having being reported to have biological activity3, it was decided to attempt alkylations of 
pyrroloisoxazoles under the same conditions as the successful acylations. 
The first to be attempted was to use an alkyl halide to be incorporated by a nucleophilic 
substitution reaction.  1-Bromobutane was selected as the haloalkane and the 
pyrroloisoxazole used in all cases attempted was from the valine-based series, 125a.  The 
reaction was methodologically the same as the acylations, with the pyrroloisoxazole being 
stirred to -78 oC in dry THF and the base (1.1 equiv n-butyllithium) added.  After 10 minutes 
the 1-bromobutane was charged to the reaction mixture which was left to stir for 2 hours 
followed by quenching with saturated ammonium chloride.  After extraction of the aqueous 
layer with ethyl acetate, drying over magnesium sulfate and concentration under a reduced 
pressure, quantitative recovery of the valine pyrroloisoxazole starting material was 
obtained, with no sign of any alkylation product, Scheme 58. 
This result was disappointing, so modifications were made to the reaction conditions in that 
the temperature was increased; instead of quenching with saturated ammonium chloride 
solution at -78 oC the reaction was allowed to warm to room temperature over the 2 hours 
and quenched at 23 oC.  This also, after washings, drying and concentration, returned all the 
pyrroloisoxazole starting material.  The assumption was made that the alkyl halide was not 
reactive enough and therefore it was decided to use 3-bromo-1-propene as it is more 
reactive.  Again allowing the reaction to reach room temperature before quenching also led 
to the isolation of starting material, with no indication of any desired reaction occurring.  
The next alteration was to again increase reaction temperature, with the idea that if any 
observed reaction occurred, of any yield, the reaction time could be increased later if 
required.  The reaction was now heated to reflux after initial addition of the n-butyl-lithium 
at -78oC, and addition of the 3-bromo-1-propene, but yet again only pyrroloisoxazole 
starting material was apparent after work up, Scheme 58. 
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Scheme 58. Attempts at N-alkylation of valine pyrroloisoxazole using 1-bromobutane  
The last attempt at N-alkylation was to increase the reactivity of the allyl bromide by adding 
potassium iodide as a nucleophilic catalyst.  The reaction was performed as before, heated 
to reflux, but with 1 equiv potassium iodide with the intention that there would be ion 
exchange forming 1-iodo-prop-3-ene in situ and therefore increasing the reactivity of the 
allyl halide.  This did not lead to a successful reaction and instead, as seen in all other 
attempts, only returned the pyrroloisoxazole starting material after work up, Scheme 59. A 
summary of all the conditions tried is shown in Table 5. 
 
Scheme 59. Attempts at N-alkylation of valine pyrroloisoxazole using 3-bromo-prop-3-ene  
Table 5.  N-Alkylation conditions attempted  
Ref. 1 2 3 4 5 
Substrate 1-
Bromobutane 
1-
Bromobutane 
Allyl Bromide Allyl Bromide Allyl Bromide 
Time 2 Hr 2 Hr 2 Hr 2 Hr 2 Hr 
Temperature -78oC -78oC to rt -78oC to rt -78oC to reflux -78oC to 
reflux 
Ion Catalyst None None None None Potassium 
Iodide 
125a 145 
146 125a 
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These results were disappointing, but it was decided that the N-acyl compounds contained 
sufficient diversity to continue the synthesis with them alone and not to spend more time 
developing the alkylation reaction.  This also indicates that the nucleophilicity of the 
nitrogen anion formed by the deprotonation is not sufficient enough to attack the alkyl and 
allyl halides. 
2.3.3 – Reduction of the N-Acyl Pyrroloisoxazoles 
In the synthesis of acyltetramic acids, the produced N-acyl pyrroloisoxazoles would next 
require the isoxazole to be ring opened to give an enaminoketone which could subsequently 
be hydrolysed to give the N,3-diacyltetramic acid.  The conditions for this reduction in the 
case of NH-pyrroloisoxazoles have already been established by Jones in previous 
publications56,57 and consisted of two different reaction protocols, one for saturated and 
one for unsaturated C-3 acyl substituents.   
The reaction conditions for the opening of the isoxazole ring developed for 
pyrroloisoxazoles with saturated C-3 substituents were a hydrogenation using hydrogen gas 
with a palladium on carbon catalyst.  This was successfully completed on the (S)-5-butyryl-6-
(2-methylethyl)-3-methyl-5,6-dihydro-4H-pyrrolo[3,4-c]isoxazol-4-one (137a) and (S)-5-
butyryl-6-(2-methylpropanyl)-3-methyl-5,6-dihydro-4H-pyrrolo[3,4-c]isoxazol-4-one (137b) 
systems and involved suspending the pyrroloisoxazoles in ethanol followed by addition of 
this suspension to a dry, nitrogen-filled reaction flask already containing the palladium on 
carbon in ethanol.  The reaction vessel was then evacuated using a vacuum pump and 
subsequently filled with nitrogen gas, repeated three times before repeating this purge 
technique with hydrogen gas.  The reaction solution was then left under an atmosphere of 
hydrogen gas and stirred vigorously for 17 hours at room temperature before being purged 
a further three times with nitrogen gas before allowing in air.  The reaction mixture was 
then filtered through a celite pad and concentrated under a reduced pressure to yield the 
crude enaminoketone (147), which was purified using Prep-TLC eluting with ethyl 
acetate:light petroleum (3:1 v/v).  Confirmation of the desired product was obtained by 
accurate mass spectrometry, IR analysis, 13C and 1H NMR spectroscopy (Scheme 60).  The 1H 
NMR spectra were distinctive in that a peak pattern identical to the pyrroloisoxazole was 
observed but with the addition of two broad singlets for the new amine group, one at 6.1 
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ppm and another at 9.4 ppm.  This large splitting between the two peaks also identified that 
the product was an enaminoketone, with strong hydrogen bonds between one of the amine 
hydrogen atoms and the adjacent ketone, and not the alternative tautomeric imino-enol. 
 
 
Scheme 60. Hydrogenation ring opening of isoxazole ring  
The other reaction conditions utilised were to produce the same enaminoketone but using 
an N-unsaturated acyl pyrroloisoxazole, namely (S,E)-5-(But-2-enoyl)-3-methyl-6-phenyl-5,6-
dihydro-4H-pyrrolo[3,4-c]isoxazol-4-one (148).  The double carbon-carbon bond in the acyl 
group can be reduced by H2 and palladium on carbon, so an alternative method had to be 
used, specifically using molybdenum hexacarbonyl in moist acetonitrile.  This ability of 
molybdenum hexacarbonyl was first observed and explained by Nitta in 198590 and 
following his work it was utilised by our group in earlier syntheses.57  The reaction required 
(S,E)-5-(But-2-enoyl)-3-methyl-6-phenyl-5,6-dihydro-4H-pyrrolo[3,4-c]isoxazol-4-one (139c) 
to be dissolved in acetonitrile:water (4:1 v/v) and added to molybdenum hexacarbonyl, 
upon which the reaction mixture was heated to reflux for 1 hour before the addition of 2M 
aqueous hydrochloric acid, followed by a further 1 hour stirring at reflux.  The reaction 
mixture was then allowed to cool before filtering through celite.  The aqueous filtrate was 
extracted with dichloromethane, washed with water and saturated brine, dried over 
magnesium sulfate and concentrated under a reduced pressure to yield the impure 
enaminoketone.  This was isolated pure using Prep-TLC eluting with ethyl acetate:light  
petroleum (3:1 v/v) with confirmation of the desired product obtained by accurate mass 
spectrometry, IR analysis, 13C and 1H NMR spectroscopy, Scheme 61.  The 1H NMR spectrum 
again contained the distinguishing broad singlets signifying the formation of an 
enaminoketone whilst also containing the relevant hydrogen resonances for the 
unsaturated carbon side chain.  
a – R1 –(CH3)2CH,  
b – R1 – (CH3)2CHCH2 
 
137 
147 
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Scheme 61. Reduction using molybdenum hexacarbonyl ring opening of isoxazole ring  
This process provided us with three novel enaminoketone compounds containing N-
acylation that were also suitable for biological testing as the structure of the enaminoketone 
pyrrolidine is electronically similar to the final acyltetramic acid. 
 
2.3.4 – Hydrolysis of the N-Acyl Pyrrolidine compounds 
From the outset of this synthesis, this stage was a concern that required research. The issue 
was that this step required a hydrolysis reaction, which in earlier examples of its use had not 
presented a problem, but we now had N-acylation to give an imide which can easily be 
hydrolysed back to the amide.  The first attempted hydrolysis used the previously 
established sodium hydroxide hydrolysis in THF:water91,57 which involved adding the (S)-3-
acetyl-4-amino-1-butanoyl-5-isobutyl-1H-pyrrol-2(5H)-one (147b) to a solution of THF and 
2M sodium hydroxide and stirring at reflux for 20 hours, Scheme 62.  The work up required 
an acidification to remove excess hydroxide and an organic extraction, drying and 
concentration under a reduced pressure.  This inevitably led to the hydrolysis of the imide 
and yielded a known acyltetramic acid, which was characterised by the reappearance of the 
amide proton at 6.5 ppm in a 1H NMR analysis and an upfield shift in the alpha proton on 
the adjacent carbon, 2.5 ppm in imide and 2.0 ppm in amide.  Although this compound was 
not fully characterised extensive separations led to the decomposition of this compound.  It 
was decided to attempt very mild conditions and work toward more vigorous conditions, 
with the idea to preserve material.   
139c 148 
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Scheme 62. Attempted leucine enaminoketone hydrolysis using 2 M sodium hydroxide 
The next effort was made using just water as a source of hydrolysis, which after 24 hours at 
room temperature yielded only unchanged (S)-3-acetyl-4-amino-1-butyryl-5-isobutyl-1H-
pyrrol-2(5H)-one (147b) starting material based on 1H NMR spectroscopy data, obtained 
after work up and concentration under a reduced pressure, Scheme 63.   
 
 
 
Scheme 63. Attempted leucine enaminoketone hydrolysis using water 
A subsequent reaction, using a 0.1 M solution of sodium hydroxide at room temperature 
overnight, again lead to the hydrolysis of the imide, as identified by NMR spectroscopy,  
Scheme 64, so it was decided that other methods for the amine removal would be 
investigated. 
 
 
Scheme 64. Attempted leucine enaminoketone hydrolysis using 0.1 M sodium hydroxide 
147b 149 
147b 149 
147b 149 
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After the attempts made at a basic hydrolysis, the next logical step was an acid hydrolysis.  
This was attempted by dissolving (S)-3-acetyl-4-amino-1-butyryl-5-isobutyl-1H-pyrrol-2(5H)-
one (147b) in a minimum amount of ethanol and stirring with 2M hydrochloric acid for 24 
hours at room temperature.  After an organic extraction using dichloromethane, the 
potential product was concentrated under a reduced pressure and analysis by NMR 
spectroscopy showed there had been no reaction and enaminoketone starting material was 
re-isolated, Scheme 65.   
 
 
Scheme 65. Attempted leucine enaminoketone acid hydrolysis using 2M hydrochloric acid 
This was disappointing as all attempts at hydrolysis had failed, therefore another 
methodology was required.  In 2009, a previous group member had used a method of 
diazotisation to remove an amine in a related pyridone series92.  In this technique the (S)-3-
acetyl-4-amino-1-butyryl-5-isobutyl-1H-pyrrol-2(5H)-one (147b) was dissolved in ethanol 
and added to 3M sulfuric acid, before adding sodium nitrite in water at 0 oC.  This solution 
was then stirred at 0 oC for 1 hour before being heated to 50 oC and further stirred for 
another hour.  The aqueous layer was extracted with ethyl acetate, dried over magnesium 
sulfate and concentrated under a reduced pressure to yield a yellow oil.  Upon analysis by 
1H NMR spectroscopy the isolated compound was shown to be a mixture of residual (S)-3-
acetyl-4-amino-1-butyryl-5-isobutyl-1H-pyrrol-2(5H)-one (147b) and degraded material, 
presumable due to the strong acid conditions.  Separation by prep-TLC yielded none of the 
desired acyltetramic acid, Scheme 66. 
147b 149 
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Scheme 66. Attempted leucine enaminoketone diazotisation using sodium nitrite 
All available known routes to obtain this elusive acyltetramic acid structure have ended in 
either isolation of (S)-3-acetyl-4-amino-1-butyryl-5-isobutyl-1H-pyrrol-2(5H)-one (147b) 
starting material or the removal of the N-acyl elaboration. A summary of the condition 
attempted is shown in Table 6.  This result is disappointing in the synthesis of acyltetramic 
acids but along the way, this synthetic approach has yielded a large library of novel 
compounds as masked reutericyclin analogues (pyrroloisoxazoles and enaminoketones), all 
suitable for biological testing.  
Table 6.  Enaminoketone hydrolysis or diazotisation methods  
REF. 1 2 3 4 5 
TYPE OF REACTION Base 
Hydrolysis 
Base 
Hydrolysis 
Base 
Hydrolysis 
Acid 
Hydrolysis 
Diazotisation 
REACTANT 
(CONCENTRATION)  
H2O NaOH         
(0.1 M) 
NaOH           
(2 M) 
HCl          
(2 M) 
NaNO2 
TIME 20 Hr 20 Hr 20 Hr 20 Hr 3 Hr 
TEMPERATURE 
RESULT 
reflux 
no 
reaction 
 rt 
N-acyl 
hydrolysis 
-rt 
N-acyl 
hydrolysis 
rt 
no 
reaction 
0oC to 50oC  
no reaction 
 
This work was accepted for publication in Chemical Communications93 and can be found in 
the appendix of this thesis. 
 
147b 149 
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2.4 – Model Isoxazole Synthesis and Elaboration  
Due to the expense of synthesising the pyrroloisoxazole units, both in time and money, it 
was decided that a model of the (S)-5-butyryl-6-isopropyl-3-methyl-5,6-dihydro-4H-
pyrrolo[3,4-c]isoxazol-4-one (125a) would be produced which would be used to assess the 
success of elaboration techniques and determine which should transferred to the full 
pyrroloisoxazole. 
The model would need to contain the isoxazole ring with a methyl group at C-5 
(corresponding to C-3 of the pyrroloisoxazole) as well as a carbonyl group substituted at the 
C-4 position.  It was initially proposed that an ester carbonyl (150) would be suitable to 
mimic the amide we see in the pyrroloisoxazole but, as discussed later, this proved 
unsuitable and an amide (151) was used (Figure 26).  
 
Figure 26. A pyrroloisoxazole example (125a), ester model (150) and amide model (151) 
The synthesis of these isoxazoles was developed from a synthesis used previously in our 
research group94 which involved a two stage one-pot reaction to provide the ester 
containing isoxazole. 
The first of these reactions is an enamine (152) formation, as seen before by the addition of 
pyrrolidine to ethyl acetoacetate (153) dissolved in toluene with heating to reflux under 
Dean-Stark conditions to remove the water produced, Scheme 67.  The amount of water 
formed can be measured and from this it was determined the reaction was complete after 
18 h and, after removing excess solvent under a reduced pressure, a sample was taken for 
spectroscopic analysis.  1H NMR spectroscopy showed the formation of the new double 
bond and the addition of the pyrrolidine group to the molecule, with IR spectroscopy and 
mass spectrometry confirming this in a 99% yield. 
125a 
–
CHCH
CH3 
 
150 
–
CHCH
CH3 
 
151 
–
CHCH
CH3 
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Scheme 67. Enamine formation from ethyl acetoacetate 
The second of the two stages was the cycloaddition to form an isoxazole ring and 
subsequent elimination of the pyrrolidine to produce the aromaticity seen in the final 
isoxazole.  The reactive 1,3-dipole nitrile oxide (81) required had to be formed in situ due to 
its instability.  To produce this, firstly, triethylamine was added to the newly formed 
enamine, followed by nitroethane (154) in chloroform and the reaction mixture was cooled 
to 0 0C.  When the mixture had reached 0 0C phosphorus oxychloride (155) was added 
dropwise over 1.5 h to ensure a controlled reaction, after which time the reaction mixture 
was allowed to warm to room temperature and stirred overnight, Scheme 68.  The organic 
layer was then washed with aqueous acid, base and brine to remove excess triethylamine 
and other water soluble impurities.  After drying and concentration under reduced pressure, 
ethyl 3,5-dimethylisoxazole-4-carboxylate (150), as a yellow thick oil, was confirmed by 
NMR spectroscopy showing the new ring system, supported by IR spectroscopy and mass 
spectrometric data in a 47% yield.  A suggested mechanism for the formation of the nitrile 
oxide and subsequent 1,3-dipolar cycloaddition can be seen in Scheme 69. 
 
Scheme 68. 1,3-Dipolar cycloaddition producing model isoxazole 
153 
–
CHCH
CH3 
 
152 
–
CHCH
CH3 
 
153 
–
CHCH
CH3 
 
150 
–
CHCH
CH3 
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Scheme 69. Proposed mechanism for the 1,3-dipolar cycloaddition producing ethyl 3,5-
dimethylisoxazole-4-carboxylate (150) 
Once the ethyl ester containing isoxazole (150) had been synthesised a series of reactions 
were investigated.  The first was a repeat of the anion formation and aldol reaction with 
pentanal using nBuLi as a base, previously successfully completed on the valine-based 
pyrroloisoxazole, (S)-5-Butyryl-6-isopropyl-3-methyl-5,6-dihydro-4H-pyrrolo[3,4-c]isoxazol-
4-one (125a) but not reproducibly.  This required adding nBuLi dropwise to the isoxazole in 
dry THF at -780C over 1 h.  The freshly distilled pentanal was added in excess and the 
reaction mixture stirred for a further hour before the reaction was quenched by the 
addition of water and 2M HCl, and evaporated to yield a yellow oil, Scheme 70.  Preliminary 
NMR spectroscopy showed a mixture of starting materials and impurities, with no peaks 
suggesting desired product.  The IR also showed very minimal amounts of hydroxyl group, 
which would be expected from aldol addition. 
154 
–
CHCH
CH3 
 
155 
–
CHCH
CH3 
 
150 
–
CHCH
CH3 
 
153 
–
CHCH
CH3 
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Scheme 70. Attempted aldol reaction of isoxazole 156 using nBuLi 
After this unsuccessful reaction it was decided to attempt to a new reaction where an aldol 
style nucleophilic addition and elimination would occur on a formaldehyde unit.  This would 
provide a vinyl group for cross metathesis or conjugate addition investigations.  As 
formaldehyde is a gas and only available commercially as a gas or as an aqueous solution, 
which would be detrimental to this dry reaction; it was decided to use paraformaldehyde, a 
polymerised version of the aldehyde that requires heat to depolymerise and produce 
formaldehyde.   
Based on past success on the pyrroloisoxazole with non-enolisable aldehydes, sodium 
methoxide was used as a base, bought in commercially as it was assumed that the n-BuLi 
could have reacted as a nucleophile in the previous reaction.  Sodium methoxide was 
dissolved in methanol and added to a suspension of ethyl 3,5-dimethylisoxazole-4-
carboxylate (150) in dry methanol and stirred at room temperature for 2 minutes.  The 
paraformaldehyde was then suspended in dry methanol and heated to reflux under a 
nitrogen atmosphere for 3 hours.  After separation in water and extraction using 
chloroform, drying and evaporation under vacuum afforded a yellow oil, Scheme 71. Again, 
preliminary NMR spectroscopy showed a mixture of starting materials and impurities, with 
no desired peaks such as that of the new alkene (157). 
 
Scheme 71. Attempted aldol reaction of isoxazole using sodium methoxide and 
formaldehyde 
150 
–
CHCH
CH3 
 
156 
–
CHCH
CH3 
 
150 
–
CHCH
CH3 
 
157 
–
CHCH
CH3 
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With this unsuccessful reaction, it was decided to repeat a previously successful experiment 
performed on the pyrroloisoxazole in earlier published work75,94 to test the reactivity of the 
isoxazole model.  The reaction was to perform the aldol condensation with an aromatic 
aldehyde, benzaldehyde, which was attempted using the same methodology as seen for the 
paraformaldehyde reaction where sodium methoxide was dissolved in methanol and added 
to a suspension of the ethyl 3,5-dimethylisoxazole-4-carboxylate (150) in dry methanol and 
the mixture stirred at room temperature for 2 minutes.  The benzaldehyde was then added 
in dry methanol and the mixture heated to reflux under a nitrogen atmosphere for 3 hours.  
After separation in water and extraction using chloroform, drying and reduction under 
vacuum, a yellow oil was obtained, Scheme 72. Again, preliminary NMR spectroscopy 
showed a mixture of starting materials and impurities, with none of the expected peaks 
relating to the new alkene bond (158).      
 
Scheme 72. Attempted aldol reaction of isoxazole using sodium methoxide on to 
benzaldehyde 
This led to the assumption that ethyl 3,5-dimethylisoxazole-4-carboxylatewas not a valid 
model and was not proving to accurately mimic the behaviour of the pyrroloisoxazole.  The 
task was then to synthesis a new model with a secondary amide in the place of the ethyl 
ester.  This functional group conversion is a reliable and commonly accepted process which 
could be completed in three stages. 
The first stage was to hydrolyse the ester to produce an acid.  Base hydrolysis was initiated 
by addition of sodium hydroxide in water to the ethyl 3,5-dimethylisoxazole-4-carboxylate 
(150) and stirring to reflux for 4 h, after which the solution was left to cool and washed with 
chloroform to remove any unreacted organic starting material, retaining the aqueous layer.  
This fraction was then acidified with concentrated hydrochloric acid to pH 3, at which time a 
thick white precipitate had formed.  The white precipitate was collected by Buchner 
150 
–
CHCH
CH3 
 
158 
–
CHCH
CH3 
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filtration and dissolved in chloroform, dried over magnesium sulfate and concentrated 
under a reduced pressure to yield 3,5-dimethylisoxazole-4-carboxylic acid (159) as a white 
crystalline solid in an 81% yield, Scheme 73.  This was confirmed by NMR spectroscopy with 
the absence of the ethyl group signals and the appearance in the IR spectrum of a large 
hydroxyl peak. 
 
Scheme 73. Functional group conversion of an ethyl ester to carboxylic acid on isoxazole  
The carboxylic acid was now to be converted in one-pot to the amide over two stages.  The 
first stage was to halogenate the carboxylic acid to yield an acid chloride which would 
provide a good leaving group.  The 3,5-dimethylisoxazole-4-carboxylic acid (159) was stirred 
in neat thionyl chloride for 2 h and heated to reflux; during the heating (before reaching 
reflux) effervescence was observed which was assumed to be the formation of sulfur 
dioxide, Scheme 74. The excess thionyl chloride was removed under a reduced pressure and 
the brown residue (160) was then taken up in dichloromethane.  Due to the instability of the 
acid chloride in air it was decided to continue directly through to the next stage of the 
reaction with no further analysis or purification. 
 
Scheme 74.  Conversion of a carboxylic acid to an acid chloride 
In order to mimic the pyrroloisoxazole, the most accurate amide to form was a secondary 
amide with a methyl group on the nitrogen atom.  It was therefore decided to use 
methylamine to form the amide, which is only available commercially in aqueous solution.  
Therefore, to 3,5-dimethylisoxazole-4-carbonyl chloride (160) in dichloromethane was 
150 
–
CHCH
CH3 
 
159 
–
CHCH
CH3 
 
160 
–
CHCH
CH3
 
159 
–
CHCH
CH3 
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added methylamine in 1M sodium hydroxide solution to ensure the aqueous layer remained 
basic and guarantee the amine would continue to be reactive and not over-protonated.  The 
reaction occurred at the interface between the layers, which therefore required the 
reaction to be stirred vigorously for 48 h, Scheme 75.  The product was isolated after 
separation with water, extraction with dichloromethane, drying of the organic layer and 
evaporation under a reduced pressure to afford the N,3,5-trimethylisoxazole-4-carboxamide 
(151) in 84% yield, which was confirmed by 1H NMR spectroscopy by the addition of amide 
signals to the isoxazole.   
 
 
Scheme 75. Conversion of an acid chloride to an amide 
A mechanism for this one-pot synthesis is illustrated in Scheme 76. 
160 
–
CHCH
CH3 
 
151 
–
CHCH
CH3 
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Scheme 76. Mechanism for the conversion of carboxylic acid to an amide 
Once N,3,5-trimethylisoxazole-4-carboxamide (151) had been produced, it was now possible 
to assess the reactivity of this model to provide a comparison with the pyrroloisoxazole, 
which was done with repeats of the two experiments conducted on the ethyl 3,5-
dimethylisoxazole-4-carboxylate (150).   These methodologies can be seen above but the 
reactions are also shown in Scheme 77 and Scheme 78.  The results obtained, however, 
were the same as seen in the earlier model with both reactions resulting in unidentifiable 
products.  The NMR spectroscopic signature that was required to confirm product formation 
was the new alkene proton signals shown to be around 6-7 ppm with a specific splitting 
pattern, which was not observed in any fraction. 
. 
159 
–
CHCH
CH3 
 
160 
–
CHCH
CH3 
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–
CHCH
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Scheme 77. Attempted aldol reaction on paraformaldehyde on N,3,5-trimethylisoxazole-4-
carboxamide 
 
 
Scheme 78. Attempted aldol reaction on benzaldehyde on N,3,5-trimethylisoxazole-4-
carboxamide 
These experiments were repeated several times with different reaction times, solvents and 
bases until successful conditions were identified, which is summarised in Table 7.   
 
 
 
 
 
 
 
 
151 
–
CHCH
CH3 
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Table 7.  Table showing range of results from a range of model isoxazole reactions 
Ref.* Isoxazole Base 
(2.5 eq.) 
Time/ 
Temperature 
Aldehyde Solvent Yield 
156 Ethyl Ester nBuLi 2 h / -780C Pentanal THF - 
157 Ethyl Ester NaOMe 3 h / reflux Paraformaldehyde Methanol - 
158 Ethyl Ester NaOMe 3 h / reflux Benzaldehyde Methanol - 
162 Amide **NaOMe 3 h / reflux Benzaldehyde Methanol - 
162 Amide **NaOMe 24 h/ reflux Benzaldehyde Methanol - 
161 Amide **NaOMe 3 h / reflux Paraformaldehyde Methanol - 
162 Amide nBuLi 3 h / reflux Benzaldehyde THF - 
162 Amide **NaOtBu 24 h/ reflux Benzaldehyde THF/tBuOH 24% 
161 Amide **NaOtBu 24 h/ reflux Paraformaldehyde THF/tBuOH - 
Note that all solvents used were dry, either freshly distilled or bought dry. Also that ethyl 
ester isoxazole is ethyl 3,5-dimethylisoxazole-4-carboxylate (150) and amide isoxazole is 
N,3,5-trimethylisoxazole-4-carboxamide (151 ). *Denotes the number reference for the 
product, ** Denotes where the base was freshly prepared 
An advance came when it was decided to use a slightly stronger base, sodium tert-butoxide, 
due to concerns the deprotonation was not occurring.  The sodium tert-butoxide was freshly 
prepared by adding sodium to tert-butanol at room temperature under a nitrogen 
atmosphere and heated to reflux until the sodium had fully dissolved to give a cloudy, 
colourless solution, typically around taking 45 minutes.  This solution was then transferred 
directly to a vessel containing N,3,5-trimethylisoxazole-4-carboxamide (151) and 
benzaldehyde suspended in freshly distilled dry THF via a cannula.  The solution immediately 
began to darken and turn red as the deprotonation occurred; this became a signal that the 
deprotonation was successful. 
This red colour remained in the solution throughout the 3 hours of stirring at reflux, until 
separation by water and ethyl acetate, with the aqueous layer being extracted with ethyl 
acetate.  The organic phase, now a yellow colour, was then dried and concentrated under a 
reduced pressure to yield the crude mixture containing alkene product (162) as a yellow oil.  
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The 1H NMR spectroscopic analysis showed two new doublets with couplings of 16.3 Hz.  
This was used to identify the product fraction isolated by column chromatography, eluting 
with light petroleum: ethyl acetate (2:1 v/v), which enabled full characterisation of the 
desired aldol product, (E)-N,3-dimethyl-5-(2-phenylethenyl)isoxazole-4-carboxamide (162).  
Although the experiment was successful, the yield was low (26%).  Scheme 79 is shown 
below which depicts the successful reaction conditions.   
 
Scheme 79. Successful conditions for the aldol reaction on to benzaldehyde 
The paraformaldehyde reaction has not yet been successful and the conclusion was drawn 
that paraformaldehyde may not be a good source of formaldehyde in this reaction.  Due to 
this lack of success of this reaction, cross metathesis investigations could not be completed.  
However, once it was identified that the tert-butoxide anion was able to remove the proton 
on the C-5 methyl group, the results then needed to be transferred from the model to the 
pyrroloisoxazole.  The aim was now to complete the reaction without the use of a protic 
solvent, as the pyrroloisoxazole had previously undergone aldol reactions under these 
conditions.57  The next reaction to attempt on the model was therefore to use tert-butoxide 
without the excess protic tert-butanol solvent, which was completed by using commercially 
available potassium tert-butoxide dissolved in dry THF.  The reaction was attempted by 
dissolving N,3,5-trimethylisoxazole-4-carboxamide in dry THF followed by addition of the 
potassium tert-butoxide in dry THF at room temperature, which led to no obvious colour 
change.  This clear and colourless solution was then refluxed for 1 hour before adding the 
benzaldehyde, after which the reaction mixture turned a vibrant yellow and, after a further 
3 hours at reflux, darkened to a deep red. The presumed aldol reaction was then heated to 
reflux overnight with stirring and after workup, involving a water wash, drying over MgSO4 
and concentration under a reduced pressure, yielded N,3-dimethyl-5-(2-oxo-2-
162 
–
CHCH
CH3 
 
151 
–
CHCH
CH3 
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phenylethyl)isoxazole-4-carboxamide (163) as a major product at 33%, with no other 
recognisable minor products, Scheme 80. 
 
Scheme 80. Conditions for the aldol reaction to form the ketone with benzaldehyde 
The reaction was unexpected as the oxidised form of the aldol adduct alcohol was achieved.  
The presence of the ketone was confirmed initially by the occurrence of a singlet integrating 
for 2 protons at 4.63 ppm in the NMR spectrum (which was assigned as the 2 hydrogens on 
the alpha methylene group to the ketone) and the absence of the previous methyl group at 
2.55 ppm and of signals seen in the aldol condensation product alkene.  The product was 
also confirmed by high resolution mass spectrometry by identification of the molecular ion.  
This mode of reaction can be identified as a possible disproportionation and in 1853 was 
specifically described for aldehydes with no alpha hydrogens such as benzaldehyde by 
Cannizzaro.95  One possible pathway is hydride transfer from the initial aldol hydroxy adduct 
to reduce the excess benzaldehyde (Scheme 81). 
151 163 
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Scheme 81. A suggested mechanism for the disproportionation reaction described 
Upon further investigation this ketone could be successfully reduced to the alcohol by 
stirring with sodium borohydride in ethanol for 1 hour to yield the alcohol 5-(2-hydroxy-2-
phenylethyl)-N,3-dimethylisoxazole-4-carboxamide (166) in 98%, Scheme 82.  This was again 
confirmed by NMR analysis which showed the complete removal of the peak at 4.63 ppm 
and the addition of a new splitting pattern for 2 protons at 3-3.5 ppm (assigned as the 
methylene group) and a further new peak showing doublet of doublets coupling and 
integrating for 1 proton at 5.10 ppm (assigned as the new methine hydrogen on the 
alcoholic carbon). 
 
151 
164 
165 
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Scheme 82. Conditions for the reduction to form the alcohol from the ketone 
Once the alcohol was confirmed an attempt was made to dehydrate it using para-
toluenesulfonic acid (PTSA) as seen before under Dean-Stark conditions,75  but this reaction 
failed and no alkene was identified.  The reaction was done on a very small scale which 
could have contributed to the failure to identify desire product as the analysis showed no 
major product, instead suggesting degradation, Scheme 83.  
 
Scheme 83. Conditions for the attempted dehydration of the alcohol to form an alkene 
Given the success of the N-acylation reactions on the pyrroloisoxazole series, it was decided 
to attempt a diacylation on the model isoxazole amide.  This reaction therefore required a 
base, commercial potassium tert-butoxide added in 3 equivalence, to be added to N,3,5-
trimethylisoxazole-4-carboxamide (151) suspended in dry THF at room temperature before 
the addition of an excess amount of butyryl chloride and heating to reflux overnight, 
Scheme 84.  This reaction yielded no desired product of either the mono- or diacylated 
isoxazole, which confirms concerns that the anion formation or reactivity of this methyl 
group is unreliable.  This provides an explanation of the non-reproducibility and relatively 
low yields for the aldol reactions attempted. 
163 166 
166 167 
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Scheme 84. Conditions for the attempted diacylation of amide model isoxazole  
At this point it was found that we had some (S)-6-(1-methylethyl)-3-methyl-5,6-dihydro-4H-
pyrrolo[3,4-c]isoxazol-4-one (151) remaining and therefore this diacylation was attempted 
on it.  As seen before the base, n-butyllithium in this case, was added (3 equiv) to the 
pyrroloisoxazole at -780C and the mixture stirred for 3 hours at this temperature under a 
nitrogen atmosphere to form the appropriate anions.  To this reaction was charged an 
excess amount of butyryl chloride and stirred for a further 2 hours at -780C under a nitrogen 
atmosphere.  After work-up and purification, the major product isolated was the mono-N-
acylated compound, (S)-5-Butyryl-6-isopropyl-3-methyl-5,6-dihydro-4H-pyrrolo[3,4-
c]isoxazol-4-one (137a), in a 92% yield. This was confirmed by comparing analysis data with 
the previous data collected for this compound, Scheme 85 and it gave further evidence as to 
the lack of formation of any methyl anion. 
Scheme 85. Conditions for the attempted diacylation of valine pyrroloisoxazole   
 
 
151 168 
137a 169 125a 
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2.5 – Laccarin Analogue Synthesis 
The next, and final, strand of research completed is the attempted synthesis of an analogue 
(18) of the natural alkaloid laccarin (30, Figure 27), which began with the commercially 
available and cheap L-ornithine (170).  There are protected versions of L-ornithine available 
commercially but they are more expensive and only offer protection to the two free amines 
and not the acid function.  Therefore, the first stage in the synthesis of the laccarin analogue 
(18) was to protect the acid by converting it to an ethyl ester in an esterification.  Note that 
the analogue contains the opposite enantiomeric configuration to that seen in the natural 
product; this would require starting with D-ornithine, which is more expensive, so was not 
used in this work.  
 
Figure 27. Laccarin (30) and the synthetically fessable anaolouge (18) 
To the L-ornithine hydrochloride salt or (S)-2,5-diaminopentanoic acid hydrochloride (170) 
in dry ethanol was added freshly distilled acetyl chloride, stirred and heated to reflux for 18 
hours overnight.  This process produced the desired ethyl ester, as salts of both amine 
groups due to the hydrogen chloride produced during the reaction.  The  product required 
extensive heating, over 7 hours, in a vacuum oven at 80 0C to drive off all the water and 
solvent to yield (S)-5-ethoxy-5-oxopentane-1,4-diaminium chloride (171) as a dry white 
powder in 99% yield, Scheme 86.  The product structure was confirmed by NMR 
spectroscopy, with the appearance of the ethyl group and disappearance of the acidic 
proton, mass spectrometric identification of a molecular ion and IR analysis showing 
appropriate bond vibrations. 
 
Scheme 86. Esterification of L-ornithine 
18 30 
170 171 
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The next reaction was another protection step to protect the free amine groups as Boc 
derivatives, as seen in earlier syntheses but now with two to protect.  This was completed as 
seen before, differing only in the requirement to add 2 equiv di-tert-butyl dicarbonate 
dropwise to a solution in dichloromethane containing L-ornithine ethyl ester bis-
hydrochloride salt (171), which was followed by 2 equivs of triethylamine and stirring the 
mixture at room temperature overnight.  Subsequent washing with citric acid, to remove 
unreacted starting material, and a saturated brine wash was followed by drying over 
magnesium sulfate and concentrating under a reduced pressure to yield the desired ethyl 
(S)-2,5-bis((tert-butoxycarbonyl)amino)pentanoate (172)  as a colourless oil in good yield 
(64%), Scheme 87.  The product was confirmed by the appearance of two tert-butyl groups 
in the NMR analysis along with the L-ornithine ethyl ester.  IR spectroscopy and mass 
spectrometry identifying the molecular ion also confirmed the structure. 
 
Scheme 87. Di-protection of L-ornithine ethyl ester   
As seen earlier in the synthesis of the valine- and leucine-based pyrroloisoxazoles, the next 
stage required is to reduce the ethyl ester in (S)-ethyl 2,5-bis((tert-
butoxycarbonyl)amino)pentanoate (172) to an aldehyde in (S)-2,5-bis (tert-
butyloxycarbonylamino)pentanal (173).  This was performed using 2.5 equivalence of 
diisobutylaluminium hydride in toluene over 4 hours at -78 0C to prevent epimerization of 
the central chiral unit.  This is usually a very successful method and provided good results 
yielding the aldehyde (64%) as a clear colourless oil, Scheme 88, which required no further 
purification and was added directly to the next reaction.  Characterisation was achieved on 
a sample removed before commencing with the next reaction and confirmed the structure 
as (S)-tert-butyl 5-oxopentane-1,4-diyldicarbamate (173) by 1H NMR spectroscopy, 
acknowledged by the removal of the ethyl group and addition of an aldehyde proton signal.  
This was supported by mass spectrometric identification of the molecular ion and IR 
analysis.   
171 172 
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Scheme 88. Reduction of L-ornithine ethyl ester to aldehyde 
The formation of the oxime was the next stage: the crude (S)-di-tert-butyl (5-oxopentane-
1,4-diyl)dicarbamate (173) was dissolved in the least amount of ethanol and added to an 
aqueous solution containing 2 equivs of hydroxylamine hydrochloride and 4 equivs of 
sodium acetate.  This method of oxime formation from aldoximes by condensation of the 
aldehyde with hydroxylamine hydrochloride and sodium acetate has been previously used 
and is shown to be reliable both in our work and that of others80.  
As seen before in the L-valine and L-leucine series, an initial white precipitate was observed, 
which had to be re-dissolved with the minimum amount of ethanol.  The solution was 
heated to 70 0C for 30 mins, during which time a watchglass was placed over the neck of the 
round bottomed reaction flask to restrict solvent loss, and after this time the flask was 
cooled to room temperature and placed in the refrigerator (2-5 0C) overnight.  After this 
time a white precipitate had formed which was removed by filtration and identified as the 
product oxime (S)-tert-butyl 5-(hydroxyimino)pentane-1,4-diyldicarbamate (174).  A white 
solid, remaining after extraction with ethyl acetate from the filtrate and drying, filtering and 
concentrating the combined organic under a reduced pressure, was also identified as the 
desired product (174), Scheme 89.  The total yield collected from this reaction was an 
excellent 96% and, in both cases the NMR spectrum in d6-DMSO, showed shifting of the sp2 
CH signal, and mass spectrometric identification of the molecular ion and IR analysis 
supported the oxime assignment.  
 
Scheme 89. Oxime formation from aldehyde of Boc-protected L-ornithine  
172 173 
173 174 
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The next stage was the 1,3-dipolar cycloaddition, the first part of which was the chlorination 
of the oxime (174).  This chlorination was achieved by adding N-chlorosuccinimide 
portionwise to the oxime (174) at 0 0C in chloroform, followed by heating to reflux 
overnight, during which time a colour change from pale blue to green to brown was 
observed, Scheme 90.  The structure of (S)-tert-butyl 5-chloro-5-(hydroxyimino)pentane-1,4-
diyldicarbamate (175) was confirmed, after work-up, drying and concentration, by 1H NMR 
spectroscopy, with the disappearance appearance of oxime alpha-proton, mass 
spectrometric identification of the molecular ion and IR analysis. 
 
Scheme 90. Chlorination of the L-ornithine oxime 
To a solution of (S)-tert-butyl 5-chloro-5-(hydroxyimino)pentane-1,4-diyldicarbamate (175) 
in chloroform heated to reflux was added 2 equivalence tert-butyl 3-(pyrrolidin-1-yl)but-2-
enoate (72) followed by an equivalent amount of triethylamine dropwise over 1 h, required 
to initiate the reaction by forming the nitrile oxide in situ.  The mixture was heated to reflux 
for a further 3 h, then separated between water and chloroform and the organic layer 
washed with citric acid solution, to remove excess base, and sodium hydroxide solution, to 
remove acidic impurities, and finally with saturated brine solution.  The organic layer was 
dried over magnesium sulfate, filtered and concentrated under reduced pressure to yield a 
crude dark brown thick oil.  The oil was subjected to purification by column chromatography 
eluting with light petroleum:ethyl acetate (3:1 v/v) to finally provide the new isoxazole (176) 
as a yellow oil in a disappointing 5% yield, Scheme 91.  This reaction was shown to have 
produced some isoxazole with a full characterisation by NMR spectroscopy, the 13C 
spectrum confirming the formation of 3 new quaternary carbons and the incorporation of 
the tert-butyl group, mass spectrometric identification of the molecular ion and IR analysis.  
We do not know the reason for the low yield; it may be due to side chain interference, but 
we have no evidence for this. 
 
174 175 
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Scheme 91. 1,3-Dipolar cycloaddition of L-Ornithine 
The next stage was to remove all the protecting groups to prepare the molecule for a 
peptide coupling reaction.  This was done using the same methodology as described earlier, 
using TFA in 30 fold excess and stirring for 4 hours, followed by concentration to yield a 
brown residue and subsequent addition of 2M HCl and stirring overnight, Scheme 92.  The 
product bis-hydrochloride salt (S)-1-(4-carboxy-5-methylisoxazol-3-yl)butane-1,4-
diammonium dichloride (177) was identified in quantitative recovery and confirmed by 13C 
NMR spectroscopy and mass spectrometry but due to the complexity of the 1H spectrum it 
could not be confirmed using this technique.  The complexity observed was possibly due to 
the mixture of different possible salts present and their interaction with deuterated protic 
solvent, D2O. 
 
Scheme 92. Deprotection of L-ornithine isoxazole 
The formation of the new amide, bond closing the pyrrolidone ring, was the next stage in 
the synthesis of a laccarin analogue.  This was attempted, as seen before in the L-valine 
series, using the EDCI (123) method, which was chosen as the amount of PS-CDI (124) 
available to us was low and this material is very expensive so it was determined to use the 
less expensive method and the T3P reaction had not yet been established at this point in 
our research.  The EDCI (123) process required the use of N-hydroxysuccinimide (120) as an 
activator and dimethylformamide as a solvent.  All these were combined with the 3-(1-
175 176 
176 177 
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amino-2-methylpropyl)-5-methylisoxazole-4-carboxylic acid hydrochloride salt (177) at 00C 
and stirred at room temperature overnight, 17 hours.  Triethylamine was then added to 
neutralise salts and the reaction left again overnight stirring.  After extracting the aqueous 
layer with ethyl acetate and washing with acid and base to remove the impurities, the 
solution was concentrated under a reduced pressure, Scheme 93.  (S)-6-(3-aminopropyl)-3-
methyl-5,6-dihydro-4H-pyrrolo[3,4-c]isoxazol-4-one (178) could not be identified in a crude 
NMR spectrum or by mass spectrometry.  The acid wash was analysed to see if any material 
had been transferred into it due to protonation making it more soluble in an aqueous layer.  
Unfortunately, it was not found to be present in any washings and the reaction was deemed 
unsuccessful.  Repeat attempts also failed and consequently a new strategy was required. 
 
Scheme 93. Attempted peptide coupling reaction using L-ornithine series 
Acting on the assumption that the additional long carbon chain at C-5 of the new ring was 
interfering with lactam formation, it was decided to reduce the isoxazole ring before the 
lactam formation.  This method required the synthesis of a protected isoxazole species 
which could then undergo a hydrogenation to form an enaminoketone, and as seen before 
in the N-acylation reactions, we also know these enaminoketones are stable under acidic 
conditions.  This would help to add flexibility for the new ring formation by removing the N-
O bond.  It then followed that by changing the enamine to contain an ethyl group may 
enable a potential spontaneous lactam ring closure, Scheme 94. 
177 178 
New Routes to Acyltetramic Acids and Analogues – James Bullous 
 
115 
 
Scheme 94. Suggested route towards L-ornithine-derived lactam enaminoketone   
The next reaction required was therefore to form the ethyl ester enamine, which was 
successfully synthesised from ethyl acetoacetate (152) and pyrrolidine under Dean-Stark 
conditions in a maximum of 99% yield, Scheme 95. 
 
Scheme 95. Ethyl ester enamine formation 
The next stage was again to form the isoxazole, except now with the ethyl ester enamine.  
This was attempted following the earlier discussed procedure by adding ethyl 3-(pyrrolidin-
1-yl)but-2-enoate (153) to (S)-tert-butyl 5-chloro-5-(hydroxyimino)pentane-1,4-
diyldicarbamate (175) in chloroform after which the solution was heated to reflux followed 
by the addition of triethylamine dropwise over 1 h.  The mixture was heated to reflux for a 
further 3 h, then worked up as previously described, dried over magnesium sulfate, filtered 
and concentrated under a reduced pressure to yield a crude dark brown thick oil.  The oil 
was subjected to purification by column chromatography eluting with light petroleum:ethyl 
acetate but none of the fractions isolated were identifiable by NMR spectroscopy, Scheme 
96.  A marker for the isoxazole is the presence of the methyl group giving a singlet 
integrating for 3 protons at 2.5-2.6 ppm in the 1H NMR spectrum, but no fractions displayed 
this signal.  
153 152 
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Scheme 96. Attempted 1,3-dipolar cycloadddition using L-ornithine series and ethyl 
enamine 
This was disappointing and the research ended due to a lack of time and other research 
priorities.  This provides a strong basis for other projects to build upon with potential further 
work to be discussed later. 
 
 
 
 
 
 
 
 
 
 
 
 
 
175 176 
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3.0 – Conclusion 
3.1 – L-Valine and L-Leucine Pyrroloisoxazole Formation and Elaboration 
This report has shown the research conducted towards pyrroloisoxazoles in their role as 
masked forms of acyltetramic acids. 
Across both amino ester series investigated the desired 1,3-dipolar cycloaddition reactants 
were successfully completed to yield the protected isoxazoles tert-butyl 3-(1-tert-
butoxycarbonylamino-2-methylpropyl)-5-methylisoxazole-4-carboxylate (111a) and tert-
butyl 3-(1-tert-butoxycarbonylamino-2-methylbutyl)-5-methylisoxazole-4-carboxylate 
(111b).  The production of these isoxazoles proceeded in good overall yields with a 
maximum of 35% being achieved over the 5 steps, Scheme 97. 
 
 
Scheme 97. Synthesis conducted from starting material to isoxazole 
The isolation of the chlorination product of the oxime products was developed in this 
research and was significant as it provided evidence the cycloaddition reaction itself was 
higher yielding than first perceived.  The solubility of the isolated chloro-oximes in a range 
of solvents also enabled a solvent study to be completed, which confirmed that the most 
efficient solvent in a selection of three with varied polarity was chloroform. 
This isoxazoles were subsequently deprotected leaving the molecules as the hydrochloride 
salts 1-(4-carboxy-5-methyl-1,2-oxazol-3-yl)-2-methylpropan-1-ammonium hydrochloride 
(118a) and 1-(4-carboxy-5-methyl-1,2-oxazol-3-yl)-2-methylbutan-1-ammonium 
110 111 
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hydrochloride (118b).  These salts were then cyclised to form the bicyclic pyrroloisoxazole 
systems using different coupling agents (EDCI (123), along with an activator (HOSu, 120), 
and PS-CDI (124). No significant difference was observed in the yield with a high of 59% 
being reported when using PS-CDI after purification by column chromatography, which was 
required in all cases.  This was until a method was developed utilising the recently 
commercialised peptide coupling agent T3P (126), which enabled the L-valine- and L-
leucine-derived pyrroloisoxazoles to be synthesized in maximum of 68% yield with no 
requirement for purification after a simple work up, Scheme 98.  
 
 
Scheme 98. Successful peptide coupling reaction producing the pyrroloisoxazole 
Upon successful synthesis, 3-methyl-6-(propan-2-yl)-5,6-dihydro-4H-pyrrolo[3,4-
c][1,2]oxazol-4-one (125), was subjected to an anion condensation on to an aldehyde in an 
aldol fashion, Scheme 99.  Table 8 shows the selection of aldehydes added to the C-3 methyl 
position, albeit in low yields.  Limited material and non-reproducibility meant that full 
characterisation was not obtained except in the of crotonaldehyde addition. 
 
Scheme 99. General synthesis for the aldol reaction 
The dehydration of these alcohol products by PTSA acidification was attempted and, in all 
cases, yielded no desired products, Scheme 100.  Product decomposition could have 
occurred as the TLC showed a large number of compounds with similar Rf values in all 
solvent systems attempted. 
118 125 
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Table 8. Products formed in the aldol reaction 
Ref. Aldehyde Yield  
127 Pentanal 6%  
128 Decanal 28%  
129 Isobutyraldehyde 32%  
130 Cyclohexanecarboxylaldehyde 28% 
131 Crotonaldehyde 30% 
 
  
 
 
 
Scheme 100. Summary of failed dehydration reactions 
Possible explanations include small scales necessary, around 20mg-30mg, which could have 
led to detection errors.  Also, a separation was required and, although crude NMR spectra 
were obtained, separations were not completed successfully as Rf values were too similar 
and the products contained too many impurities.  It is also thought that a condensation 
under acidic conditions could be destructive to the molecule, so therefore further work on 
this reaction could investigate the substitution of other leaving groups at the alcohol 
position. 
In a modification to add a different leaving group to the alcohol, preparation of the acetyl 
adduct, was attempted by quenching the aldol reaction with freshly distilled acetyl chloride.  
Results here are to date inconclusive. 
127 – R1 –CH2CH2CH2CH3 
128 – R1 –CH2(CH2)7CH3  
129 – R1 –CH2[CH3]2 
130 – R1 –C6H11 
131 – R1 –CHCHCH3 
 
132 – R2 –CH2CH2CH2CH3 
133 – R2 –CH2(CH2)7CH3  
134 – R2 –CH2[CH3]2 
135 – R2 –C6H11 
136 – R2 –CHCHCH3 
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In conclusion of the further elaborations on the pyrroloisoxazole moieties, acylations at the 
lactam nitrogen were successfully completed.  The conditions required for this were 1.1 
equiv of n-butyl-lithium stirred at -78oC for 10 minutes followed by addition of the acyl 
chloride (1.1 equiv) and stirring for 3 hours, which after work up provided a library of N-
acylpyrroloisoxazoles in a range of moderate to excellent yields.  The library of analogues 
produced is shown in Table 9 with individual yields. 
N-Alkylation reactions were unsuccessful after several attempts in a range of conditions, 
summarised in Table 10.  These results were disappointing, but it was determined that the 
N-acyl compounds contained sufficient diversity to continue the synthesis with them alone 
and further effort was not expanded in developing the alkylation reaction.  This indicates 
that the nucleophilicity of the nitrogen anion formed by the deprotonation is not sufficient 
to attack the alkyl and prop-1-enyl halides 
Table 9.  Library of N-Acyl Compounds formed with respective yields 
   
   
  
 
137a E-139a 140a 
141a 137b 138a 
140b 141b E-139b 
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Table 10.  N-Alkylation conditions attempted  
Ref. 1 2 3 4 5 
Substrate 1-
Bromobutane 
1-
Bromobutane 
Allyl Bromide Allyl Bromide Allyl Bromide 
Time 2 Hr 2 Hr 2 Hr 2 Hr 2 Hr 
Temperature -78oC -78oC to rt -78oC to rt -78oC to reflux -78oC to 
reflux 
Ion Catalyst None None None None Potassium 
Iodide 
 
The acylations were successful in providing a library of 12 novel ‘masked’ analogues of the 
biologically active natural product reutericyclin, which are available for biological testing.  
They are of interest as mimics of the natural products.  The next requirement in the pursuit 
of the 3-acyltetramic acids was to cleave the isoxazole ring, for which two successful 
method were described.  The first of these techniques involved a hydrogenation: subjecting 
two saturated N-acylpyrroloisoxazoles to a hydrogen atmosphere over palladium on carbon 
provided the enaminoketones in an average 50% yield after purification, Scheme 101.  
 
 
138b E-138c 137c 
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Scheme 101. Hydrogenation ring opening of isoxazole ring  
The second reduction conditions utilised also produced the enaminoketone functionality 
but were unsuitable for an N-unsaturated acylpyrroloisoxazole, namely the N-crotonyl 
phenylglycine-derived pyrroloisoxazole which contained a double carbon-carbon bond in 
the acyl group.  This alkene can be reduced by H2 and palladium on carbon, so the 
alternative method had to be used. This was accomplished using molybdenum hexacarbonyl 
in moist acetonitrile in an acceptable 50% yield, Scheme 102. 
 
 
Scheme 102. Reduction using molybdenum hexacarbonyl ring opening of isoxazole ring  
This process provided us with  a further 3 novel enaminoketone compounds containing N-
acylation that were also suitable for biological testing as the structure of the enaminoketone 
pyrrolidine is electronically similar to the final acyltetramic acid.  
The last stage identified a problem in which the hydrolysis of the enaminoketone to form a 
1,3-dicarbonyl function was difficult to achieve. This occurred as the N-acyl groups either 
were hydrolysed, leading to a previously synthesised 3-acyltetramic acid, or the conditions 
were not strong enough to complete the required hydrolysis.  A summary of the conditions 
a – R1 –(CH3)2CH,  
b – R1 – (CH3)2CHCH2 
 
137 147 
139c 148 
New Routes to Acyltetramic Acids and Analogues – James Bullous 
 
123 
and their results is shown in Table 11. 
Table 11.  Enaminoketone hydrolysis or diazotisation methods  
REF. 1 2 3 4 5 
TYPE OF REACTION Base 
Hydrolysis 
Base 
Hydrolysis 
Base 
Hydrolysis 
Acid 
Hydrolysis 
Diazotisation 
REACTANT 
(CONCENTRATION)  
H2O NaOH         
(0.1 M) 
NaOH           
(2 M) 
HCl          
(2 M) 
NaNO2 
TIME 20 Hr 20 Hr 20 Hr 20 Hr 3 Hr 
TEMPERATURE 
RESULT 
reflux 
no 
reaction 
 rt 
N-acyl 
hydrolysis 
-rt 
N-acyl 
hydrolysis 
rt 
no 
reaction 
0oC to 50oC  
no reaction 
 
These results mean further study is necessary, but the main stream of the research did 
produce a range of compounds that would be suitable for biological testing and showed a 
new style of reactivity to which the useful pyrroloisoxazole moieties can be utilised. 
This work was accepted for publication in Chemical Communications93 and can be found in 
the appendix of this thesis. 
 
3.2 –Model Formation and Reactivity 
The model chemistry was planned as a route to towards quickly and inexpensively 
determining which reactions and condition may lead to a successful reaction on the 
pyrroloisoxazole and, therefore, maximising time spent on following encouraging leads.  The 
model was made in two versions after several failed reactions with ethyl 3,5-
dimethylisoxazole-4-carboxylate (ethyl ester, 150), where N,3,5-trimethylisoxazole-4-
carboxamide (amide, 151) (Scheme 103) is a closer model and yielded a successful result.  
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Scheme 103. Models and pyrroloisoxazole. 
The N,3,5-trimethylisoxazole-4-carboxamide model (151), was produced in 5 steps from 
ethyl acetoacetate (152) and is shown in Scheme 104. 
 
Scheme 104. Summary of model product 
 
Once the model was formed a number of reactions were completed attempting to find 
appropriate reaction conditions, these are summarised in Table 12. 
 
 
 
125a 150 151 
152 
153 
150 
159 160 
151 
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Table 12.  Summary showing results from model isoxazole reaction 
Ref.* Isoxazole Base Time/ 
Temperature 
Aldehyde Solvent Yield 
156 Ethyl Ester nBuLi 2 h / -780C Pentanal THF - 
157 Ethyl Ester NaOMe 3 h / reflux Paraformaldehyde Methanol - 
158 Ethyl Ester NaOMe 3 h / reflux Benzaldehyde Methanol - 
162 Amide **NaOMe 3 h / reflux Benzaldehyde Methanol - 
162 Amide **NaOMe 24 h/ reflux Benzaldehyde Methanol - 
161 Amide **NaOMe 3 h / reflux Paraformaldehyde Methanol - 
162 Amide nBuLi 3 h / reflux Benzaldehyde THF - 
162 Amide **NaOtBu 24 h/ reflux Benzaldehyde THF/tBuOH 24% 
161 Amide **NaOtBu 24 h/ reflux Paraformaldehyde THF/tBuOH - 
163 Amide KOtBu 24 h/ reflux Benzaldehyde  THF 33%a 
166 Amide Ketone - 24 h/ reflux PTSA Toluene 99% 
168 Amide KOtBu 24 h/ reflux Butryrl Chloride THF - 
 
Note that all solvents used were dry, either freshly distilled or brought dry. Also that ethyl 
ester isoxazole is ethyl 3,5-dimethylisoxazole-4-carboxylate (150) and amide isoxazole is 
N,3,5-trimethylisoxazole-4-carboxamide (151).*Denotes were the base was freshly 
prepared.** Denotes the number reference for the product, a Represents the synthesis of the 
ketone 
The table shows that only one condition tested was successful in accomplishing the aldol 
condensation reaction, producing a new alkene bond.  This required tert-butoxide as a base 
in dry THF with stirring overnight for 24 hours, and the specific reaction is shown in Scheme 
105. 
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Scheme 105. Successful aldol condensation reaction 
The table also shows the assumed disproportionation reaction in which the attempted aldol 
reaction resulted in the synthesis of the ketone, an oxidised version of the desired alcohol.  
This was confirmed by NMR spectroscopy.  This ketone could be reduced with sodium 
borohydride to give an alcohol, Scheme 106.  This alcohol could not be dehydrated to the 
previously synthesised alkene through addition of PSTA and under Dean-Stark conditions, 
after which only unidentified decomposed material was recovered. 
Scheme 106. Conditions for the aldol reaction to form the ketone with benzaldehyde and 
subsequent reduction by NaBH4. 
An N,C-diacylation attempt was made on the amide model and the L-valine-based 
pyrroloisoxazole using previously successful bases and an excess of butyryl chloride.  In the 
case of the model amide, no identifiable products were isolated after several attempts.  The 
pyrroloisoxazole did not afford the diacylated product but did return the mono-N-acylated 
compound in a 92% yield.  This confirmed that the anion formed at the methyl group was 
only weakly nucleophilic, being extensively stabilised by delocalisation, Scheme 107. 
151 166 
151 167 
163 
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Scheme 107. Possible resonance structures seen in pyrroloisoxazole 
Further investigation of C-deprotonation and reaction is required.  
 
3.3 –Laccarin Analogue Synthesis 
The synthesis of a laccarin analogue appeared to be an ideal extension of the synthesis to 
more than the directly targeted 3-acyltetramic acids.  The Boc protected oxime, (S)-ethyl 
2,5-bis((tert-butoxycarbonyl)amino)pentanoate (172) was produced in four stages from the 
commercially available and cheap L-ornithine (170) on an overall yield of 40%, which was 
good over the four stages as an additional esterification was required.  The cycloaddition 
was then completed successfully with enamine tert-butyl 3-(pyrrolidin-1-yl)but-2-enoate 
(72) in a low 5% yield over two stages directly from the oxime. The next deprotection 
reaction was confirmed based on mass spectrometry and 13C NMR.  This hydrochloride salt 
was then tried in a cyclisation to form the new pyrrolidine-ring, which proved unsuccessful 
in several attempts.  The research undertaken towards synthesis of the laccarin analogue 
has been summarised in Scheme 108. 
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Scheme 108. Summary towards synthesis of a laccarin analogue 
We attempted to reverse the order of steps, by the synthesis of an ethyl ester substituted 
isoxazole which would be ring opened by hydrogenation then treated with a peptide 
coupling agent.  This synthesis was unsuccessful in that although the chloro-oxime was 
isolated, the 1,3-dipolar cycloaddition was unsuccessful.  The characteristic methyl group 
seen at 2.5-2.6 ppm in the NMR spectra of the 5-methyl isoxazoles was not observed 
(Scheme 109).   
 
 
174 
170 
72 
178 
171 
172 173 
176 
177 
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Scheme 109. Attempted 1,3-dipolar cycloadddition using L-ornithine series and ethyl 
enamine 
This was disappointing but the project could be built upon by either completing the 
synthesis with the tert-butyl ester followed immediately by hydrogenation as well as 
potentially using the recent modification of T3P as a coupling agent. 
 
3.4 – Potential Further Work 
Further investigations are needed to find a reliable route to C-3 (Me) deprotonation of the 
pyrroloisoxazoles.  Enaminoketone hydrolysis of N-acylated tetramides also requires 
additional investigation. 
The laccarin synthesis has several potential routes that could be attempted, for example 
following the developed procedure to form the tert-butyl ester isoxazole then 
hydrogenation.  The other main alteration is to try using T3P as an effective coupling agent 
for the lactam ring closing reaction, which could result in the successful formation of the 
pyrroloisoxazole which could under the enaminoketone formation and subsequent 
hydrolysis as previously planned. 
 
 
 
175 176 
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4.0 – Experimental 
4.1 – General Procedure 
All reactions, unless otherwise stated, were completed under a nitrogen atmosphere and 
room temperature, which refers to an ambient temperature of 19-25 0C.  All glassware, 
needles and syringes used were either new, therefore used straight from the sealed original 
packaging, or were washed prior to use using acetone and dried in an oven (150 0C), with 
the exception of plastic syringes, which were dried on the bench top.  Temperatures of 0 0C 
were achieved by using an ice bath, -78 0C was reached by using a dry ice-acetone mixture in 
a Dewar vessel.  Experiments requiring heat were completed by using heating mantles, with 
a thermometer, and a hot plate fitted around a round bottomed flask.  Dry experiments 
were ensured by placing a round bottomed flask under a nitrogen flow and then heating it 
strongly with a flame gun to remove the moisture. 
TLC plates used to analyse products and reaction progress were aluminium backed silica gel 
F245 plates (produced by Merck) and were visualised either under UV light (at 254 nm) or by 
using a phosphomolybdic acid, ninhydrin or vanillin dip.  When chromatography was used to 
separate products, columns were loaded with silica gel (60 Å) which was purchased from 
Fluorochem.  
Anhydrous THF was freshly distilled from sodium-benzophenone.  Where light petroleum is 
stated, this refers to the 40 0C – 60 0C boiling range and most other reactants used were not 
further purified after purchase, with the exception of the aldehydes used which were 
purified by distillation or by dissolving in diethyl ether and washing with sodium 
bicarbonate, and all products were acquired from Sigma-Aldrich or Merck.  Deuterated-
chloroform (CDCl3), deuterated-water (D2O) and deuterated-dimethyl sulfoxide (d6-DMSO) 
were used in all cases as nuclear magnetic resonance spectroscopy (NMR) solvents and kept 
dry using molecular sieves, which were oven heated and dried on the high vacuum for 1 h 
prior to adding them to the solvent, and stored in a desiccator.  Tetramethylsilane (TMS) 
was added to the NMR solvents as a standard. 
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The NMR spectra, both carbon (13C) and hydrogen (1H), were acquired using a Bruker DPX-
400MHz spectrometer which provided frequencies of 100MHz for 13C and 400MHz for 1H 
analysis.  All chemical shifts are reported in parts per million (ppm) where the TMS peak was 
an internal standard (at 0 ppm) and coupling constants (J) are all reported in Hz.  The infra-
red spectroscopic analysis was completed using a Perkin Elmer Paragon 1000 spectrometer 
and sodium chloride plates, where the sample was dried onto the plates by dissolving it in 
DCM and then loading it to the plate. Mass spectrometry results were obtained on a 
Thermo Fisher Exactive Accurate Mass Spectrometer with Advion Triversa Nanomate 
automation.  Melting points were identified by using a Stewart Scientific SMP3 Melting 
Point Apparatus. 
References have been given if the methodology used was similar and if the characterisation 
data were comparable to the source.  
I would like to thank Dr. Mark Elsegood of Loughborough University for his help and support 
in obtaining the X-ray crystallography data shown in this report.  Also I would like to thank 
Dr. Mark Edgar for his expertise and advice in NMR spectroscopy analysis and techniques.  
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4.2 – Preparation of Pyrroloisoxazole from L-Valine  
 
tert-Butyl 3-(pyrrolidin-1-yl)but-2-enoate (72)75  
Pyrrolidine (10 g, 11.74 mL, 141 mmol) was added to a 500 mL round bottomed flask 
containing tert-butyl 3-oxobutanoate (20 g, 20.81 mL, 126 mmol) in toluene (250 mL).  The 
reaction mixture was heated to reflux under Dean-Stark conditions for 4 h.  The reaction 
mixture was then left to cool to room temperature before removing the excess solvent 
under reduced pressure.  This yielded the product as a cream solid (26.4 g, 99%); mp 97.1-
100.2 °C, lit.79 mp 96-98 °C; MS: m/z calculated for C12H21NO2 (MNa+): 234.1465.  Found 
234.1461; IR νmax (CHCl3)/cm-1 2959 (CCH), 2800 (CH2, CH3), 1634 (CO), 1583 (CC), 1130 (CN); 
1H NMR δH (400 MHz; CDCl3) 1.39 (9H, s, C(CH3)3), 1.83 (4H, t, J 7.6, 2xsymmetrical (CH2)), 
2.35 (3H, s, CHCCH3), 3.16-3.20 (4H, br. m, 2xsymmetrical (CH2)N), 4.33 (1H, s, CHCCH3); 13C 
NMR δC (100 MHz; CDCl3) 16.5 (CH3), 25.2 (CH2), 28.7 (C(CH3)3), 47.8 (CH2), 85.0 (CHCCH3), 
158.9 (CN), 169.2 (COO). 
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(S)-methyl 2-((tert-butoxycarbonyl)amino)-3-methylbutanoate (106a)75 
Triethylamine (2 eq, 24.2 g, 33.3 mL, 239 mmol) was added dropwise to S-valine methyl 
ester hydrochloride salt (20.0 g, 119 mmol) in dichloromethane (400 mL) over 60 minutes at 
0 oC.  Di-tert-butyl dicarbonate (1.1 eq, 27.2 g, 125 mmol) in DCM (22 mL) was added 
dropwise over 60 minutes at 0 oC, after which the reaction mixture was stirred for a further 
60 minutes at 0 oC.  After this time the clear colourless reaction mixture was cooled to room 
temperature and stirred continuously for 18 h, under a nitrogen atmosphere.   The reaction 
mixture, now a colourless clear solution, was washed with citric acid solution (1 M, 250 mL) 
and saturated brine (2 x 200 mL), then dried using magnesium sulfate which was removed 
by filtration and the product was achieved removing the excess solvent under a reduced 
pressure as a clear colourless oil (27.0 g, 99%); [α]Drt +21.5 (c 1, CHCl3), lit.96 [α]Drt +22 (c 1, 
MeOH); MS: m/z calculated for C11H21NO4 (MNa+): 254.1363.  Found 254.1358; IR νmax 
(CHCl3)/cm-1 3206 (NH), 2962 (CH2, CH3), 1726 (C=O), 1556 (NH), 1309 (CN), 1254 (C-O); 1H 
NMR δH (400 MHz; (CDCl3)) 0.82 (3H, d, J 6.8 Hz, CH(CH3)), 0.88 (3H, d, J 7.2 Hz, CH(CH3)), 
1.38 (9H, s, C(CH3)3), 1.99-2.11 (1H, m, CH(CH3)2), 3.66 (3H, s, CO2CH3), 4.15 (1H, dd, Ja 9.0 
Hz, Jb 5.0 Hz, CHNH), 5.01 (1H, broad s, CHNH); 13C NMR δC (100 MHz; (CDCl3)) 17.4 ((CH3)2), 
18.9 ((CH3)2), 28.3 (CH(CH3)2), 31.2 (C(CH3)3), 51.9 (CO2CH3), 58.5 (CHNH), , 79.7 (C(CH3), 
155.6 (NCOO), 172.9 (COO). 
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(S)-tert-Butyl (3-methyl-1-oxobutan-2-yl)carbamate (107a)75 
Diisobutylaluminium hydride (1.0 M in toluene, 41 mL, 41 mmol) was added dropwise to (S)-
tert-butyl (2-methyl-4-oxohexan-3-yl)carbamate (83) (3.3 g, 14.3 mmol) suspended in dry 
toluene (100 mL) under nitrogen at -78 oC over 4 h.  The reaction mixture was stirred under 
these conditions for a further 1 h.  Methanol (70 mL) and water (100 mL) were added and 
the mixture was then stirred vigorously for 2 h.  The aqueous phase was separated and 
extracted with ethyl acetate (3 x 50 mL) and the combined organic layers were washed with 
brine (2 x 50 mL).  The organic fraction was dried using magnesium sulfate, filtered and 
concentrated under reduced pressure to yield the aldehyde as a clear, colourless oil (2.60 g, 
91%); [α]Drt +36.2 (c 1, CHCl3); MS: m/z calculated for C10H19NO3 (MNa+): 224.1257.  Found 
224.1255; IR νmax (CHCl3)/cm-1 3299 (NH), 2942 (CH2, CH3), 1709 (C=O), 1367 (CN), 1269 (C-
O); 1H NMR δH (400 MHz; (CDCl3)) 0.87 (3H, d, J 5.6 Hz, CH(CH3)), 0.95 (3H, d, J 6.0 Hz, 
CH(CH3)), 1.38 (9H, s, C(CH3)3), 2.12-2.28 (1H, m, CH(CH3)2), 4.15 (1H, dd, Ja 7.9 Hz, Jb 5.1 Hz, 
CHNH), 5.21 (1H, d, J 7.9 Hz, CHNH), 9.57 (1H, broad, CHO); 13C NMR δC (100 MHz; (CDCl3)) 
17.5 ((CH3)2), 18.7 ((CH3)2), 29.0 (C(CH3)3), 29.6 (CH(CH3)2), 64.5 (CHNH), 151.9 (NCOO), 199.8 
(CHO). 
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 (S)-tert-Butyl 1-(hydroxyimino)-3-methylbutan-2-yl]carbamate (109a)75 
(S)-tert-Butyl (3-methyl-1-oxobutan-2-yl)carbamate (84) (2.4 g, 11.9 mmol) in ethanol         
(50 mL) was added to hydroxylamine hydrochloride (1.65 g, 23.8 mmol) and sodium acetate 
(3.91 g, 47.7 mmol) suspended in water (50 mL).  A white precipitate formed and was re-
dissolved with ethanol (15 mL), the solution was then heated to 70 0C and stirred for 0.5 h, 
during which a watchglass was placed over the neck of the round bottomed flask to avoid 
solvent evaporation.  The reaction mixture was then allowed to cool to ambient 
temperature and was placed in the refrigerator (2-5 0C) to remove impurities via 
crystallisation for 20 h.  After this a white precipitate had formed which was removed via 
filtration.  The filtrate was then separated and extracted with ethyl acetate (3 x 70 mL).  The 
organic phases were dried over magnesium sulfate.  The excess solvent was removed under 
a reduced pressure to leave the product tert-butyl 1-(hydroxyimino)-3-methylbutan-2-
yl]carbamate as a white solid (2.20 g, 86 %); mp 111-115 °C; MS: m/z calculated for 
C10H20N2O3 (MNa+): 239.1366.  Found 239.1365; IR νmax (nujol)/cm-1 3415 (OH) 3379 (NH), 
2976 (CH2, CH3), 1709 (C=O), 1678 (CN), 1399 (NH), 1349 (CN), 1249 (C-O); 1H NMR δH (400 
MHz; (CD3)2SO)) 0.88 (6H, 2 x d, J 6.4 Hz, CH(CH3)2), 1.38 (9H, s, C(CH3)3), 1.72-1.78 (1H, m, 
CH(CH3)2), 4.55 (1H, dd, Ja 7.6 Hz, Jb 10.6 Hz, CHNH), 6.51 (1H, d, J 7.6 Hz, CHNOH), 6.99 (1H, 
d, J 10.6 Hz, CHNH), 10.9 (1H, s, OH); 13C NMR δC (100 MHz; ((CD3)2SO)) 18.6 ((CH3)2), 28.2 
(C(CH3)3), 39.4 (CH(CH3)2), 50.2 (CHNH), 149.9 (CHN), 155.2 (NCOO).   
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(S)-tert-Butyl 1-chloro-1-(hydroxyimino)-3-methylbutan-2-yl]carbamate (116a)75 
N-Chlorosuccinimide (1.1 eq, 1.47 g, 11.0 mmol) was added dropwise to (S)-tert-butyl 1-
(hydroxyimino)-3-methylbutan-2-yl]carbamate (85) (2.16 g, 9.98 mmol) suspended in 
chloroform (50 mL) at 0 oC over 60 minutes.  The reaction mixture was then heated at reflux 
for 18 h to produce the chlorinated light brown solution which was added to directly 
without purification; [α]Drt +19.6 (c 1, CHCl3); MS: m/z calculated for C10H21N2O335Cl (MNa+- 
HCl): 238.1293.  Found 238.1294; IR νmax (CHCl3)/cm-1 3350 (OH), 2985 (CH2, CH3), 1711 
(C=O), 1525 (NH), 1298 (CN), 1259 (C-O) 1095 (N-O); 1H NMR δH (400 MHz; (CDCl3)) 0.89 (3H, 
d, J 4.0 Hz, CH(CH3)), 0.92 (3H, d, J 4.0 Hz, CH(CH3)), 1.46 (9H, s, C(CH3)3), 1.96-2.03 (1H, m, 
CH(CH3)2), 4.25 (1H, br. s, OH), 4.39 (1H, t, J 9.6 Hz, CHNH), 4.97 (1H, d, J 9.6 Hz, CHNH); 13C 
NMR δC (100 MHz; (CDCl3)) 18.5 ((CH3)2), 19.3 ((CH3)2), 27.6 (C(CH3)3), 30.4 (CH(CH3)2), 59.2 
(CHNH), 79.8 (C(CH3)3, 138.2 (CHN), 167.2 (NCOO). 
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(S)-tert-Butyl 3-(1-tert-butoxycarbonylamino-2-methylpropyl)-5-methylisoxazole-4-
carboxylate (111a)75 
To freshly prepared (S)-tert-butyl 1-chloro-1-(hydroxyimino)-3-methylbutan-2-yl]carbamate 
(86) (1.3 g, 5.80 mmol) was added directly tert-butyl 3-(pyrrolidin-1-yl)butyl-2-enoate (81) (2 
eq, 2.28 g, 10.52 mmol) in one portion, followed by triethylamine (1.1 eq, 0.81 mL, 5.78 
mmol) over 60 minutes at room temperature.  The reaction mixture was heated at reflux for 
a further 3 h under a nitrogen atmosphere, cooled and subsequently poured into water (100 
mL).  The organic layer was separated and washed with citric acid solution (2 M, 200 mL), 
sodium acetate solution (5%, 100 mL) and brine (2 x 100 mL).  The brown oil was then dried 
over magnesium sulfate, filtered and concentrated under a reduced pressure to yield a light 
brown/yellow oil (1.33 g, crude 75 %).  This crude material was purified by flash 
chromatography eluting with light petroleum:ethyl acetate (3:1 v/v) to yield the product 
isoxazole as a yellow oil (0.88 g, 45% over two steps); [α]Drt -6.2 (c 1, CHCl3), lit.75 [α]Drt -8.0 (c 
10, CHCl3); MS: m/z calculated for C18H30N2O5 (MNa+): 377.2047.  Found 377.2039; IR νmax 
(CHCl3)/cm-1 3203 (NH), 2986 (CH2, CH3), 1716 (C-O), 1691 (CN), 1651 (CC), 1487 (NH), 1296 
(C-O); 1H NMR δH (400 MHz; (CDCl3)) 0.86 (3H, d, J 7.2 Hz, CH(CH3)2), 0.90 (3H, d, J 7.2 Hz, 
CH(CH3)2), 1.33 (9H, s, C(CH3)3), 1.45 (9H, s, C(CH3)3), 1.99-2.09 (1H, m, CH(CH3)2), 2.58 (3H, s, 
COCH3), 4.91 (1H, dd, Ja 7.9 Hz, Jb 15.2 Hz CHNH), 5.69 (1H, d, J 7.9 Hz, CHNH); 13C NMR δC 
(100 MHz; (CDCl3)) 13.2 (5-CH3), 17.7 ((CH3)2), 19.8 ((CH3)2), 28.0 (C(CH3)3), 28.2 (C(CH3)3), 
31.0 (CH(CH3)2), 81.5(CHNH), 107.8 (C(CH3)3), 155.8 (C(CH3)3), 161.2 (CCO), 165.4 (CN), 166.0 
(CCO), 174.4 (NCOO), 200.0 (COO). 
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 (S)-3-(1-Amino-2-methylpropyl)-5-methylisoxazole-4-carboxylic acid hydrochloride 
(118a)75 
Trifluoroacetic acid (30 eq, 34.6 mL, 448.6 mmol) was added to tert-butyl (S)-3-(1-tert-
butyloxycarbonylamine-2-methylpropyl)-5-methylisoxazole-4-carboxylate (87) (5.30 g,  
14.95 mmol).  The mixture was stirred at room temperature for 4.5 h to produce a brown 
paste, which was concentrated under a reduced pressure. The dry residue was then 
resuspended in hydrochloric acid (30 eq, 2 M, 224 mL, 448.6 mmol) and the mixture was 
stirred at room temperature for a further 1 h.  The excess acid was removed under a 
reduced pressure producing a pink/brown residue which was dissolved in water (100 mL) 
and washed with ethyl acetate (3 x 70 mL), retaining the aqueous phase.  The aqueous 
phase was evaporated to dryness under reduced pressure, yielding 3-(1-amino-2-
methylpropyl)-5-methylisoxazole-4-carboxylic acid hydrochloride as a yellow/brown 
crystalline solid ( 3.5 g, 99%); [α]Drt -5.6 (c 1, MeOH), lit.75 [α]Drt -9.8 (c 13, MeOH); mp 183-
187 oC; MS: m/z calculated for C9H15N2O3 (MH+): 199.1076.  Found 199.1076; IR νmax 
(CHCl3)/cm-1 3010 (OH), 2923 (CH3), 1709 (CO), 1689 (CN), 1646 (CC), 1429 (NH), 1396 (OH), 
1352 (CN); 1H NMR δH (400 MHz; ((CD3)2SO)) 0.90 (3H, d, J 6.8 Hz, CH(CH3)2), 1.05 (3H, d, J 
6.8 Hz, CH(CH3)2), 2.21-2.33 (1H, m, CH(CH3)2), 2.67 (3H, s, CH3), 4.64-4.65 (1H, m, CHNH), 
8.78 (3H, s, NH3); 13C NMR δC (100 MHz; ((CD3)2SO)) 13.1 (5-CH3), 18.3 ((CH3)2), 17.9 ((CH3)2), 
30.6 (CH(CH3)2), 51.2 (CHNH), 108.7 (CC), 160.3 (CN), 162.7 (NCOO), 175.7 (COO). 
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(S)-5,6-Dihydro-6-(1-methylethyl)-3-methyl-4H-pyrrolo[3,4-c]isoxazol-4-one (125a)75 
(S)-3-(1-Amino-2-methylpropyl)-5-methylisoxazole-4-carboxylic acid hydrochloride (93) (1.5 
g, 6.39 mmol) was dissolved in dry DMF/DCM (1:9, 20 mL) and stirred under a nitrogen 
atmosphere for 15 minutes.  To this mixture was then added the polystyrene-carbodiimide 
(2.5 eq, 13.32 g, 15.98 mmol) and triethylamine (1.97 mL, 14.06 mmol) and stirring was 
continued at room temperature and under a nitrogen atmosphere for a further 48 h.  The 
remaining polystyrene-carbodiimide was removed by filtration, washing with dry DMF/DCM 
(1:9, 5 mL).  The filtrate was then washed with saturated potassium carbonate solution (2 x 
30 mL) and brine (2 x 30 mL) and dried using magnesium sulfate.  The solution was 
concentrated under reduced pressure to obtain an orange/brown solid (1.2 g, 80%).  This 
solid was separated using flash chromatography with ethyl acetate and light petroleum (5:1 
v/v) to give a pale yellow solid identified as (S)-5,6-dihydro-6-(1-methylethyl)-3-methyl-4H-
pyrrolo[3,4-c]isoxazol-4-one  (600 mg, 59%); [α]Drt +7.9 (c 1, CHCl3), lit.75 [α]Drt +7.9 (c 1, 
CHCl3), lit.75 [α]Drt +6.8 (c 12.3, CHCl3); mp 167-170 °C; MS: m/z calculated for C9H12N2O2 
(MH+): 181.0970.  Found 181.0970; IR νmax (CHCl3)/cm-1 3220 (NH), 3017 (CH3), 1700 (CO), 
1653 (CC), 1465 (NH), 1390 (CN), 1133 (COC); 1H NMR δH (400 MHz; (CDCl3)) 1.04 (3H, d, J 
4.0 Hz, CH(CH3)2), 1.10 (3H, d, J 6.2 Hz, CH(CH3)2), 2.05-2.14 (1H, m, CH(CH3)2), 2.65 (3H, s, 
CH3), 4.50 (1H, d, J 5.3 Hz, CHNH), 6.32 (1H, broad, CHNH); 13C NMR δC (400 MHz; (CDCl3)) 
12.1 (CH3), 17.6 ((CH3)2), 18.3 ((CH3)2), 31.5 (CH(CH3)2), 58.6 (CHNH), 113.8 (CCO), 163.1 
(CN), 166.2 (CO), 171.3 (NCO).  Crystals were able to be grown from DCM and the data can 
be found later in this report. 
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(S)-5,6-Dihydro-6-(1-methylethyl)-3-methyl -4H-pyrrolo[3,4-c]isoxazol-4-one (125a) 
1-[3-(Dimethylamino)propyl]-3-ethylcarbodiimide hydrochloride  (EDCI) (1.09 g, 7.03 mmol, 
1.1 eq) was added to a suspension of (S)-3-(1-amino-2-methylpropyl)-5-methylisoxazole-4-
carboxylic acid hydrochloride (93) (0.50 g, 2.13 mmol) and N-hydroxysuccinimide (0.81 g, 
7.03 mmol, 1.1 eq) in dry dimethylformamide (50 mL) at 0 0C.  The reaction mixture was 
stirred at room temperature for 17 h.  Triethylamine (1.96 mL, 15.46 mmol, 2.2 eq) was 
added and the reaction mixture left to stir for a further 17 h and then concentrated under a 
reduced pressure.  The residue was dissolved in ethyl acetate (60 mL) and washed with 
water (60 mL), hydrochloric acid (2M, 60 mL), saturated sodium bicarbonate solution (60 
mL) and saturated brine (60 mL).  The organic layer was dried over magnesium sulfate, 
filtered and concentrated under a reduced pressure to yield a beige solid (0.23 g, 60 %).  The 
solid was purified by column chromatography using silica gel as absorbent and ethyl 
acetate:light petroleum (5:1 v/v) as eluent to yield (100) as a white solid (600 mg, 40%); 
Characterisation data were identical to those reported above. 
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(S)-5,6-Dihydro-6-(1-methylethyl)-3-methyl-4H-pyrrolo[3,4-c]isoxazol-4-one (125a) 
(S)-3-(1-Amino-2-methylpropyl)-5-methylisoxazole-4-carboxylic acid hydrochloride (93) 
(2.70 g, 11.5 mmol) in ethyl acetate (20.0 mL) was stirred under a nitrogen atmosphere for 
15 minutes at 0 0C.  To this was then added triethylamine (4.00 mL, 28.8 mmol) and the 
reaction mixture stirred for a further 10 minutes before the addition of propylphosphonic 
anhydride solution (T3P) (50% (w/w) in ethyl acetate, 8.78 g, 6.59 mL, 13.8 mmol) at 00C.  
Stirring was continued and the mixture allowed to warm to room temperature and under a 
nitrogen atmosphere for a further 17 h.  The reaction mixture was then washed with citric 
acid solution (1M, 50.0 mL) saturated potassium carbonate solution (2 x 30.0 mL) and brine 
(2 x 30.0 mL) and dried using magnesium sulfate.  The solution was then concentrated under 
a reduced pressure to obtain pure (S)-5,6-dihydro-6-(1-methylethyl)-3-methyl-4H-
pyrrolo[3,4-c]isoxazol-4-one as a white solid (1.15 g, 59%); Characterisation data were 
identical to those reported above. 
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4.3 – Preparation of the Pyrroloisoxazole from L-Leucine  
 
 (S)-Methyl 2-((tert-butoxycarbonyl)amino)-4-methylpentanoate (106b)  
Triethylamine (2 eq, 22.26 g, 30.68 mL, 220.0 mmol) was added dropwise to L-leucine 
methyl ester (20.0 g, 110.0 mmol) in dichloromethane (400 mL) over 60 minutes at 0 oC.  Di-
tert-butyl dicarbonate (1.1 eq, 25.11 g, 115.5 mmol) in DCM (60 mL) was added dropwise 
over 60 minutes at 0 oC, after which the reaction mixture was stirred for a further 60 
minutes at 0 oC.  After this time the clear, colourless reaction mixture was cooled to room 
temperature and stirred continually for 18 h, under a nitrogen atmosphere.   The reaction 
mixture, now a colourless clear solution, was washed with citric acid solution (1 M, 250 mL) 
and saturated brine (2 x 200 mL), then dried using magnesium sulfate which was removed 
by filtration and the product was achieved removing the excess solvent under a reduced 
pressure as a clear colourless oil (26.2 g, 97%); [α]Drt -13.2 (c 1, CHCl3); MS: m/z calculated 
for C12H23NO4 (MNa+): 268.1519.  Found 268.1515; IR νmax (CHCl3)/cm-1 3436 (NH), 2984 
(CH2, CH3), 1713 (C=O), 1502 (NH), 1368 (CN), 1265 (C-O); 1H NMR δH (400 MHz; (CDCl3)) 
0.90 (3H, d, J 2.4 Hz, CH(CH3)), 0.95 (3H, d, J 2.4 Hz, CH(CH3)), 1.42 (9H, s, C(CH3)3), 1.49-1.51 
(1H, m, CH(CH3)2), 1.52-1.59 (1H, m, CH2CH(CH3)2), 1.65-1.69 (1H, m, CH2CH(CH3)2), 3.61 (3H, 
s, CO2CH3), 4.39 (1H, dd, Ja 8.1 Hz, Jb 4.2 Hz, CHNH), 4.98 (1H, broad s, CHNH); 13C NMR δC 
(100 MHz; (CDCl3)) 21.8 ((CH3)2), 22.8 ((CH3)2), 24.7 (CH(CH3)2), 28.7 (C(CH3)3), 41.7 (CH2), 
51.4 (CO2CH3), 56.0 (CHNH), 79.7 (C(CH3)3, 155.4 (NCOO), 174.0 (COO). 
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(S)-tert-Butyl (4-methyl-1-oxopentan-2-yl)carbamate (108b)  
Diisobutylaluminium hydride (1.0 M in toluene, 133 mL, 133 mmol) was added dropwise to 
(S)-methyl 2-((tert-butoxycarbonyl)amino)-4-methylpentanoate (106b) (13.1 g, 53.3 mmol) 
suspended in dry toluene (100 mL) under nitrogen at -78 oC over 4 h.  The reaction mixture 
was stirred under these conditions for a further 1 h.  Methanol (70 mL) was added to 
quench excess DIBAL and the solution was added to Rochelle salt (50 g) in water (100 mL) 
and the mixture was then stirred vigorously for 2 h.  The aqueous phase was separated and 
extracted with ethyl acetate (3 x 50 mL) and the combined organic layers were washed with 
brine (2 x 50 mL).  The organic fraction was dried using magnesium sulfate, filtered and 
concentrated under a reduced pressure to yield the aldehyde as a clear, colourless oil (10.63 
g, 93%); [α]Drt +21.5 (c 1, CHCl3); MS: m/z calculated for C11H22NO3 (MNa+): 239.1492.  Found 
239.1487; IR νmax (CHCl3)/cm-1 3429 (NH), 2986 (CH2, CH3), 2820 (OC-H), 2730 ((OC-H), 1709 
(C=O), 1502 (NH), 1368 (CN), 1265 (C-O); 1H NMR δH (400 MHz; (CDCl3)) 0.87 (3H, d, J 2.4 Hz, 
CH(CH3)), 0.87 (3H, d, J 2.4 Hz, CH(CH3)), 1.28-1.35 (1H, m, CH(CH3)2), 1.40 (9H, s, C(CH3)3), 
1.57-1.65 (1H, m, CH2CH(CH3)2), 1.68-1.77 (1H, m, CH2CH(CH3)2), 4.15-4.21 (1H, br. m, 
CHNH), 5.13 (1H, br. d, J 4.0 Hz, CHNH), 9.50 (1H, s, CHO); 13C NMR δC (100 MHz; (CDCl3)) 
22.3 ((CH3)2), 23.7 ((CH3)2), 25.3 (CH(CH3)2), 28.3 (C(CH3)3), 37.9 (CH2), 57.9 (CHNH), 80.8 
(C(CH3)3, 156.1 (NCOO), 200.6 (CHO). 
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 (S)-tert-Butyl (1-(hydroxyimino)-4-methylpentan-2-yl)carbamate (109b)  
(S)-tert-Butyl (4-methyl-1-oxopentan-2-yl)carbamate (108b) (10.62 g, 49.4 mmol) in ethanol 
(50 mL) was added to hydroxylamine hydrochloride (6.86 g, 98.7 mmol) and sodium acetate 
(16.15 g, 197.0 mmol) suspended in water (100 mL).  A white precipitate formed and was re-
dissolved with ethanol (18 mL), the solution was then heated to 70 0C and stirred for 0.5 h, 
during which a watchglass was placed over the neck of the round bottomed flask to avoid 
solvent evaporation.  The reaction mixture was then allowed to cool to ambient 
temperature and was placed in the refrigerator (2-5 0C) to remove impurities via 
crystallisation for 20 h.  After this a white precipitate had formed which was removed via 
filtration.  The filtrate was then separated and extracted with ethyl acetate (3 x 70 mL) and 
then washed with saturated potassium carbonate solution (100 mL).  The combined organic 
phases were dried over magnesium sulfate.  The excess solvent was removed under reduced 
pressure to leave the product (S)-tert-butyl (1-(hydroxyimino)-4-methylpentan-2-
yl)carbamate as a white solid (2.20 g, 86 %); mp 182-184oC; [α]Drt -18.87 (c 3.9, CHCl3); MS: 
m/z calculated for C11H22N2O3 (MNa+): 253.1523.  Found 253.1519; IR νmax (CHCl3)/cm-1 3427 
(OH), 3389 (NH), 2982 (CH2, CH3), 1701 (C=O), 1501 (NH), 1367 (CN), 1266 (C-O) 1028 (N-O); 
1H NMR δH (400 MHz; ((CD3)2SO)) 0.85 (3H, d, J 2.4 Hz, CH(CH3)), 0.87 (3H, d, J 2.4 Hz, 
CH(CH3)), 1.19-1.25 (1H, m, CH(CH3)2), 1.37 (9H, s, C(CH3)3), 1.37-1.40 (1H, m, CH2CH(CH3)2), 
1.51-1.57 (1H, m, CH2CH(CH3)2), 2.50 (1H, s, OH), 4.69-4.75 (1H, br. m, CHNH), 6.50 (1H, d, J 
3.6 Hz, CHNH), 10.83 (1H, s, CHN); 13C NMR δC (100 MHz; ((CD3)2SO)) 21.9 ((CH3)2), 23.0 
((CH3)2), 24.2 (CH(CH3)2), 28.2 (C(CH3)3), 39.8 (CH2), 44.1 (CHNH), 77.2 (C(CH3)3, 151.9 (CHN), 
155.3 (NCOO). 
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(S)-tert-Butyl (1-chloro-1-(hydroxyimino)-4-methylpentan-2-yl)carbamate (116b)  
N-Chlorosuccinimide (1 eq, 0.772g, 5.78 mmol) was added dropwise to  (S)-tert-butyl (1-
(hydroxyimino)-4-methylpentan-2-yl)carbamate (109b) (1.14 g, 5.26 mmol) suspended in 
chloroform (50 mL) at 0 oC over 60 minutes.  The reaction mixture was then heated at reflux 
for 18 h to produce the chlorinated light brown solution. The chlorinated product was able 
to be isolated by washing the cooled solution with water (200 mL) and saturated brine (200 
mL) before drying the organic layers with MgSO4, filtration and concentration under 
reduced pressure to yield the chlorinated oxime as an orange oil (5.85 g, 75 %); [α]Drt +21.5 
(c 1, CHCl3); MS: m/z calculated for C11H21N2O3Cl (MNa+- HCl): 251.1362.  Found 251.1366; IR 
νmax (CHCl3)/cm-1 3321 (OH), 2962 (CH2, CH3), 1701 (C=O), 1503 (NH), 1368 (CN), 1265 (C-O) 
1166 (N-O); 1H NMR δH (400 MHz; (CDCl3)) 0.90 (3H, d, J 2.4 Hz, CH(CH3)), 0.93 (3H, d, J 2.4 
Hz, CH(CH3)), 1.20-1.30 (1H, m, CH(CH3)2), 1.45 (9H, s, C(CH3)3), 1.45-1.49 (1H, m, 
CH2CH(CH3)2), 1.54-1.58 (1H, m, CH2CH(CH3)2), 3.69 (1H, s, OH), 4.61-4.67 (1H, br. m, CHNH), 
4.95 (1H, d, J 3.9 Hz, CHNH); 13C NMR δC (100 MHz; (CDCl3)) 21.9 ((CH3)2), 23.1 ((CH3)2), 24.8 
(CH(CH3)2), 28.4 (C(CH3)3), 41.8 (CH2), 43.1 (CHNH), 79.9 (C(CH3)3, 140.5 (CHN), 156.9 
(NCOO). 
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(S)-tert-Butyl 3-(1-((tert-butoxycarbonyl)amino)-3-methylbutyl)-5-methylisoxazole-4-
carboxylate (111b)  
To freshly prepared (S)-tert-butyl (1-chloro-1-(hydroxyimino)-4-methylpentan-2-
yl)carbamate (116b) (3.26 g, 12.30 mmol) was added tert-butyl 3-(pyrrolidin-1-yl)butyl-2-
enoate (81) (2 eq, 5.32 g, 24.60 mmol) in one portion, followed directly by triethylamine (1.1 
eq, 1.89 mL, 13.53 mmol) over 60 minutes at room temperature.  The reaction mixture was 
heated at reflux for a further 3 h under a nitrogen atmosphere, cooled and subsequently 
poured into water (200 mL).  The organic layer was separated and washed with citric acid 
solution (2 M, 200 mL), sodium acetate solution (5%, 100 mL) and brine (2 x 100 mL).  The 
brown oil was then dried over magnesium sulfate, filtered and concentrated under a 
reduced pressure to yield a light brown/yellow oil (4.4 g, crude 97 %).  This crude material 
was purified by flash chromatography eluting with light petroleum:ethyl acetate (7:1 v/v) to 
yield the product isoxazole as a yellow oil (1.60 g, 60%); [α]Drt -6.0 (c 2.5, CHCl3); MS: m/z 
calculated for C19H32N2O5 (MNa+): 391.2203.  Found 391.2200; IR νmax (CHCl3)/cm-1 3365 
(NH), 3055, 2982 (CH2, CH3), 1708 (C=O), 1643 (C=C), 1502 (NH), 1393 (CN), 1318 (C-O), 1168 
(C-O-C); 1H NMR δH (400 MHz; (CDCl3)) 0.97 (3H, d, J 3.6 Hz, CH(CH3)), 0.99 (3H, d, J 3.6 Hz, 
CH(CH3)), 1.45 (9H, s, C(CH3)3), 1.51-1.54 (2H, m, CH2CH(CH3)2), 1.62(9H, s, C(CH3)3), 1.65-
1.71 (1H, m, CH(CH3)2), 2.54 (3H, s, CH3), 4.80-4.89 (1H, br. m, CHNH), 5.50 (1H, d, J 4.2 Hz, 
CHNH); 13C NMR δC (100 MHz; (CDCl3)) 13.5 (5-CH3) 22.6 ((CH3)2), 24.8 ((CH3)2), 27.1 
(CH(CH3)2), 27.8 (C(CH3)3), 43.6 (CH2), 47.0 (CHNH), 79.6 (C(CH3)3, 81.5 (C(CH3)3, 154.9 
(OCNH), 161.5 (CNO), 163.7 (CH3CO), 175.1 (CO2tBu). 
New Routes to Acyltetramic Acids and Analogues – James Bullous 
 
147 
 
(S)-3-(1-Amino-3-methylbutyl)-5-methylisoxazole-4-carboxylic acid hydrochloride (118b)75 
Trifluoroacetic acid (30 eq, 8.0 mL, 105 mmol) was added to (S)-tert-butyl 3-(1-((tert-
butoxycarbonyl)amino)-3-methylbutyl)-5-methylisoxazole-4-carboxylate (111b).  The 
mixture was stirred at room temperature for 4.5 h to produce a brown paste, which was 
concentrated under a reduced pressure. The dry residue was then resuspended in 
hydrochloric acid (30 eq, 2 M, 52.5 mL, 105 mmol) and the mixture was stirred at room 
temperature for a further 1 h.  The excess acid was removed under a reduced pressure 
producing a pink/brown residue which was dissolved in water (100 mL) and washed with 
ethyl acetate (3 x 70 mL), retaining the aqueous phase.  The aqueous phase was evaporated 
to dryness under reduced pressure, yielding (S)-3-(1-amino-3-methylbutyl)-5-
methylisoxazole-4-carboxylic acid hydrochloride as a yellow/brown crystalline solid ( 610 mg 
g, 70 %); [α]Drt -3.0 (c 2.0, H2O); mp 189-190 oC; MS: m/z calculated for C10H16N2O3Cl (MNa+-
HCl): 235.1053.  Found 235.1053; IR νmax (CHCl3)/cm-1 3365 (NH), 3055, 2982 (CH2, CH3), 
1708 (C=O), 1643 (C=C), 1502 (NH), 1393 (CN), 1318 (C-O), 1168 (C-O-C); 1H NMR δH (400 
MHz; (D2O)) 0.75 (3H, d, J 2.8 Hz, CH(CH3)), 0.79 (3H, d, J 2.8 Hz, CH(CH3)), 1.35-1.42 (1H, m, 
CH(CH3)2), 1.66-1.73 (1H, m, CH2CH(CH3)2), 1.78-1.85 (1H, m, CH2CH(CH3)2), 2.58 (3H, s, CH3), 
4.80 (1H, t, J 7.6 Hz, CHNH); 13C NMR δC (100 MHz; (D2O)) 13.2 (5-CH3) 21.1 ((CH3)2), 23.6 
((CH3)2), 23.9 (CH(CH3)2),  39.9 (CH2), 45.7 (CHNH), 108.0 (CCO), 160.0 (CNO), 168.9 (CCO), 
178.3 (CO2H). 
 
 
 
New Routes to Acyltetramic Acids and Analogues – James Bullous 
 
148 
 
 
(S)-5,6-Dihydro-2-methylpropyl-3-methyl-4H-pyrrolo[3,4-c]isoxazol-4-one (125b)75 
(S)-3-(1-Amino-3-methylbutyl)-5-methylisoxazole-4-carboxylic acid hydrochloride (116b) 
(1.3 g, 5.54 mmol) was dissolved in dry DMF/DCM (1:9, 20 mL) and stirred under a nitrogen 
atmosphere for 15 minutes.  To this mixture was then added the polystyrene-carbodiimide 
(2.5 eq, 11.55 g, 13.85 mmol) and triethylamine (1.71 mL, 12.2 mmol) and stirring was 
continued at room temperature and under a nitrogen atmosphere for a further 48 h.  The 
remaining polystyrene-carbodiimide was removed by filtration, washing with dry DMF/DCM 
(1:9, 5 mL).  The filtrate was then washed with saturated potassium carbonate solution (2 x 
30 mL) and brine (2 x 30 mL) and dried using magnesium sulfate.  The solution was 
concentrated under a reduced pressure to obtain an orange/brown solid (1.0 g, 70%).  This 
solid was separated using flash chromatography with ethyl acetate and light petroleum (5:1 
v/v) to give a pale yellow solid identified as (S)-5,6-dihydro-2-methylpropyl-3-methyl-4H-
pyrrolo[3,4-c]isoxazol-4-one (520 mg, 51%); [α]Drt +1.2 (c 2.0, CHCl3), mp 180-182 °C; m/z 
calculated for C10H14N2O2 (MNa+): 217.0947.  Found 217.0948; IR νmax (CHCl3)/cm-1 3372 (N-
H), 3054 (C-H), 1701 (C=O), 1650 (C=C), 1603 (C-C), 1421 (NH), 1265 (CN), 1130 (COC); 1H 
NMR δH (400 MHz; (CDCl3)) 0.98 (3H, d, J 7.2 Hz, CH(CH3)2), 1.00 (3H, d, J 7.2 Hz, CH(CH3)2), 
1.65-1.76 (2H, m, CH2), 1.92-1.97 (1H, m, CH(CH3)2), 2.65 (3H, s, CH3), 4.72 (1H, t, J 7.2 Hz, 
CHNH), 6.32 (1H, br. s, CHNH); 13C NMR δC (400 MHz; (CDCl3)) 13.9 (CH3), 21.0 ((CH3)2), 22.1 
((CH3)2), 29.7 (CH(CH3)2), 51.3 (CH2), 60.4 (CHNH), 113.4 (CCO), 163.2 (CN), 166.1 (CO), 171.1 
(NCO). 
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(S)-5,6-Dihydro-2-methylpropyl-3-methyl-4H-pyrrolo[3,4-c]isoxazol-4-one (125b)75 
1-[3-(Dimethylamino)propyl]-3-ethylcarbodiimide hydrochloride  (EDCI) (1.1 eq., 0.872 g, 
5.62 mmol) was added to a suspension of (S)-3-(1-amino-3-methylbutyl)-5-methylisoxazole-
4-carboxylic acid hydrochloride (116b) (0.400 g, 1.70 mmol) and N-hydroxysuccinimide (1.1 
eq., 0.65 g, 5.62 mmol) in dry dimethylformamide (50 mL) at 0 0C.  The reaction mixture was 
stirred at room temperature for 17 h.  Triethylamine (2.2 eq., 1.57 mL, 12.4 mmol) was 
added and the reaction mixture was left to stir for a further 17 h and then concentrated 
under a reduced pressure.  The residue was dissolved in ethyl acetate (60 mL) and washed 
with water (60 mL), hydrochloric acid (2M, 60 mL), saturated sodium bicarbonate solution 
(60 mL) and saturated brine (60 mL).  The organic layer was dried over magnesium sulfate, 
filtered and concentrated in vacuo to yield a beige solid (0.184 g, 48%).  The solid was 
purified by column chromatography using silica gel as absorbent and ethyl acetate:light 
petroleum (5:1 v/v) as eluent to yield a white solid (480 mg, 32%); Characterisation data 
were identical to those reported above. 
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(S)-5,6-Dihydro-2-methylpropyl-3-methyl-4H-pyrrolo[3,4-c]isoxazol-4-one (125b)75 
 (S)-3-(1-Amino-3-methylbutyl)-5-methylisoxazole-4-carboxylic acid hydrochloride (116b) 
(250 mg, 1.00 mmol) in ethyl acetate (20 mL) was stirred under a nitrogen atmosphere for 
15 minutes at 00C.  To this was then added triethylamine (2.5 eq, 0.35 mL, 2.50 mmol) and 
the reaction mixture stirred for a further 10 minutes before the addition of 
propylphosphonic anhydride solution (T3P) (50% w/w in ethyl acetate, 0.76 g, 0.57 mL, 1.2 
mmol) at 00C.  Stirring was continued and the mixture allowed to warm to room 
temperature and under a nitrogen atmosphere for a further 17 h.  The reaction mixture was 
then washed with citric acid solution (1M, 50 mL), saturated potassium carbonate solution 
(2 x 30 mL) and brine (2 x 30 mL) and dried using magnesium sulfate.  The solution was then 
concentrated under a reduced pressure to obtain the pure pyrroloisoxazole product with no 
need for further purification (131.3 mg, 68%); Characterisation data were identical to those 
reported above. 
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4.4 – Aldol Reactions at C-3 Position of L-Valine Pyrroloisoxazole (125a) 
  
 
(S)-3-(2-Hydroxyhexyl)-6-(-1-methylethyl)-5,6-dihydro-4H-pyrrolo[3,4-c][1,2]oxazol-4-one 
(127)75 
n-Butyllithium (3.2 eq, 2.5 M solution in hexanes, 0.08 mL, 0.2 mmol) was added dropwise 
to a solution of the pyrroloisoxazole (S)-6-(1-methylethyl)-3-methyl-5,6-dihydro-4H-
pyrrolo[3,4-c]isoxazol-4-one (125a) (10 mg, 0.063 mmol) in THF (5 mL) at - 78 0C and kept 
under a nitrogen atmosphere.  The solution was stirred at this temperature for 2 h, after 
which freshly distilled pentanal (1 mL, excess) was added in one portion and stirring 
continued for at - 78 0C for 2 h, after which the solution turned yellow.  The reaction was 
quenched by the addition of water (5 mL) and the mixture acidified with hydrochloric acid  
(5 mL, 2 M).  The mixture was concentrated under vacuum and the resulting yellow oil was 
suspended in water (5 mL) and ethyl acetate (5 mL).  The aqueous phase was then extracted 
using ethyl acetate (2 x 5 mL), before the combined organic phases were washed with brine 
(10 mL) and dried over MgSO4, filtered and concentrated under a vacuum to yield a yellow 
solid.  This material was then purified using flash chromatography eluting with ethyl acteate 
and petroleum ether (5:1 v/v) to yield the product as a white solid (1 mg, 6 %); mp 115-120 
oC; m/z calculated for C14H21N2O3 (MH+): 267.1625.  Found 267.1629; 1H NMR δH (400 MHz; 
(CDCl3)) 0.82 (3H, d, J 8.7 Hz, CH(CH3)2), 0.88 (3H, d, J 6.8 Hz, CH(CH3)2), 1.38 (9H, br.s, 
CH2CH2CH2CH3), 2.01-2.09 (1H, m, CH(CH3)2), 3.67 (2H, s, CH2), 3.90 (1H, br. s, CH(OH), 4.12-
4.19 (1H, m, CHNH), 4.93-5.01 (1H, m, CHNH); 13C NMR δC (100 MHz; (CDCl3)) 14.1 (CH3CH2), 
17.7 ((CH3)2), 18.2 ((CH3)2), 22.5 (CH3CH2) 22.6 (CH3CH2CH2), 28.0 (CH2CHOH), 31.5 
(CH(CH3)2), 36.7 (CH2), 59.1 (CHNH), 67.5 (CHOH), 112.8 (CCO), 169.7 (CO), 170.9 (CN), 171.0 
(NCO). 
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(S)-3-(2-Hydroxyundecyl)-6-(1-methylethyl)-5,6-dihydro-4H-pyrrolo[3,4-c][1,2]oxazol-4-one 
(128)75 
Decanal was suspended in diethyl ether and washed with saturated potassium carbonate 
solution to remove any acidic impurities.  The organic fraction was dried (MgSO4), filtered 
and concentrated under a reduced pressure to achieve the pure aldehyde, confirmed by 
NMR spectroscopy.  n-Butyllithium (3.2 eq, 2.5 M solution in hexanes, 0.08 mL, 0.2 mmol) 
was added dropwise to a solution of the pyrroloisoxazole (S)-6-(1-methylethyl)-3-methyl-
5,6-dihydro-4H-pyrrolo[3,4-c]isoxazol-4-one (125a) (100 mg, 0.55 mmol) in THF (5 mL) at      
- 78 0C and kept under a nitrogen atmosphere.  The solution was stirred at this temperature 
for 2 h.  Purified decanal (1 mL, excess) was then added in one portion and stirring 
continued for at - 78 0C for 2 h, at t.  The reaction was quenched by the addition of water    
(5 mL) and the mixture acidified with hydrochloric acid (5 mL, 2 M).  The mixture dried over 
MgSO4, filtered and concentrated under a reduced pressure and the resulting yellow oil was 
suspended in water (5 mL) and ethyl acetate (5 mL).  The aqueous phase was then extracted 
by using ethyl acetate (2 x 5 mL), before the combined organic phases were washed with 
brine (10 mL) and dried under vacuum to yield a yellow oil (900 mg, 100%).  This was 
purified by flash chromatography eluting with ethyl acetate and light petroleum (5:1 v/v) to 
yield a mixture of products, which was separated again under the same conditions to give 
the desired product as an pale yellow oil (27 mg, 28 %); m/z calculated for C19H32N2O3 
(MH+): 337.2486.  Found 337.2488; 1H NMR δH (400 MHz; (CDCl3)) 0.77 (3H, t, J 8.1Hz, CH3), 
0.92 (3H, d, J 5.8 Hz, CH(CH3)2), 1.01 (3H, d, J 5.3 Hz, CH(CH3)2), 1.12-1.29 (14H, m, 7 x CH2), 
1.41-1.50 (2H, m, CH2CHOH), 1.96-2.05 (1H, m, CH(CH3)2), 2.55 (2H, s, CH2CHOH), 4.10 (1H, 
s, CHOH), 4.50-4.52 (1H, m, CHNH), 6.55 (1H, d, J 8.0 Hz, CHOH), 8.22 (1H, broad, CHNH). 
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(S)-3-(2-Hydroxy-3-methylbutyl)-6-(1-methylethyl)-5,6-dihydro-4H-pyrrolo[3,4-
c][1,2]oxazol-4-one (129)75 
2-Methylpropanal was suspended in diethyl ether and washed with saturated potassium 
carbonate solution to remove any acidic impurities.  The organic fraction was then dried 
(MgSO4), filtered and concentrated under a reduced pressure to achieve the pure aldehyde, 
confirmed by NMR spectroscopy.  n-Butyllithium (3.2 eq, 2.5 M solution in hexanes, 0.08 
mL, 0.2 mmol) was added dropwise to a solution of the pyrroloisoxazole (S)-6-(1-
methylethyl)-3-methyl-5,6-dihydro-4H-pyrrolo[3,4-c]isoxazol-4-one (125a) (100 mg, 0.55 
mmol) in THF (5 mL) at - 78 0C and kept under a nitrogen atmosphere.  The solution was 
stirred at this temperature for 2 h.  Purified 2-methylpropanal (1 mL, excess) was then 
added in one portion and stirring continued for at - 78 0C for 2 h.  The reaction was 
quenched by the addition of water (5 mL) and the mixture acidified with hydrochloric acid  
(5 mL, 2 M).  The mixture was dried over MgSO4, filtered and concentrated under a reduced 
pressure and the resulting yellow oil was suspended in water (5 mL) and ethyl acetate (5 
mL).  The aqueous phase was then extracted by using ethyl acetate (2 x 5 mL), before the 
combined organic phases were washed with brine (10 mL) and dried under vacuum to yield 
a yellow oil (845 mg, 100%).  This was purified by flash chromatography eluting with ethyl 
acetate and light petroleum (5:1 v/v) to yield the desired product as a light yellow oil (30 
mg, 32 %); m/z calculated for C13H20N2O3 (MNa+): 275.1366.  Found 275.1370; 1H NMR δH 
(400 MHz; (CDCl3)) 0.92 (3H, d, J 2.8 Hz, CH(CH3)2), 0.96 (3H, d, J 3.6 Hz, C(CH3)2) , 0.99 (3H, 
d, J 3.6 Hz, C(CH3)2), 1.02 (3H, d, Ja 2.8 Hz, CH(CH3)2), 2.01-2.11 (1H, m, CH(CH3)2), 2.95-3.01 
(2H, m, CH2CHOH), 3.82 (1H, s, CHOH), 4.43 (1H, dd, Ja 2.8 Hz, Jb 6.0 Hz, CHNH), 6.25 (1H, 
broad, CHNH), 7.20 (1H, s, CHOH).  
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(S)-3-(2-Cyclohexyl-2-hydroxyethyl)-6-(1-methylethyl)-5,6-dihydro-4H-pyrrolo[3,4-
c][1,2]oxazol-4-one (130)75 
Cyclohexanecarboxaldehyde was suspended in diethyl ether and washed with saturated 
potassium carbonate solution to remove any acidic impurities.  The organic fraction was 
then dried (MgSO4), filtered and concentrated under a reduced pressure to achieve the pure 
aldehyde, confirmed by NMR spectroscopy.  n-Butyllithium (3.2 eq, 2.5 M solution in 
hexanes, 0.08 mL, 0.2 mmol) was added dropwise to a solution of the pyrroloisoxazole (S)-6-
(1-methylethyl)-3-methyl-5,6-dihydro-4H-pyrrolo[3,4-c]isoxazol-4-one (125a) (100 mg, 0.55 
mmol) in THF (5 mL) at - 78 0C and kept under a nitrogen atmosphere.  The solution was 
stirred at this temperature for 2 h.  Purified cyclohexanecarboxaldehyde (1 mL, excess) was 
then added in one portion and stirring continued for at - 78 0C for 2 h.  The reaction was 
quenched by the addition of water (5 mL) and the mixture acidified with hydrochloric acid (5 
mL, 2 M).  The mixture was dired over MgSO4, filtered and concentrated under a reduced 
pressure and the resulting yellow oil as suspended in water (5 mL) and ethyl acetate (5 mL).  
The aqueous phase was then extracted by using ethyl acetate (2 x 5 mL), before the organic 
phases were washed with brine (10 mL) and dried under vacuum to yield a crude yellow oil 
(800 mg, 100%).  This was purified by flash chromatography eluting with ethyl acetate and 
light petroleum (5:1 v/v) to yield the desired product as a light yellow oil (45 mg, 28%); m/z 
calculated for C16H24N2O3 (MH+): 293.1860.  Found 293.1856; 1H NMR δH (400 MHz; (CDCl3)) 
1.04 (3H, d, Ja 3.6 Hz, CH(CH3)2), 1.09 (3H, d, Ja 4.0 Hz, CH(CH3)2), 1.29 (10H, s, C5H10), 2.03-
2.09 (1H, m, CH(CH3)2), 3.04-3.08 (2H, m, CH2CHOH), 3.82 (1H, s, CHOH), 4.90 (1H, dd, Ja 2.0 
Hz, Jb 5.2 Hz, CHNH), 6.65 (1H, broad, CHNH), 7.19 (1H, s, CHOH). 
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(S)-3-[(2-Hydroxypent-3-en-1-yl]-6-(1-methylethyl)-5,6-dihydro-4H-pyrrolo[3,4-
c][1,2]oxazol-4-one (131)75 
n-Butyllithium (10.0 eq, 0.975 M solution in hexanes, 1.20 mL, 1.10 mmol) was added 
dropwise to a solution of the pyrroloisoxazole (S)-6-(1-methylethyl)-3-methyl-5,6-dihydro-
4H-pyrrolo[3,4-c]isoxazol-4-one (130) (20.0 mg, 0.110 mmol) in THF (10 mL) at - 78 0C and 
kept under a nitrogen atmosphere.  The solution was stirred at this temperature for 2 h.  
But-2-enal (cis:trans mixture, 1 mL, excess) was then added in one portion and stirring 
continued for at - 78 0C for 2 h.  The reaction was quenched by the addition of water (5 mL) 
and the mixture acidified with hydrochloric acid (5 mL, 2 M) and separated by adding ethyl 
acetate (30 mL).  The aqueous phase was then extracted (2 x 30 mL), before the combined 
organic phases were washed with brine (30 mL) and dried over MgSO4, filtered and 
concentrated under a reduced pressure to yield a crude yellow oil which was purified by 
prep-TLC eluting with ethyl acetate:petrol (1:1 v/v) to yield the desired product (S)-3-[(2-
hydroxypent-3-en-1-yl]-6-(1-methylethyl)-5,6-dihydro-4H-pyrrolo[3,4-c][1,2]oxazol-4-one as 
a clear colourless oil (8.70 mg, 30 %); m/z calculated for C13H18N2O3 (MH+): 251.1351.  Found 
251.1351; IR νmax (nujol)/cm-1 3262 (OH), 2896 (CH3), 1709 (CO), 1659 (CN); 1H NMR δH (400 
MHz; (CDCl3)) 1.12 (3H, d, J 4.2 Hz, CH(CH3)2), 1.20 (3H, d, J 4.2 Hz, CH(CH3)2), 1.72 (3H, d, J 
7.2 Hz, CHCH3), 2.11-2.19 (1H, m, CH(CH3)2), 3.21 (2H, d, J 7.2 Hz, CH2CHOH), 4.51 (1H, dd, Ja 
2.8 Hz, Jb 6.0 Hz, CHNH), 4.61 (1H, br. s, OH), 5.60-5.70 (1H, m, CHCH3), 5.81-5.89 (1H, m, 
C(OH)CH),  6.12 (1H, broad, CHNH), 13C NMR δc (100 MHz; (CDCl3)) 15.6 (CH2), 10.2 (CH3), 
21.0 ((CH3)2), 22.1 ((CH3)2), 29.7 (CH(CH3)2), 51.3 (CH2), 57.1 (CHOH) 60.4 (CHNH), 113.4 
(CCO), 125.6 (HC=CH), 130.1 (HC=CH), 163.2 (CN), 166.1 (CO), 171.1 (NCO). 
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4.5 – Attempted Dehydration of the Aldol Adducts   
 
 
(S,E)-3-(Hex-1-en-1-yl)-6-isopropyl-5,6-dihydro-4H-pyrrolo[3,4-c]isoxazol-4-one (132)75 
p-Toluenesulfonic acid (26 mg, 0.138 mmol) was suspended in toluene (10 mL) and added 
dropwise to (S)-3-(2-Hydroxyhexyl)-6-(-1-methylethyl)-5,6-dihydro-4H-pyrrolo[3,4-
c][1,2]oxazol-4-one (127) (22.8 mg, 0.120 mmol) in toluene (20 mL) and heated under Dean-
Stark conditions for 17 h with stirring.  The reaction mixture was then partitioned between 
ethyl acetate (30 mL) and saturated sodium carbonate solution (30 mL), followed by a 
washing with saturated brine (30 mL).  The organic fraction was collected, dried over 
magnesium sulfate and concentrated under reduced pressure.  Upon thin layer 
chromatographic analysis it was shown to contain multiple products but, after separation 
via flash column chromatography eluting with ethyl acetate and light petroleum (5:1 v/v), 
no dehydrated product could be identified. 
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(S,E)-3-(3,3-Dimethylbut-1-en-1-yl)-6-isopropyl-5,6-dihydro-4H-pyrrolo[3,4-c]isoxazol-4-
one (134)75 
p-Toluenesulfonic acid (20.8 mg, 0.110 mmol) was suspended in toluene (10 mL) and added 
dropwise to (S)-3-(2-hydroxy-3-methylbutyl)-6-(1-methylethyl)-5,6-dihydro-4H-pyrrolo[3,4-
c][1,2]oxazol-4-one (129) (34.2mg, 0.096 mmol) in toluene (20 mL) and heated under Dean-
Stark conditions for 17 h with stirring.  The reaction mixture was then partitioned between 
ethyl acetate (30 mL) and saturated sodium carbonate solution (30 mL), followed by a 
washing with saturated brine (30 mL).  The organic fraction was collected, dried over 
magnesium sulfate and concentrated under reduced pressure.  Upon thin layer 
chromatographic analysis it was shown to contain multiple products but, after separation 
via flash column chromatography eluting with ethyl acetate and light petroleum (5:1 v/v), 
no dehydrated product could be identified. 
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3-[Undecyl-1-en-1-yl]-6-(1-methylethyl)-5,6-dihydro-4H-pyrrolo[3,4-c][1,2]oxazol-4-one 
(133)75 
p-Toluenesulfonic acid (18.2 mg, 0.097 mmol) was suspended in toluene (10 mL) and added 
dropwise to (S)-3-(2-hydroxyundecyl)-6-(1-methylethyl)-5,6-dihydro-4H-pyrrolo[3,4-
c][1,2]oxazol-4-one (128) (30.0 mg, 0.084 mmol) in toluene (20 mL) and heated under Dean-
Stark conditions for 17 h with stirring.  The reaction mixture was then partitioned between 
ethyl acetate (30 mL) and saturated sodium carbonate solution (30 mL), followed by a 
washing with saturated brine (30 mL).  The organic fraction was collected, dried over 
magnesium sulfate and concentrated under reduced pressure.  Upon thin layer 
chromatographic analysis it was shown to contain multiple products but, after separation 
via flash column chromatography eluting with ethyl acetate and light petroleum (5:1 v/v), 
no dehydrated product could be identified. 
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3-[2-Cyclohexylethenyl]-6-(1-methylethyl)-5,6-dihydro-4H-pyrrolo[3,4-c][1,2]oxazol-4-one 
(135)75 
p-Toluenesulfonic acid (15.6 mg, 0.083 mmol) was suspended in toluene (10 mL) and added 
dropwise to (S)-3-(2-Cyclohexyl-2-hydroxyethyl)-6-(1-methylethyl)-5,6-dihydro-4H-
pyrrolo[3,4-c][1,2]oxazol-4-one (130) (25.7 mg, 0.072 mmol) in toluene (20 mL) and heated 
under Dean-Stark conditions for 17 h with stirring.  The reaction mixture was then 
partitioned between ethyl acetate (30 mL) and saturated sodium carbonate solution (30 
mL), followed by a washing with saturated brine (30 mL).  The organic fraction was 
collected, dried over magnesium sulfate and concentrated under reduced pressure.  Upon 
thin layer chromatographic analysis it was shown to contain multiple products but, after 
separation via flash column chromatography eluting with ethyl acetate and light petroleum 
(5:1 v/v), no dehydrated product could be identified.  
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3-[Penta-1,3-dien-1-yl]-6-(1-methylethyl)-5,6-dihydro-4H-pyrrolo[3,4-c][1,2]oxazol-4-one 
(136)75 
p-Toluenesulfonic acid (13 mg, 0.069 mmol) was suspended in toluene (10 mL) and added 
dropwise to (S)-3-[(2-Hydroxypent-3-en-1-yl]-6-(1-methylethyl)-5,6-dihydro-4H-pyrrolo[3,4-
c][1,2]oxazol-4-one (131) (21.4 mg, 0.06 mmol) in toluene (20 mL) and heated under Dean-
Stark conditions for 17 h with stirring.  The reaction mixture was then partitioned between 
ethyl acetate (30 mL) and saturated sodium carbonate solution(30 mL), between by a 
washing with saturated brine (30 mL).  The organic fraction was collected, dried over 
magnesium sulfate and concentrated under reduced pressure.  Upon thin layer 
chromatographic analysis it was shown to contain multiple products but, after separation 
via flash column chromatography eluting with ethyl acetate and light petroleum (5:1 v/v), 
no dehydrated product could be identified. 
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4.6 – N-Acylation and Alkylation on Pyrroloisoxazole Moiety  
4.6.1 – N-Acylation Reactions 
 
(S)-5-Butanoyl-5,6-dihydro-6-(1-methylethyl)-3-methyl-4H-pyrrolo[3,4-c]isoxazol-4-one 
(137a)  
(S)-6-(1-Methylethyl)-3-methyl-5,6-dihydro-4H-pyrrolo[3,4-c]isoxazol-4-one (125a) (72.8 mg, 
0.404 mmol) was suspended in dry THF (25 mL), cooled to -78 0C and stirred under a 
nitrogen atmosphere.  To this solution was then added n-butyl-lithium (1.1 eq., 2.0 M in 
hexanes, 0.22 mL, 0.444 mmol) in one portion and the mixture stirred for 15 minutes at this 
temperature, during which time the solution turned yellow.  Butanoyl chloride (1.1 eq., 50.0 
L, 0.44 mmol) was then added in two equal portions over 10 minutes and the reaction 
mixture stirred at -78 0C for a further hour before being quenched by saturated ammonium 
chloride solution.  The reaction solution was then tested for pH to ensure neutrality had 
been achieved, and separated between water (20 mL) and ethyl acetate (25 mL).  The 
organic layer was retained, dried over MgSO4, filtered and concentrated under reduced 
pressure to produce the product as a yellow oil (90 mg, 89%); [α]Drt +36.0 (c 5.0x10-3, CHCl3); 
MS: m/z calculated for C13H18N2O3 (MNa+): 273.1210.  Found 273.1211; IR νmax (CHCl3)/cm-1 
3025 (CH3), 1725 (C=O), 1689 (C=C), 1650 (NC=O), 1389 (CN), 1250 (C-C), 1131 (COC); 1H 
NMR δH (400 MHz; CDCl3) 0.50 (3H, d, J 6.8 Hz, CH(CH3)2) 0.91 (3H, t, J 7.2 Hz, CH2CH3), 1.18 
(3H, d, J 6.8 Hz, CH(CH3)2), 1.55-1.61 (2H, m, CH2CH3), 2.62 (3H, s, 5-CH3), 2.68-2.72 (1H, m, 
CH(CH3)2), 2.80 (1H, dt, Ja 7.6 Hz, Jb 14.8 Hz, C(O)CH2), 2.90 (1H, dt, Ja 7.6 Hz, Jb 14.8 Hz, 
C(O)CH2), 5.13 (1H, d, J 4 Hz, CHN(CO)2); 13C NMR δC (100 MHz; CDCl3) 11.8 (5-CH3), 12.8 
(CH2CH3), 13.1 (CH3), 17.0 (CH2CH3), 17.9 (CH3), 27.0 (CH(CH3)2), 38.2 (C(O)CH2), 59.9 
(CHN(CO)2), 113.0 (CCCH3), 159.5 (CHCN), 165.0 (CCCH3), 168.6 (NC(O)C), 173.2 (NC(O)CH2). 
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(S,E)-5-(But-2-enoyl)-(1-methylethyl)-3-methyl-5,6-dihydro-4H-pyrrolo[3,4-c]isoxazol-4-one 
(139a)  
(S)-6-(1-methylethyl)-3-methyl-5,6-dihydro-4H-pyrrolo[3,4-c]isoxazol-4-one (125a) (56.0 mg, 
0.311 mmol) was suspended in dry THF (25 mL), cooled to -78 0C and stirred under a 
nitrogen atmosphere.  To this solution was then added n-butyllithium (1.1 eq., 2.0 M in 
hexanes, 0.171 mL, 0.342 mmol) in one portion and the mixture stirred for 15 minutes at 
this temperature, during which time the solution turned yellow.  But-2-enoyl chloride       
(1.1 eq., 33.0 L, 0.342 mmol) was then added in two equal portions over 10 minutes and 
the reaction mixture stirred at -78 0C for a further hour before being quenched by saturated 
ammonium chloride solution.  The reaction solution was then tested for pH to ensure 
neutrality had been achieved and separated between water (20 mL) and ethyl acetate       
(25 mL).  The organic layer was retained, washed with saturated potassium carbonate 
solution (50 mL), dried over MgSO4, filtered and concentrated under reduced pressure to 
produce the product as a white crystalline solid (37.5 mg, 63%); mp. 109-111oC; [α]Drt +65.3 
(c 15.0 x10-3, CHCl3); MS: m/z calculated for C13H16N2O3 (MNa+): 271.1053.  Found 271.1056; 
IR νmax (CHCl3)/cm-1 3054 (CH3), 1741 (C=O), 1682 (C=C), 1642 (NC=O), 1337 (CN), 1292 (C-C), 
1138 (COC); 1H NMR δH (400 MHz; CDCl3) 0.53 (3H, d, J 6.8 Hz, CH(CH3)2), 1.16 (3H, d, J 6.8 
Hz, CH(CH3)2), 1.58 (3H, dd, Ja 1.6 Hz, Jb 4.2 Hz, CHCH3), 2.62 (3H, s, 5-CH3), 2.68-2.71 (1H, m, 
CH(CH3)2), 5.18 (1H, d, J 3.6 Hz, CHN(CO)2), 7.10 (1H, dq, Ja 6.8 Hz, Jb 11.6 Hz, CHCH3), 7.22 
(1H, d, Ja 1.6 Hz, C(O)CH); 13C NMR δC (100 MHz; CDCl3) 12.4 (5-CH3), 14.6 (CH3), 18.5 (CH3), 
18.6 (CHCH3), 28.1 (CH(CH3)2), 61.0 (CHN(CO)2), 114.0 (CCCH3), 122.1 (CHCH3), 146.5 
(C(O)CH), 160.7 (CHCN), 166.0 (CCCH3), 167.3 (NC(O)C), 169.6 (NC(O)CH2).  X-ray data for 
this compound are available at the end of this report. 
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(S)-5-Benzoyl-(1-methylethyl)-3-methyl-5,6-dihydro-4H-pyrrolo[3,4-c]isoxazol-4-one (138a)  
(S)-6-(1-Methylethyl)-3-methyl-5,6-dihydro-4H-pyrrolo[3,4-c]isoxazol-4-one (125a) (59.0 mg, 
0.327 mmol) was suspended in dry THF (25 mL) and cooled to -78 0C and stirred under a 
nitrogen atmosphere.  To this solution was then added n-butyllithium (1.1 eq., 2.0 M in 
hexanes, 0.180 mL, 0.360 mmol) in one portion and the mixture stirred for 15 minutes at 
this temperature, during which time the solution turned yellow.  Benzoyl chloride (1.1 eq., 
42.0 L, 0.360 mmol) was then added in two equal portions over 10 minutes and the 
reaction mixture stirred at -78 0C for a further hour before being quenched by saturated 
ammonium chloride solution.  The reaction solution was then tested for pH to ensure 
neutrality had been achieved and separated between water (20 mL) and ethyl acetate (25 
mL).  The organic layer was retained, washed with saturated potassium carbonate solution 
(50 mL), dried over MgSO4, filtered and concentrated under reduced pressure to produce 
the product as a yellow oil (82.0 mg, 89%); [α]Drt +52.0 (c 5.0 x10-3, CHCl3); MS: m/z 
calculated for C16H11N2O3 (MH+): 279.0764.  Found 279.0742; IR νmax (CHCl3)/cm-1 3608 (Ar-
H), 3054 (CH3), 1796 (C=O), 1688 (C=C), 1421 (NC=O), 1389 (CN), 1265 (C-C), 1155 (COC); 1H 
NMR δH (400 MHz; CDCl3), 0.85 (3H, d, J 6.8, CH(CH3)2), 1.28 (3H, d, J 6.8, CH(CH3)2), 1.55-
1.58 (1H, m, CH(CH3)2), 2.65 (3H, s, 5-CH3), 5.54 (1H, d, J 4 Hz, CHN(CO)2), 7.20-7.52 (2H, m, 
Ar-H), 7.54-7.59 (1H, m, Ar-H), 7.65-7.71 (2H, m, Ar-H); 13C NMR δC (100 MHz; CDCl3) 12.3 (5-
CH3), 15.3 (CH3), 18.7 (CH3), 28.4 (CH(CH3)2), 60.9 (CHN(CO)2), 113.6 (CCCH3), 128.0 (Ar-C), 
129.0 (2Ar-C), 132.3 (2Ar-C), 134.6 (Ar-C), 159.7 (CHCN), 167.5 (CCCH3), 169.9 (NC(O)C), 
170.4 (NC(O)CH2). 
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(S)-(1-Methylethyl)-3-methyl-5-(2,2-dimethylpropanoyl)-5,6-dihydro-4H-pyrrolo[3,4-
c]isoxazol-4-one (141a)  
(S)-6-(1-Methylethyl)-3-methyl-5,6-dihydro-4H-pyrrolo[3,4-c]isoxazol-4-one (125a) (57.0 mg, 
0.316 mmol) was suspended in dry THF (25 mL), cooled to -78 0C and stirred under a 
nitrogen atmosphere.  To this solution was then added n-butyllithium (1.1 eq., 2.0 M in 
hexanes, 0.174 mL, 0.348 mmol) in one portion and the mixture stirred for 15 minutes at 
this temperature, during which time the solution turned yellow.  2,2-Dimethylpropanoyl 
chloride (1.1 eq., 42.8 L, 0.348 mmol) was then added in two equal portions over 10 
minutes and the reaction mixture stirred at -78 0C for a further hour before being quenched 
by saturated ammonium chloride solution.  The reaction solution was then tested for pH 
using indicator paper to ensure neutrality had been achieved and separated between water 
(20 mL) and ethyl acetate (25 mL).  The organic layer was retained, washed with saturated 
potassium carbonate solution (50 mL), dried over MgSO4, filtered and concentrated under a 
reduced pressure to produce the product as a yellow oil (74.1 mg, 89%); [α]Drt +42.1 (c 4.75 
x10-3, CHCl3); MS: m/z calculated for C14H20N2O3 (MNa+): 287.1366.  Found 287.1368; IR νmax 
(CHCl3)/cm-1 3029 (CH3), 1717 (C=O), 1656 (C=C), 1621 (NC=O), 1398 (CN), 1261 (C-C), 1139 
(COC); 1H NMR δH (400 MHz; CDCl3) 0.61 (3H, d, J 6.8, CH(CH3)2), 1.20 (3H, d, J 6.8, CH(CH3)2), 
1.40 (9H, s, C(CH3)3), 2.45-2.51 (1H, m, CH(CH3)2), 2.66 (3H, s, 5-CH3), 5.13 (1H, d, J 4 Hz, 
CHN(CO)2); 13C NMR δC (100 MHz; CDCl3) 12.3 (5-CH3), 14.7 (CH3), 18.5 (CH3), 26.3 (C(CH3)3), 
29.4 (CH(CH3)2), 42.2 (C(CH3)3), 62.0 (CHN(CO)2), 114.1 (CCCH3), 159.3 (CHCN), 167.3 
(CCCH3), 169.4 (NC(O)C), 180.5 (NC(O)CH2). 
 
New Routes to Acyltetramic Acids and Analogues – James Bullous 
 
165 
 
(S)-5-Decanoyl-(1-methylethyl)-3-methyl-5,6-dihydro-4H-pyrrolo[3,4-c]isoxazol-4-one 
(140a)  
(S)-6-(1-Methylethyl)-3-methyl-5,6-dihydro-4H-pyrrolo[3,4-c]isoxazol-4-one (125a) (50.0 mg, 
0.277 mmol) was suspended in dry THF (25 mL), cooled to -78 0C and stirred under a 
nitrogen atmosphere.  To this solution was then added n-butyllithium (1.1 eq., 1.65 M in 
hexanes, 0.185 mL, 0.305 mmol) in one portion and the mixture stirred for 15 minutes at 
this temperature, during which time the solution turned yellow.  Decanoyl chloride (1.1 eq., 
63.0 L, 0.305 mmol) was then added in two equal portions over 10 minutes and the 
reaction mixture stirred at -78 0C for a further hour before being quenched by saturated 
ammonium chloride solution.  The reaction solution was then tested for pH to ensure 
neutrality had been achieved and separated between water (20 mL) and ethyl acetate (25 
mL).  The organic layer was retained, washed with saturated potassium carbonate solution 
(50 mL), dried over MgSO4, filtered and concentrated under reduced pressure to produce 
the product as a yellow oil (57.4 mg, 63%); [α]Drt -40.0 (c 5.0 x10-3, CHCl3); MS: m/z 
calculated for C19H30N2O3 (MNa+): 357.2149.  Found 357.2149; IR νmax (CHCl3)/cm-1 2965 
(CH3), 1749 (C=O), 1675 (C=C), 1599 (NC=O), 1398 (CN), 1265 (C-C), 1131 (COC); 1H NMR δH 
(400 MHz; CDCl3) 0.57 (3H, d, J 6.8, CH(CH3)2) 0.87 (3H, t, J 7.2, CH2CH3), 1.23 (3H, d, J 6.8, 
CH(CH3)2), 1.27-1.45 (12H , br. m, 6CH2), 1.64-1.72 (1H, m, C(O)CH2CH2), 2.68 (3H, s, 5-CH3)2), 
2.71-2.77 (1H, m, CH(CH3)2), 2.91 (1H, dt, Ja 7.6 Hz, Jb 14.8 Hz, C(O)CH2), 3.01 (1H, dt, Ja 7.6 
Hz, Jb 14.8 Hz, C(O)CH2), 5.15 (1H, d, J 3.6 Hz, CHN(CO)2); 13C NMR δC (100 MHz; CDCl3) 12.3 
(5-CH3), 14.1 (CH2CH3), 14.6 (CH(CH3)2), 18.5 (CH(CH3)2), 22.7 (CH2), 24.6 (CH2), 28.1 
(CH(CH3)2), 29.2 (CH2), 29.3 (CH2), 29.4 (CH2), 29.5 (CH2), 31.9 (C(O)CH2CH2), 37.4 (C(O)CH2), 
60.9 (CHN(CO)2), 114.0 (CCCH3), 160.5 (CHCN), 167.3 (CCCH3), 169.6 (NC(O)C), 174.5 
(NC(O)CH2). 
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(S)-5-Butyryl-3-methyl-6-phenyl-5,6-dihydro-4H-pyrrolo[3,4-c]isoxazol-4-one (137c)  
(S)-3-Methyl-6-phenyl-5,6-dihydropyrrolo[3,4-c]isoxazol-4-one (125c) (54.0 mg, 0.252 
mmol) was suspended in dry THF (25 mL), cooled to -78 0C and stirred under a nitrogen 
atmosphere.  To this solution was then added n-butyllithium (1.1 eq., 2.0 M in THF, 0.139 
mL, 0.278 mmol) in one portion and the reaction was then stirred for 15 minutes at this 
temperature, during which time the solution turned yellow.  Butanoyl chloride (1.1 eq., 30 
mg, 30 L, 0.278 mmol) was then added in two equal portions over 10 minutes and the 
reaction mixture stirred at -78 0C for a further hour before being quenched by saturated 
ammonium chloride solution.  The reaction solution was then tested for pH to ensure 
neutrality had been achieved and separated between water (20 mL) and ethyl acetate (25 
mL).  The organic layer was retained, dried over MgSO4, filtered and concentrated under 
reduced pressure to produce the product as a white crystalline solid (31.0 mg, 57%); mp 
120-121oC; [α]Drt +4.0 (c 12.5 x10-3, CHCl3); MS: m/z calculated for C16H16N2O3 (MNa+): 
307.1053.  Found 307.1054; IR νmax (CHCl3)/cm-1 3054 (CH3), 1745 (C=O), 1701 (C=C), 1644 
(NC=O), 1381 (CN), 1227 (C-C), 1111 (COC); 1H NMR δH (400 MHz; CDCl3) 0.85 (3H, t, J 7.2 Hz, 
CH2CH3), 1.53-1.61 (2H, q, J 7.6 Hz, CH2CH3), 2.62 (3H, s, CH3), 2.85-2.90 (2H, m, CH2CH2CH3), 
6.17 (1H, s, CHNH), 7.17-7.23 (5H, m, Ar(H)); 13C NMR δC (100 MHz; (CDCl3)) 11.5 (CH2CH3), 
12.6  (2CH3), 16.6 (CH2CH3), 38.1 (CH2CH2CH3), 57.2 (CHNH), 111.5 (CCO), 125.3, 127.7, 128.0 
(Ar(C)), 134.9 (C-Ar), 158.9 (CN), 168.2 (CCO), 169.9 (NCOC), 172.2 (NCOCH2). 
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(S,E)-5-(But-2-enoyl)-3-methyl-6-phenyl-5,6-dihydro-4H-pyrrolo[3,4-c]isoxazol-4-one (139c)  
(S)-3-Methyl-6-phenyl-5,6-dihydropyrrolo[3,4-c]isoxazol-4-one (125c) (33.0 mg, 0.154 
mmol) was suspended in dry THF (25 mL), cooled to -78 0C and stirred under a nitrogen 
atmosphere.  To this solution was then added n-butyllithium (1.1 eq., 1.408 M in THF, 0.120 
mL, 0.170 mmol) in one portion and the mixture stirred for 15 minutes at this temperature, 
during which time the solution turned yellow.  But-2-enoyl chloride (1.1 eq., 16.0 L, 0.170 
mmol) was then added in two portions over 10 minutes and the reaction mixture stirred at  
-78 0C for a further hour before being quenched by saturated ammonium chloride solution.  
The reaction solution was then tested for pH to ensure neutrality had been achieved and 
separated between water (20 mL) and ethyl acetate (25 mL).  The organic layer was 
retained, dried over MgSO4, filtered and concentrated under reduced pressure to produce 
the product as a white crystalline solid (22.0 mg, 50%); mp 122-125oC; [α]Drt -4.6 (c 11.0 x10-
3, CHCl3); MS: m/z calculated for C16H14N2O3 (MNa+): 305.0900.  Found 305.0900; IR νmax 
(CHCl3)/cm-1 3054, 2986 (CH3), 1744 (C=O), 1718 (C=C), 1641 (NC=O), 1421 (CN), 1217 (C-C); 
1H NMR δH (400 MHz; CDCl3) 1.98 (3H, dd, Ja 1.6 Hz, Jb 6.8 Hz, CHCH3), 2.73 (3H, s, CH3), 6.53 
(1H, s, CHNH), 7.14 (1H, qd, Ja 6.8 Hz, Jb 13.6, (C(O)CH), 7.27 (1H, dq, Ja 6.8 Hz, Jb 7.2 Hz, 
CHCH3), 7.30-7.38 (5H, m, Ar(H)); 13C NMR δC (100 MHz; (CDCl3)) 11.2 (5-CH3), 13.2  (CHCH3), 
57.4 (CHN(CO)2), 111.6 (CCCH3), 122.4 (CHCH3), 125.4 (Ar-C), 127.8 (2Ar-C), 134.7 (2Ar-C), 
146.2 (C(O)CH), 159.2 (CHCN), 165.8 (CCCH3), 169.2 (NC(O)C), 171.2 (NC(O)CH2). 
 
New Routes to Acyltetramic Acids and Analogues – James Bullous 
 
168 
 
(S)-5-Butanoyl-6-(3-methylbutyl)-3-methyl-5,6-dihydro-4H-pyrrolo[3,4-c]isoxazol-4-one 
(137b)  
(S)-6-(1-Methylethyl)-3-methyl-5,6-dihydro-4H-pyrrolo[3,4-c]isoxazol-4-one (125b) (33.0 
mg, 0.170 mmol) was suspended in dry THF (25 mL), cooled to -78 0C and stirred under a 
nitrogen atmosphere.  To this solution was added n-butyllithium (1.1 eq., 1.408 M in THF, 
0.133 mL, 0.187 mmol) in one portion and the mixture stirred for 15 minutes at this 
temperature, during which time the solution turned yellow.  Butanoyl chloride (1.1 eq., 19.3 
L, 0.187 mmol) was then added in two equal portions over 10 minutes and the reaction 
mixture stirred at -78 0C for a further hour before being quenched by saturated ammonium 
chloride solution.  The reaction solution was then tested for to ensure neutrality had been 
achieved and separated between water (20 mL) and ethyl acetate (25 mL).  The organic 
layer was retained, washed with saturated potassium carbonate solution (50 mL), dried over 
MgSO4, filtered and concentrated under reduced pressure to produce the product as a 
yellow oil (33.8 mg, 76%); [α]Drt +86.2 (c 14.15 x10-3, CHCl3); MS: m/z calculated for 
C14H20N2O3 (MNa+): 287.1366.  Found 287.1367; IR νmax (CHCl3)/cm-1 3054 (CH3), 1738 (C=O), 
1696 (C=C), 1644 (NC=O), 1382 (CN), 1215 (C-C), 1143 (COC); 1H NMR δH (400 MHz; CDCl3) 
0.84 (3H, d, J 6.8, CH(CH3)2), 0.95 (3H, t, J 7.2, CH2CH3), 1.01 (3H, d, J 6.8, CH(CH3)2), 1.40 (1H, 
t, J 9.6 Hz, CHCH2CH), 1.60-1.69 (1H, m, CH2CH3), 1.92-1.95 (1H, m, CH(CH3)2), 2.01 (1H, t, J 
9.6 Hz, CHCH2CH), 2.61 (3H, s, 5-CH3)2), 2.82-2.92 (2H, m, C(O)CH2), 5.19 (1H, d, J 3.6 Hz, 
CHN(CO)2); 13C NMR δC (100 MHz; CDCl3) 11.3 (5-CH3), 12.7 (CH2CH3), 16.7 (CH3), 22.7 
(CH2CH3), 23.5 (CH3), 26.9 (CH(CH3)2), 38.2 (CHCH2CH), 39.6 (C(O)CH2), 53.7 (CHN(CO)2), 
111.9 (CCCH3), 159.0 (CHCN), 168.4 (CCCH3), 170.0 (NC(O)C), 173.1 (NC(O)CH2). 
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(S,E)-5-(But-2-enoyl)-6-(1-methylethyl)-3-methyl-5,6-dihydro-4H-pyrrolo[3,4-c]isoxazol-4-
one (139b)  
(S)-6-(1-Methylethyl)-3-methyl-5,6-dihydro-4H-pyrrolo[3,4-c]isoxazol-4-one (125b) (50.0 
mg, 0.275 mmol) was suspended in dry THF (25 mL), cooled to -78 0C and stirred under a 
nitrogen atmosphere.  To this solution was added n-butyllithium (1.1 eq., 1.408 M in THF, 
0.201 mL, 0.283 mmol) in one portion and the mixture stirred for 15 minutes at this 
temperature, during which time the solution turned yellow.  But-2-enoyl chloride (1.1 eq., 
27.0 L, 0.283 mmol) was then added in two equal portions over 10 minutes and the 
reaction mixture stirred at -78 0C for a further hour before being quenched by saturated 
ammonium chloride solution.  The reaction solution was then tested fro pH to ensure 
neutrality had been achieved and separated between water (20 mL) and ethyl acetate (25 
mL).  The organic layer was retained, washed with saturated potassium carbonate solution 
(50 mL), dried over MgSO4, filtered and concentrated under reduced pressure to produce 
the product as a yellow oil (65.0 mg, 95%); [α]Drt +67.1 (c 32.5 x10-3 CHCl3); MS: m/z 
calculated for C14H18N2O3 (MNa+): 285.1210.  Found 285.1212; IR νmax (CHCl3)/cm-1 3054, 
2986 (CH3), 1739 (C=O), 1679 (C=C), 1642 (NC=O), 1335 (CN), 1216 (C-C), 1141 (COC); 1H 
NMR δH (400 MHz; CDCl3) 0.93 (3H, d, J 6.8, CH(CH3)2), 1.08 (3H, d, J 6.8, CH(CH3)2), 1.50 (1H, 
td, Ja 3.6 Hz, Jb 10.4 Hz, CHCH2CH), 1.98 (3H, dd, Ja 3.6 Hz, Jb 7.2 Hz, CHCH3), 2.01-2.04 (1H, 
m, CH(CH3)2), 2.15 (1H, td, Ja 3.6 Hz, Jb 10.4 Hz, CHCH2CH), 2.67 (3H, s, 5-CH3)2), 5.32 (1H, d, J 
3.6 Hz, CHN(CO)2), 7.16 (1H, qd, Ja 6.8 Hz, Jb 13.6 Hz, (C(O)CH), 7.22 (1H, dq, Ja 6.8 Hz, Jb 7.2 
Hz, CHCH3); 13C NMR δC (100 MHz; CDCl3) 12.4 (5-CH3), 18.1  (CHCH3), 18.6 (CH3), 21.2 (CH3), 
23.6 (CH(CH3)2), 40.6 (CHCH2CH), 54.2 (CHN(CO)2), 113.0 (CCCH3), 123.8 (CHCH3), 146.5 
(C(O)CH), 160.2 (CHCN), 166.0 (CCCH3), 169.8 (NC(O)C), 171.2 (NC(O)CH2). 
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(S)-5-Benzoyl-6-(1-methylethyl)-3-methyl-5,6-dihydro-4H-pyrrolo[3,4-c]isoxazol-4-one 
(138b)  
(S)-6-(1-methylethyl)-3-methyl-5,6-dihydro-4H-pyrrolo[3,4-c]isoxazol-4-one (125b) (43.0 mg, 
0.237 mmol) was suspended in dry THF (25 mL), cooled to -78 0C and stirred under a 
nitrogen atmosphere.  To this solution was added n-butyllithium (1.1 eq., 1.408 M in THF, 
0.185 mL, 0.261 mmol) in one portion and the mixture stirred for 15 minutes at this 
temperature, during which time the solution turned yellow.  Benzoyl chloride (1.1 eq., 30.3 
L, 0.261 mmol) was then added in two portions over 10 minutes and the reaction mixture 
stirred at -78 0C for a further hour before being quenched by saturated ammonium chloride 
solution.  The reaction solution was then tested for pH to ensure neutrality had been 
achieved and separated between water (20 mL) and ethyl acetate (25 mL).  The organic 
layer was retained, washed with saturated potassium carbonate solution (50 mL), dried over 
MgSO4, filtered and concentrated under reduced pressure to produce the product as a pale 
orange oil (30.0 mg, 43%); [α]Drt +158.7 (c 15.0 x10-3, CHCl3); MS: m/z calculated for 
C17H18N2O3 (MNa+): 321.1236.  Found 321.1237; IR νmax (CHCl3)/cm-1 3054, 2986 (CH3), 1750 
(C=O), 1678 (C=C), 1643 (NC=O), 1421 (CN), 1265 (C-C), 1156 (COC); 1H NMR δH (400 MHz; 
CDCl3) 1.03 (3H, d, J 6.8, CH(CH3)2), 1.13 (3H, d, J 6.8, CH(CH3)2), 1.75 (1H, t, J 9.2 Hz, 
CH(CH3)2), 2.05-2.13 (2H, m, CHCH2CH), 2.65 (3H, s, 5-CH3)2), 5.55 (1H, d, J 3.6 Hz, 
CHN(CO)2), 7.44-7.52 (2H, m,  Ar-H), 7.53-7.60 (3H, m, Ar-H); 13C NMR δC (100 MHz; CDCl3) 
12.3 (5-CH3), 21.4 (CH3), 23.7 (CH3), 24.7 (CH(CH3)2), 40.5 (CHCH2CH), 52.8 (CHN(CO)2), 112.7 
(CCCH3), 128.0 (2Ar-CH), 128.5 (2Ar-CH), 132.3 (Ar-CH), 134.5 (Ar-C), 159.2 (CHCN), 169.4 
(CCCH3), 169.9 (NC(O)C), 170.3 (NC(O)CH2). 
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(S)-6-(1-Methylethyl)-3-methyl-5-(2,2-dimethylpropanoyl)-5,6-dihydro-4H-pyrrolo[3,4-
c]isoxazol-4-one (141b)  
(S)-6-(1-Methylethyl)-3-methyl-5,6-dihydro-4H-pyrrolo[3,4-c]isoxazol-4-one (125b) (33.0 
mg, 0.170 mmol) was suspended in dry THF (25 mL), cooled to -78 0C and stirred under a 
nitrogen atmosphere.  To this solution was added n-butyllithium (1.1 eq., 1.408 M in THF, 
0.133 mL, 0.187mmol) in one portion and the mixture stirred for 15 minutes at this 
temperature, during which time the solution turned yellow.  2,2-dimethylpropanoyl chloride 
(1.1 eq., 23.0 L, 0.187 mmol) was then added in two equal portions over 10 minutes and 
the reaction mixture stirred at -78 0C for a further hour before being quenched by saturated 
ammonium chloride solution.  The reaction solution was then tested for pH to ensure 
neutrality had been achieved and separated between water (20 mL) and ethyl acetate (25 
mL).  The organic layer was retained, washed with saturated potassium carbonate solution 
(50 mL), dried over MgSO4, filtered and concentrated under reduced pressure to produce 
the product as a yellow oil (20.0 mg, 36%); [α]Drt +47.5 (c 8.0 x10-3, CHCl3); MS: m/z 
calculated for C15H22N2O3 (MNa+): 301.1526.  Found 301.1524; IR νmax (CHCl3)/cm-1 3054, 
2986 (CH3), 1794 (C=O), 1741 (C=C), 1643 (NC=O), 1421 (CN), 1265 (C-C), 1167 (COC); 1H 
NMR δH (400 MHz; CDCl3) 0.98 (3H, d, J 6.8, CH(CH3)2), 1.07 (3H, d, J 6.8, CH(CH3)2), 1.37 (9H, 
s, C(CH3)3), 1.69 (2H, t, J 9.6 Hz, CHCH2CH), 1.91-1.94 (1H, m, CH(CH3)2), 2.62 (3H, s, 5-CH3)2), 
5.38 (1H, d, J 3.6 Hz, CHN(CO)2); 13C NMR δC (100 MHz; CDCl3) 12.0 (5-CH3), 21.1 (CH3), 22.5 
(CH3), 25.3 (CH(CH3)2), 26.2 ((CH3)3), 40.7 (CHCH2CH), 51.2 (CHN(CO)2), 113.0 (CCCH3), 158.9 
(CHCN), 169.4 (CCCH3), 169.5 (NC(O)C), 180.2 (NC(O)CH2). 
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(S)-5-Decanoyl-6-(1-methylethyl)-3-methyl-5,6-dihydro-4H-pyrrolo[3,4-c]isoxazol-4-one 
(140b)  
(S)-6-(1-Methylethyl)-3-methyl-5,6-dihydro-4H-pyrrolo[3,4-c]isoxazol-4-one (125b) (33.0 
mg, 0.170 mmol) was suspended in dry THF (25 mL), cooled to -78 0C and stirred under a 
nitrogen atmosphere.  To this solution was added n-butyllithium (1.1 eq., 1.408 M in THF, 
0.133 mL, 0.187 mmol) in one portion and the reaction was then stirred for 15 minutes at 
this temperature, during which time the solution turned yellow.  Decanoyl chloride (1.1 eq., 
38.8 L, 0.187 mmol) was then added in two equal portions over 10 minutes and the 
reaction mixture stirred at -78 0C for a further hour before being quenched by saturated 
ammonium chloride solution.  The reaction solution was then tested for pH to ensure 
neutrality had been achieved and separated between water (20 mL) and ethyl acetate (25 
mL).  The organic layer was retained, washed with saturated potassium carbonate solution 
(50 mL), dried over MgSO4, filtered and concentrated under reduced pressure to produce 
the product as a pale yellow oil (16.0 mg, 33%); [α]Drt +94.0 (c 10.0 x10-3, CHCl3); MS: m/z 
calculated for C20H32N2O3 (MNa+): 371.2305.  Found 371.2305; IR νmax (CHCl3)/cm-1 3054, 
2987 (CH3), 1739 (C=O), 1643 (C=C), 1605 (NC=O), 1421 (CN), 1265 (C-C), 1156 (COC); 1H 
NMR δH (400 MHz; CDCl3) 0.88 (3H, t, J 6.4 Hz, CH2CH3), 0.94 (3H, d, J 6.8, CH(CH3)2), 1.10 
(3H, d, J 6.8, CH(CH3)2), 1.50 (1H, td, Ja 2.0 Hz, Jb 3.6 Hz, CHCH2CH), 1.61-1.71 (1H, m, 
C(O)CH2CH2), 1.98-2.04 (1H, m, CH(CH3)2), 2.12 (1H, td, Ja 2.0 Hz, Jb 3.6 Hz, CHCH2CH), 2.68 
(3H, s, 5-CH3)2), 2.94-2.98 (2H, m, C(O)CH2), 5.26 (1H, d, J 3.6 Hz, CHN(CO)2); 13C NMR δC (100 
MHz; CDCl3) 12.3 (5-CH3), 14.1 (CH3), 21.2 (CH2CH3), 22.7 (CH2CH3), 23.7 (CH3), 24.3 (CH2), 
24.6 (CH(CH3)2), 29.2 (CH2), 29.3 (CH2), 29.3 (CH2), 29.7 (CH2), 35.2 (C(O)CH2CH2), 39.8 
(C(O)CH2), 61.5 (CHN(CO)2), 115.1 (CCCH3), 161.0 (CHCN), 167.4 (CCCH3), 169.8 (NC(O)C), 
175.1 (NC(O)CH2). 
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(S,E)-5-(dec-2-enoyl)-6-(1-methylethyl)-3-methyl-5,6-dihydro-4H-pyrrolo[3,4-c]isoxazol-4-
one  (19)  
(S)-6-(1-Methylethyl)-3-methyl-5,6-dihydro-4H-pyrrolo[3,4-c]isoxazol-4-one (125b) (8.0 mg, 
0.040 mmol) was suspended in dry THF (10 mL), cooled to -78 0C and stirred under a 
nitrogen atmosphere.  To this solution was added n-butyllithium (1.5 eq., 1.65 M in THF, 38 
L, 0.062 mmol) in one portion and the mixture stirred for 15 minutes at this temperature, 
during which time the solution turned yellow.  (E)-Dec-2-enoyl chloride (1.5 eq., 11 mg, 12 
L, 0.062 mmol) was then added in two equal portions over 10 minutes and the reaction 
mixture stirred at -78 0C for a further hour before being quenched by saturated ammonium 
chloride solution.  The reaction solution was then tested for pH to ensure neutrality had 
been achieved and separated between water (20 mL) and ethyl acetate (25 mL).  The 
organic layer was retained, washed with saturated potassium carbonate solution (50 mL), 
dried over MgSO4, filtered and concentrated under reduced pressure to produce none of 
the desired product.  It is thought that some thionyl chloride remained in the reaction 
mixture from a previous step, which could have reacted with the anion, eventually returning 
the pyrroloisoxazole after work-up. 
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(S)-5-Butanoyl-6-(1-methylethyl)-3-(2-oxopentyl)-5,6-dihydro-4H-pyrrolo[3,4-c]isoxazol-4-
one (168)  
(S)-6-(1-Methylethyl)-3-methyl-5,6-dihydro-4H-pyrrolo[3,4-c]isoxazol-4-one (125a) (20.0 mg, 
0.110mmol) was suspended in dry THF (25 mL), cooled to -78 0C and stirred under a 
nitrogen atmosphere.  To this solution was then added n-butyllithium (3.5 eq., 0.960 M in 
hexanes, 0.401 mL, 0.385 mmol) in one portion and the mixture stirred for 15 minutes at 
this temperature, during which time the solution turned yellow.  Butanoyl chloride (10.0 eq., 
113.0 L, 1.10 mmol) was then added in two equal portions over 10 minutes and the 
reaction mixture stirred at -78 0C for a further hour before being quenched by saturated 
ammonium chloride solution.  The reaction solution was then tested for pH to ensure 
neutrality had been achieved and separated between water (20 mL) and ethyl acetate (25 
mL).  The organic layer was retained, dried over MgSO4, filtered and concentrated under 
reduced pressure to produce a crude mixture, in which the desired product could not be 
identified. 
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4.6.2 – N-Alkylation Attempts 
 
(S)-5-Butyl-6-(1-methylethyl)-3-methyl-5,6-dihydro-4H-pyrrolo[3,4-c]isoxazol-4-one (145)  
(S)-6-(1-Methylethyl)-3-methyl-5,6-dihydro-4H-pyrrolo[3,4-c]isoxazol-4-one (125a) (46.8 mg, 
0.280 mmol) was suspended in dry THF (25 mL), cooled to -78 0C and stirred under a 
nitrogen atmosphere.  To this solution was added n-butyllithium (1.1 eq., 2.0 M in THF, 
0.143 mL, 0.286 mmol) in one portion and the mixture stirred for 15 minutes at this 
temperature, during which time the solution turned yellow.  1-Bromobutane (1.1 eq., 40.0 
mg, 0.037 mL, 0.286 mmol) was then added in two equal portions over 10 minutes and the 
reaction mixture stirred at -78 0C for a further hour before being quenched by saturated 
ammonium chloride solution.  The reaction solution was then tested for pH to ensure 
neutrality had been achieved and separated between water (20 mL) and ethyl acetate (25 
mL).  The organic layer was retained, dried over MgSO4, filtered and concentrated under a 
reduced pressure to produce a white solid identified as returned pyrroloisoxazole starting 
material. 
 
 
 
 
 
 
X 
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(S)-5-Butyl-6-(1-methylethyl)-3-methyl-5,6-dihydro-4H-pyrrolo[3,4-c]isoxazol-4-one (145)  
(S)-6-(1-Methylethyl)-3-methyl-5,6-dihydro-4H-pyrrolo[3,4-c]isoxazol-4-one (125a) (46.8 mg, 
0.280 mmol) was suspended in dry THF (25 mL), cooled to -78 0C and stirred under a 
nitrogen atmosphere.  To this solution was added n-butyllithium (1.1 eq., 2.0 M in THF, 
0.143 mL, 0.286 mmol) in one portion and the mixture stirred for 15 minutes at this 
temperature, during which time the solution turned yellow.  1-Bromobutane (1.1 eq., 40.0 
mg, 0.037 mL, 0.286 mmol) was then added in two equal portions over 10 minutes and the 
reaction mixture stirred and allowed to warm to room temperature over 2 h before being 
quenched by saturated ammonium chloride solution.  The reaction solution was tested for 
pH to ensure neutrality had been achieved and separated between water (20 mL) and ethyl 
acetate (25 mL).  The organic layer was retained, dried over MgSO4, filtered and 
concentrated under a reduced pressure to produce a white solid identified as returned 
pyrroloisoxazole starting material. 
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(S)-5-Prop-2-enyl-6-(1-methylethyl)-3-methyl-5,6-dihydro-4H-pyrrolo[3,4-c]isoxazol-4-one 
(146)  
(S)-6-(1-Methylethyl)-3-methyl-5,6-dihydro-4H-pyrrolo[3,4-c]isoxazol-4-one (125a) (57.5 mg, 
0.319 mmol) was suspended in dry THF (25 mL), cooled to -78 0C and stirred under a 
nitrogen atmosphere.  To this solution was added n-butyllithium (1.1 eq., 2.0 M in THF, 
0.175 mL, 0.351 mmol) in one portion and the mixture stirred for 15 minutes at this 
temperature, during which time the solution turned yellow.  3-Bromoprop1-ene (2 eq., 77.2 
mg, 0.055 mL, 0.638 mmol) was then added in two equal portions over 10 minutes and the 
reaction mixture stirred and allowed to warm to room temperature over 2 h before being 
quenched by saturated ammonium chloride solution.  The reaction solution was tested for 
pH to ensure neutrality had been achieved and separated between water (20 mL) and ethyl 
acetate (25 mL).  The organic layer was retained, dried over MgSO4, filtered and 
concentrated under a reduced pressure to produce a white solid identified as returned 
pyrroloisoxazole starting material. 
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(S)-5-Prop-2-enyl-6-(1-methylethyl)-3-methyl-5,6-dihydro-4H-pyrrolo[3,4-c]isoxazol-4-one 
(146)  
(S)-6-(1-Methylethyl)-3-methyl-5,6-dihydro-4H-pyrrolo[3,4-c]isoxazol-4-one (125a) (43.5 mg, 
0.241 mmol) was suspended in dry THF (25 mL), cooled to -78 0C and stirred under a 
nitrogen atmosphere.  To this solution was added n-butyllithium (1.1 eq., 2.0 M in THF, 
0.133 mL, 0.266 mmol) in one portion and mixture stirred for 15 minutes at this 
temperature, during which time the solution turned yellow.  3-Bromoprop-1-ene (excess, 
140 mg, 0.10 mL, 1.165 mmol) was then added in two equal portions over 10 minutes and 
the reaction mixture stirred at reflux over 1 h before being quenched by saturated 
ammonium chloride solution.  The reaction solution was then tested for pH to ensure 
neutrality had been achieved and separated between water (20 mL) and ethyl acetate (25 
mL).  The organic layer was retained, dried over MgSO4, filtered and concentrated under a 
reduced pressure to produce a white solid identified as returned pyrroloisoxazole starting 
material. 
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(S)-5-Prop-2-enyl-6-(1-methylethyl)-3-methyl-5,6-dihydro-4H-pyrrolo[3,4-c]isoxazol-4-one 
(146)  
(S)-6-(1-Methylethyl)-3-methyl-5,6-dihydro-4H-pyrrolo[3,4-c]isoxazol-4-one (125a) (43.5 mg, 
0.241 mmol) was suspended in dry THF (25 mL) with potassium iodide (40.0 mg, 0.241 
mmol), cooled to -78 0C and stirred under a nitrogen atmosphere.  To this solution was 
added n-butyl-lithium (1.1 eq., 2.0 M in THF, 0.133 mL, 0.266 mmol) in one portion and the 
mixture stirred for 15 minutes at this temperature, during which time the solution turned 
yellow.  3-Bromoprop-1-ene (excess, 140 mg, 0.10 mL, 1.165 mmol) was then added in two 
equal portions over 10 minutes and the reaction mixture stirred at reflux over 1 h before 
being quenched by saturated ammonium chloride solution.  The reaction solution was then 
tested for pH to ensure neutrality had been achieved and separated between water (20 mL) 
and ethyl acetate (25 mL).  The organic layer was retained, dried over MgSO4, filtered and 
concentrated under a reduced pressure to produce a white solid identified as returned 
pyrroloisoxazole starting material. 
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4.7 – Isoxazole Cleavage in Pyrroloisoxazoles and Attempted Hydrolysis  
4.7.1 – Isoxazole Cleavage by Hydrogenation 
 
 
(S)-3-Acetyl-4-amino-1-butanoyl-5-(1-methylethyl)-1H-pyrrol-2(5H)-one (147a)  
To a flask flushed with nitrogen was added palladium on carbon (10% by mass, 12.0 mg) 
followed dropwise by ethanol (20 mL).  This produced a slurry, to which was added (S)-5-
butanoyl-6-(1-methylethyl)-3-methyl-5,6-dihydro-4H-pyrrolo[3,4-c]isoxazol-4-one (125a) 
(120 mg, 0.506 mmol) in ethanol (20 mL) with vigorous stirring.  The reaction vessel was 
then purged and subsequently evacuated 3 times with nitrogen and then a further 3 times 
with hydrogen gas, eventually being left under a hydrogen atmosphere for 25 hours with 
vigorous stirring.  The reaction vessel was then evacuated and purged 3 times with nitrogen 
and the slurry filtered through a Celite® pad to remove palladium on carbon.  The filtrate 
was concentrated under reduced pressure to yield product as a yellow oil (58.0 mg, 49%); 
[α]Drt +26.1 (c 8.0 x10-3, CHCl3); MS: m/z calculated for C13H20N2O3 (MNa+): 275.2987.  Found 
275.2986; IR νmax (CHCl3)/cm-1 3567 (NH), 2981 (CH3), 1769 (C=O), 1659 (C=C), 1568 (NC=O), 
1378 (CN), 1219 (C-C), 1142 (COC);); 1H NMR δH (400 MHz; CDCl3) 0.80 (3H, d, J 6.8, 
CH(CH3)2),  0.91 (3H, t, J 7.2, CH2CH3), 1.14 (3H, d, J 6.8, CH(CH3)2), 1.61-1.69 (2H, m, 
CH2CH3), 2.50 (3H, s, 5-CH3), 2.53-2.65 (1H, m, CH(CH3)2), 2.85 (1H, dt, Ja 7.6 Hz, Jb 14.8 Hz, 
C(O)CH2), 2.98 (1H, dt, Ja 7.6 Hz, Jb 14.8 Hz, C(O)CH2), 4.62 (1H, d, J 7.2 Hz, CHN(CO)2), 5.80 
(1H, br. s, HNH), 9.41 (1H, br. s, HNH); 13C NMR δC (100 MHz; CDCl3) 12.8 (5-CH3), 13.2 
(CH2CH3), 14.4 (CH3), 17.1 (CH2CH3), 17.6 (CH3), 27.5 (CH(CH3)2), 38.0 (C(O)CH2), 59.4 
(CHN(CO)2), 101.4 (CCCH3), 166.9 (CHCN), 170.9 (CCCH3), 172.3 (NC(O)C), 196.2 (NC(O)CH2). 
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(S)-3-Acetyl-4-amino-1-butanoyl-5-(1-methylethyl)-1H-pyrrol-2(5H)-one (147b)  
To a flask flushed with nitrogen was added palladium on carbon (10% by mass, 3.00 mg) 
followed dropwise by ethanol (20 mL).  This produced a slurry, to which was added (S)-5-
butanoyl-6-(1-methylethyl)-3-methyl-5,6-dihydro-4H-pyrrolo[3,4-c]isoxazol-4-one (125b) (28 
mg, 0.106 mmol) in ethanol (20 mL) with vigorous stirring.  The reaction vessel was then 
purged and subsequently evacuated 3 times with nitrogen and then with a further 3 times 
with hydrogen gas, eventually being left under a hydrogen atmosphere for 25 hours with 
vigorous stirring.  The reaction vessel was then evacuated and purged 3 times with nitrogen 
and the slurry filtered through a Celite® pad to remove palladium on carbon.  The filtrate 
was concentrated under reduced pressure to yield product as a yellow oil (15.0 mg, 52%); 
[α]Drt +31.5 (c 12.0 x10-3, CHCl3); MS: m/z calculated for C14H22N2O3 (MNa+): 289.1523.  
Found 289.1523; IR νmax (CHCl3)/cm-1 3550 (NH), 2985 (CH3), 1740 (C=O), 1650 (C=C), 1521 
(NC=O), 1374 (CN), 1246 (C-C), 1168 (COC); 1H NMR δH (400 MHz; CDCl3) 0.91 (3H, d, J 6.4 
Hz, CH(CH3)2), 0.94 (3H, d, J 2.4 Hz, CH(CH3)2), 1.01 (3H, t, J 7.2, CH2CH3), 1.25 (1H, t, J 9.6 Hz, 
CHCH2CH), 1.65-1.74 (2H, m, CH2CH3), 2.01-2.06 (1H, m, CH(CH3)2), 2.07 (1H, t, J 9.6 Hz, 
CHCH2CH), 2.52 (3H, s, 5-CH3)2), 2.92-3.02 (2H, m, C(O)CH2), 4.75 (1H, d, J 7.2 Hz, CHN(CO)2), 
6.01 (1H, br. s, HNH), 9.30 (1H, br. s, HNH); 13C NMR δC (100 MHz; CDCl3) 12.2 (CH2CH3), 17.4 
(CH2CH3), 22.4 (CH3), 22.6 (CH3), 25.4 (CH(CH3)2), 28.7 (5-CH3), 37.9 (C(O)CH2), 39.0 
(CHCH2CH), 55.1 (CHN(CO)2), 100.6 (CCCH3), 166.8 (CHCN), 172.3 (CCCH3), 172.4 (NC(O)C), 
196.16 (NC(O)CH2). 
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4.7.2 – Isoxazole Cleavage by Molybdenum Hexacarbonyl 
  
(S,E)-3-Acetyl-4-amino-1-(but-2-enoyl)-5-phenyl-1H-pyrrol-2(5H)-one (148)  
(S,E)-5-(But-2-enoyl)-3-methyl-6-phenyl-5,6-dihydro-4H-pyrrolo[3,4-c]isoxazol-4-one (125c) 
(10.0 mg, 35.5 mol) was added to molybdenum hexacarbonyl (1.0 eq., 9.40 mg, 35.5 mol) 
in a acetonitrile:water (4:1 v/v, 5.00 mL) and stirred under reflux for 1 hour.  To this 
refluxing mixture was then added 2.0 M aqueous hydrochloric acid (2.00 mL) and the 
reaction solution stirred under reflux for a further hour.  The solution was then filtered 
through Celite® and the filtrate extracted with DCM before being washed with water and 
brine.  The organic fraction was dried over magnesium sulfate and concentrated under 
reduced pressure to yield the crude enaminoketone, which was able to be purified by prep-
TLC eluting with ethyl acetate:light petrol (3:1 v/v).  The product was isolated as a clear and 
colourless oil (6.0 mg. 60%); [α]Drt +8.9 (c 9.0 x10-3, CHCl3); MS: m/z calculated for 
C16H16N2O3 (MNa+): 307.1053.  Found 307.1052; IR νmax (CHCl3)/cm-1 3250 (NH), 3059, 2916 
(CH3), 1779 (C=O), 1710 (C=C), 1649 (NC=O), 1455 (CN), 1097 (C-C); 1H NMR δH (400 MHz; 
CDCl3) 1.25 (3H, dd, Ja 1.6 Hz, Jb 6.8 Hz, CHCH3), 2.59 (3H, s, CH3), 5.56 (1H, s, CHN), 5.62 (1H, 
br. s, HNH), 7.05 (1H, qd, Ja 6.8 Hz, Jb 13.6 Hz, (C(O)CH), 7.35 (1H, dq, Ja 3.6 Hz, Jb 7.2 Hz, 
CHCH3), 7.30-7.48 (5H, m, Ar(H)), 9.01 (1H, br. s, HNH); 13C NMR δC (100 MHz; (CDCl3)) 17.8 
(5-CH3), 24.4  (CHCH3), 60.2 (CHN(CO)2), 123.1 (CCCH3), 126.0 (CHCH3), 128.3 (Ar-C), 128.5 
(2Ar-C), 144.3 (2Ar-C), 154.0 (C(O)CH), 160.1 (CHCN), 163.8 (CCCH3), 167.2 (NC(O)C), 170.4 
(NC(O)CH2).  
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4.7.3 – Attempted Hydrolysis of Enaminoketone  
 
(S,Z)-1-Butanoyl-3-(1-hydroxyethylidene)-5-(1-methylethyl)pyrrolidine-2,4-dione (149)  
To the crude enaminone (90.0 mg, 0.360 mmol) was added tetrahydrofuran (20 mL) and 
sodium hydroxide solution (2M, 60 mL) and the reaction mixture heated to reflux and 
stirred for 18 h.  After allowing the reaction mixture to return to room temperature, the 
solution was acidified using hydrochloric acid solution (1M) and the aqueous layer was 
extracted with dichloromethane (3 x 30 mL).  The combined organic layers were dried over 
magnesium sulfate, filtered and the solvent removed under reduced pressure to yield the 
crude material as a yellow/orange oil. Further purification by column chromatography 
eluting with light petroleum and ethyl acetate (1:3 v/v) afforded none of the desire 3-
acyltetramic acid. Hydrolysis of the imide bond was inferred by identification of butanoic 
acid from the column. 
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(S,Z)-1-Butanoyl-3-(1-hydroxyethylidene)-5-(1-methylethyl)pyrrolidine-2,4-dione (149)  
To the pure enaminone (10.0 mg, 0.039 mmol) was added tetrahydrofuran (20 mL) and 
sodium hydroxide solution (1.1 eq., 0.1M, 0.44 mL, 0.044 mmol) and the reaction mixture 
was left at room temperature and stirred for 18 h.  The solution was acidified using 
hydrochloric acid solution (1M) and the aqueous layer was extracted with dichloromethane 
(3 x 30 mL).  The combined organic layers were dried over magnesium sulfate, filtered and 
the solvent removed under reduced pressure to yield the crude material as a yellow/orange 
oil. Further purification was required by column chromatography eluting with light 
petroleum and ethyl acetate (1:3 v/v) to produce none of the desire 3-acyltetramic acid. 
Hydrolysis of the imide bond was inferred by identification of butanoic acid from the 
column. 
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(S,Z)-1-Butanoyl-3-(1-hydroxyethylidene)-5-(1-methylethyl)pyrrolidine-2,4-dione (149)  
To the pure enaminone (1050 mg, 0.059 mmol) was added ethanol (5 mL) followed by H2O 
(5 mL) and the reaction mixture was left at room temperature and stirred for 18 h.  The 
solution was acidified using hydrochloric acid solution (1M) and the aqueous layer was 
extracted with dichloromethane (3 x 30 mL).  The combined organic layers were dried over 
magnesium sulfate, filtered and the solvent removed under a reduced pressure to yield the 
crude material as a white powder which was identified as N-acyl enaminoketone starting 
material. Further purification by column chromatography eluting with light petroleum and 
ethyl acetate (1:3 v/v) revealed none of the desired 3-acyltetramic acid, and no hydrolysis.  
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(S,Z)-1-Butanoyl-3-(1-hydroxyethylidene)-5-(1-methylethyl)pyrrolidine-2,4-dione (149)  
To the pure enaminone (30.0 mg, 0.113 mmol) was added ethanol (5 mL) and hydrochloric 
acid (2 M, 5 mL) and the reaction mixture was left at room temperature and stirred for 18 h.  
The aqueous layer was then extracted with dichloromethane (3 x 30 mL).  The combined 
organic layers were dried over magnesium sulfate, filtered and the solvent removed under a 
reduced pressure to yield the crude material as a white powder which was identified as N-
acyl enaminoketone starting material. Further purification by column chromatography 
eluting with light petroleum and ethyl acetate (1:3 v/v) revealed none of the desire 3-
acyltetramic acid and no hydrolysis. 
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(S,Z)-1-Butanoyl-3-(1-hydroxyethylidene)-5-(1-methylethyl)pyrrolidine-2,4-dione (149)  
The pure enaminone (30.0 mg, 0.113 mmol) was suspended in sulfuric acid (3.0 M, 5 mL) 
and H2O (5 mL) to which was added sodium nitrite (1.5 eq., 20.0 mg, 0.170 mmol) and the 
reaction mixture was left at room temperature and stirred for 1 h.  The reaction mixture was 
then heated to 500C for 40 minutes and, after allowing the reaction mixture to return to 
room temperature, the aqueous layer was extracted with ethyl acetate (3 x 30 mL).  The 
combined organic layers were dried over magnesium sulfate, filtered and the solvent 
removed under reduced pressure to yield the crude material as a white powder which was 
identified as N-acyl enaminoketone starting material. Further purification by column 
chromatography eluting with light petroleum and ethyl acetate (1:3 v/v) revealed none of 
the desired 3-acyltetramic acid and no hydrolysis. 
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4.8 – Production of the Acyl Chloride Required to Synthesise Reutericyclin 
Analogues 
 
 
E-Dec-2-enoic acid (144)  
To ethyl E-dec-2-enoate (0.88g, 1 mL, 4.44 mmol) was added lithium hydroxide (2.0 eq., 
0.22g, 8.89 mmol) in water and THF (10 mL, 1:1 v/v)  and the mixture was heated to reflux 
for 17 h.  After cooling, the solution was washed with diethyl ether (50 mL) and the aqueous 
layer was acidified to pH 2-3 using concentrated hydrochloric acid.  The resultant white 
precipitate was collected by filtration and dissolved in chloroform (30 mL) which was then 
dried over magnesium sulfate, filtered and evaporated under a reduced pressure to yield 
the title compound as an oil (0.554 g, 74%); MS: m/z calculated for C10H18O2 (MH+): 
171.1380.  Found 171.1379; IR νmax (CHCl3)/cm-1 3404 (OH), 2935 (CH2, CH3), 1685 (CO), 1659 
(CC), 1423 (CN); 1H NMR δH (400 MHz; CDCl3) 0.89 (3H, t, J 6.8 Hz, CH3), 1.13-1.53 (8H, m, 
4xCH2), 1.45-1.57 (2H, m, CH2), 2.21 (2H, dt, Ja 7.2 Hz, Jb 14.4 Hz, CHCH2), 6.07 (1H, d, J 15.2 
Hz, CH=CHCOOH), 7.20-7.28 (1H, m, CH2CH=CHCOOH), 11.50 (1H, br. s, OH); 13C NMR δC 
(100 MHz; CDCl3) 14.0 (CH3), 22.8 (CH2), 24.7 (CH2), 27.4 (CH2), 29.0 (CH2), 30.8 (CH2), 31.7 
(CH2), 32.5 (CH2), 149.6 (CH), 153.4 (CH). This was a literature compound and the data 
agreed with that seen earlier. 
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E-Dec-2-anoyl chloride (142)  
E-Dec-2-enoic acid (0.225 g, 1.33 mmol) was suspended in thionyl chloride (10 eq., 1.57 g, 
0.96 mL, 13.3 mmol and stirred for 2 h at reflux.  The excess thionyl chloride was removed 
under reduced pressure to yield the chlorinated product (241 mg, up to 97%, note it was not 
isolated); MS: m/z calculated for C10H18O2 (MH+): 171.1380.  Found 171.1379; IR νmax 
(CHCl3)/cm-1 2930 (CH2, CH3), 1695 (CO), 1650 (CC), 1420 (CN); 1H NMR δH (400 MHz; CDCl3) 
0.88 (3H, t, J 6.8 Hz, CH3), 1.13-1.51 (8H, m, 4xCH2), 1.45-1.59 (2H, m, CH2), 2.29 (2H, dt, Ja 
7.2 Hz, Jb 14.4 Hz, CHCH2), 6.07 (1H, d, J 15.2 Hz, CH=CHCOOH), 7.20-7.29 (1H, m, 
CH2CH=CHCOOH); 13C NMR δC (100 MHz; CDCl3) 14.0 (CH3), 22.8 (CH2), 24.7 (CH2), 27.4 (CH2), 
29.0 (CH2), 30.8 (CH2), 31.7 (CH2), 32.5 (CH2), 152.6 (CH), 157.4 (CH). 
 
 
E-Dec-2-enoyl chloride (142)  
E-Dec-2-enoic acid (298 mg, 1.76 mmol) was suspended in toluene (20 mL) and cooled to 
0oC before adding oxalyl chloride (2.5 eq., 0.378 mL, 560 mg, 4.41 mmol) and stirred for 17 h 
to room temperature.  The excess oxalyl chloride was removed under reduced pressure to 
yield the chlorinated product (305 mg, up to 85%, note it was not fully characterised); the 
analysis was identical to that seen above. 
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4.9 – Methods using a Model Isoxazole  
4.9.1 – Model Isoxazole Synthesis  
 
Ethyl 3-(pyrrolidine-1-yl)but-2-enoate (152)94 
Ethyl 3-oxobutanoate (26.00g, 25.5 mL, 0.20 mol) and pyrrolidine (14.2g, 16.4 mL, 0.20 mol) 
were heated to reflux in try toluene (50 mL) under Dean-Stark conditions for 18 hrs, 
producing the theoretical amount of water (3.30 mL, 0.20 mol). The solvent was then 
removed under a reduced pressure to yield ethyl 3-(pyrrolidine-1-yl)but-2-enoate as a dark 
brown mobile oil (34.6g, 99%) MS: m/z calculated for C10H17NO2 (MH+): 184.1301. Found 
184.1499; IR νmax (CHCl3)/cm-1 2970 (CH), 2796 (CH2, CH3), 1652 (CO), 1569 (CC), 1196 (CN); 
1H NMR δH (400 MHz; CDCl3) 1.13-1.19 (3H, t, J 7.0 Hz, CH3CH2), 1.78-1.87 (4H, m, 
RNCH2(CH2)2CH2), 2.35 (3H, s, CH3C(N)=CH), 3.06-3.29 (4H, br.m, RNCH2(CH2)2CH2), 4.35 (1H, 
s, CHCCH3); 13C NMR δC (100 MHz; CDCl3) 16.5 (CH3), 25.2 (CH3), 47.8 (CH2), 86.0 (CHCCH3), 
160.5 (CN), 171.9 (COO). This was a literature compound and the data agreed with that seen 
earlier. 
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Ethyl 3,5-dimethylisoxazole-4-carboxylate (150)94 
Triethylamine (3 eq., 80 mL, 0.60 mol) was added directly to ethyl 3-(pyrrolidine-1-yl)but-2-
enoate (152) (34.6g, 0.20 mol) followed by nitroethane (1.1 eq., 15.80 mL, 0.22 mol) in 
chloroform (100 mL) and the solution was cooled to 0 0C.  Phosphorus (V) oxychloride (1.1 
eq., 34.0g, 0.22 mol) in chloroform (40 mL) was added dropwise over 1.5 h, the mixture 
stirred and allowed to warm to room temperature and left for 18 h.  The solution was then 
added to water (200 mL), separated, and the organic fraction washed successively with 
hydrochloric acid (6M, 70 mL), sodium hydroxide solution (5% w/v, 100 mL) and saturated 
brine (100 mL).  The organic phase was dried over magnesium sulfate and concentrated 
under reduced pressure to yield ethyl 3,5-dimethylisoxazole-4-carboxylate (15.8g, 47%,). bp 
59-610C at 0.5 mmHg, lit.94 bp 60-620C at 0.5 mmHg; MS: m/z calculated for C8H11NO3 
(MNa+): 170.0856.  Found 170.0849; IR νmax (CHCl3)/cm-1 2980 (CH3), 2951 (CH2, CH3), 1719 
(CO), 1612(CC), 1303 (CN); 1H NMR δH (400 MHz; CDCl3) 1.30 (3H, t, J 6.8 CH2CH3), 2.36 (3H, 
s, OCCH3), 2.58 (3H, s, NCCH3), 4.24 (2H, q, Ja 6.8, CH2CH3); 13C NMR δC (100 MHz; CDCl3) 11.6 
(CH2CH3), 13.2 (NCCH3), 13.9 (OCCH3), 60.4 (CH3CH2), 108.7 (C(C)4), 159.8 (CN), 162.3 
(CH3CO) 175.0 (CH2COC). 
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3,5-Dimethylisoxazole-4-carboxylic acid (159)  
To ethyl 3,5-dimethylisoxazole-4-carboxylate (150) (9.40g, 55.5 mmol) was added sodium 
hydroxide (2.70g, 6.66 mmol) in water (100 mL) and the mixture was heated at reflux for 4 
h.  After cooling, the solution was washed with chloroform (2 x 100 mL) and the aqueous 
layer was acidified to pH 2-3 using concentrated hydrochloric acid.  The resultant white 
precipitate was collected by filtration, dissolved in chloroform (100 mL) which was then 
dried over magnesium sulfate, filtered and evaporated under a reduced pressure to yield 
the title compound as a white solid (6.32g, 81%).  mp 145-1470C, lit.94 mp 146-1470C; MS: 
m/z calculated for C6H7NO3 (MH+): 142.0568.  Found 142.0562; IR νmax (CHCl3)/cm-1 3110-
3390 (OH), 2950 (CH2, CH3), 1726 (CO), 1609 (CC), 1506 (CN); 1H NMR δH (400 MHz; CDCl3) 
2.40 (3H, s, NCCH3), 2.65 (3H, s, OCCH3), 10.18 (1H, s, CO2H)); 13C NMR δC (100 MHz; CDCl3) 
11.7 (NCCH3), 13.5 (OCCH3), 108.0 (C(C)4), 160.3 (NCCH3), 167.9 (OCCH3), 176.9 (CO2H). 
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3,5-dimethylisoxazole-4-carbonyl chloride (160)87 
4-Carboxy-3,5-dimethylisoxazole (159) (6.33g, 44.9 mmol) was suspended in thionyl chloride 
(45 mL, 72.0g, 605 mmol) and the mixture stirred for 2h at reflux.  The excess thionyl 
chloride was removed under reduced pressure and the black oily chlorinated product used 
directly in the next reaction without purification. No spectroscopic analysis was taken at his 
point.  
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N,3,5-trimethylisoxazole-4-carboxamide (151)97 
To a solution of crude 3,5-dimethylisoxazole-4-carbonyl chloride (160) (7.16g, 44.9 mmol) in 
DCM (80 mL) was added methylamine (40% w/w in aqueous solution, 4.17g, 53.8 mmol) in a 
sodium hydroxide solution (1M, 80 mL) and the mixture stirred at reflux for 20 h.  The 
reaction mixture was cooled to room temperature and the aqueous layer extracted with 
DCM (2 x 100 mL).  The organic fractions were combined and dried using magnesium sulfate, 
filtered and concentrated under reduced pressure to yield N,3,5-trimethylisoxazole-4-
carboxamide as a white solid (5.81g, 84%).  MS: m/z calculated for C7H10N2O2 (MH+): 
155.0895. Found 155.0901; 1H NMR δH (400 MHz; CDCl3) 2.36 (3H, s, NCCH3), 2.55 (3H, s, 
OCCH3), 2.90 (3H, d, J 4.8, NHCH3) 5.61 (1H, br. s, NHCH3); 13C NMR δC (100 MHz; CDCl3) 13.9 
(NCCH3), 15.7 (OCCH3), 26.5 (CONHCH3), 110.0 (C(C)4), 160.8 (NCCH3), 168.6 (OCCH3), 176.9 
(CO2NHCH3). No melting point test or IR analysis was done on this compound. 
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4.9.2 – Model Aldol Reactions 
 
Ethyl 5-(2-hydroxylhexyl)-3-methyliosoxazole-4-carboxylate (156)75  
n-Butyllithium (1.30 M in hexanes, 54.6 mL, 70.9 mmol, 1.2 eq.) was added dropwise to 
ethyl 3,5-dimethylisoxazole-4-carboxylate (150) (10.0g, 59.0 mmol) in THF (50 mL) at -78 0C 
and under nitrogen atmosphere.  The mixture was stirred for 1 h at -78 0C and freshly 
distilled pentanal (10 mL, excess) was added followed by a further 1 h of stirring.  The 
reaction mixture was then added to water (50 mL) and hydrochloric acid (2 M, 50 mL) which 
was subsequently removed under reduced pressure to leave a thick yellow/brown oil. The 
oil was then separated by the addition of ethyl acetate (50 mL) and water (50 mL) and the 
organic phase further extracted with ethyl acetate (50 mL).  The combined organic layers 
were washed with saturated brine (50 mL) and dried over magnesium sulfate before being 
concentrated under a reduced pressure to yield a brown oil which was shown by 1H NMR 
spectroscopy to contain no desired product. 
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Ethyl 3-methyl-5-ethenylisoxazole-4-carboxylate (157)79  
Sodium methoxide (2.5 eq, 0.37g, 16.23 mmol) was dissolved in methanol (100 mL) and was 
then added to a suspension of ethyl 3,5-dimethylisoxazole-4-carboxylate (150) (1.0 g, 6.49 
mmol) in dry methanol (20 mL) and the mixture stirred at room temperature for 2 minutes.  
To this mixture was added paraformaldehyde (0.42g, 7.16 mmol) in dry methanol (50 mL). 
The reaction mixture was then heated at reflux under a nitrogen atmosphere for 3 h.  The 
cooled mixture was then separated between water (50 mL) and chloroform (50 mL) and the 
aqueous layer further extracted with chloroform (2 x 50 mL), the organic layers were 
combined, dried over magnesium sulfate and concentrated under a reduced pressure to 
give a yellow oil that was shown to contain a number of compounds by TLC (3:1 petrol:ethyl 
acetate v/v), none of which was identified by 1H NMR spectroscopy as the desired product. 
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Ethyl 3-methyl-5-(2-phenylethenyl)isoxazole-4-carboxylate (158)79  
Sodium methoxide (2.5 eq, 2.24g, 41.55 mmol) was dissolved in methanol (100 mL) and was 
then added to a suspension of ethyl 3,5-dimethylisoxazole-4-carboxylate (150) (3.0 g, 16.62 
mmol) in dry methanol (20 mL) and the mixture stirred at room temperature for 2 minutes.  
To this mixture was added benzaldehyde (3.90g, 3.72 mL, 36.6 mmol) in dry methanol (50 
mL). The reaction mixture was then heated at reflux under a nitrogen atmosphere for 3 h.  
The cooled solution was separated between water (50 mL) and chloroform (50 mL) and the 
aqueous layer extracted with chloroform (2 x 50 mL), the organic layers were combined, 
dried over magnesium sulfate and concentrated under reduced pressure to give a yellow oil 
that was shown to contain a number of compounds by TLC (3:1 light petrol:ethyl acetate 
v/v), none of which were identified by 1H NMR spectroscopy as the desired product. 
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(E)-N,3-Dimethyl-5-(2-phenylethenyl)isoxazole-4-carboxamide (162)79  
Sodium (2.2 eq, 0.329, 14.29 mmol) was dissolved in methanol (25 mL) and the mixture 
stirred at 0 0C under nitrogen atmosphere for 30 minutes until all the sodium had dissolved.  
This cloudy mixture was then added to a suspension of N,3,5-trimethylisoxazole-4-
carboxamide (151) (1.0 g, 6.49 mmol) in dry methanol (20 mL) and stirred at room 
temperature for 2 minutes and to this reaction mixture was added benzaldehyde (1.51g, 
14.29 mmol) and the mixture heated at reflux under a nitrogen atmosphere for 3 h.  The 
solution was then separated between water (50 mL) and chloroform (50 mL) and the 
aqueous layer further extracted with chloroform (2 x 50 mL), the organic layers were 
combined, dried over magnesium sulfate and concentrated under reduced pressure to give 
a yellow oil that was shown to contain a number of compounds by TLC (3:1 light petrol:ethyl 
acetate v/v), none of which were identified by 1H NMR spectroscopy as the desired product. 
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(E)-N,3-Dimethyl-5-(2-phenylethenyl)isoxazole-4-carboxamide (162)79  
Sodium (2.2 eq, 0.329, 14.29 mmol) was dissolved in methanol (25 mL) and the mixture 
stirred at 0 0C under nitrogen atmosphere for 30 minutes until all the sodium had dissolved.  
This cloudy mixture was then added to a suspension of N-3,5-trimethylisoxazole-4-
carboxamide (151) (1.0 g, 6.49 mmol) in dry methanol (20 mL) and the mixture stirred at 
room temperature for 2 minutes and to this reaction mixture was added benzaldehyde 
(1.51g, 14.29 mmol) and the mixture then heated at reflux under a nitrogen atmosphere 
overnight, 17 h.  The cooled solution was then separated between water (50 mL) and 
chloroform (50 mL) and the aqueous layer extracted with chloroform (2 x 50 mL), the 
organic layers were combined, dried over magnesium sulfate and concentrated under 
reduced pressure to give a yellow oil that was shown to contain a number of compounds by 
TLC (3:1 light petrol:ethyl acetate v/v), none of which were identified by 1H NMR 
spectroscopy as the desired product. 
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N,3-Dimethyl-5-(2-phenylethenyl)isoxazole-4-carboxamide (161)79 
Sodium (2.2 eq, 0.329, 14.29 mmol) was dissolved in methanol (25 mL) and the mixture 
stirred at 0 0C under nitrogen atmosphere for 30 minutes until all the sodium had dissolved.  
This cloudy mixture was then added to a suspension of N,3,5-trimethylisoxazole-4-
carboxamide (151) (1.0 g, 6.49 mmol) in dry methanol (20 mL) and the mixture stirred at 
room temperature for 2 minutes and to this reaction mixture was added paraformaldehyde 
(0.84g, 14.29 mmol) and the mixture was then heated at reflux under a nitrogen 
atmosphere for 3 h.  The solution was then separated between water (50 mL) and 
chloroform (50 mL) and the aqueous layer further extracted with chloroform (2 x 50 mL), 
the organic layers were combined, dried over magnesium sulfate and concentrated under a 
reduced pressure to give a yellow oil that was shown to contain a number of compounds by 
TLC (3:1 light petrol:ethyl acetate v/v), none of which were identified by 1H NMR 
spectroscopy as the desired product. 
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E-N,3-Dimethyl-5-(2-phenylethenyl)isoxazole-4-carboxamide (162)75  
n-Butyl-lithium (2.29M in toluene, 5.68 mL, 13.0 mmol) was added dropwise to a suspension 
of N,3,5-trimethylisoxazole-4-carboxamide (151) (0.91 g, 5.91 mmol) in dry THF (20 mL) and 
the mixture stirred at room temperature for 2 minutes and to this reaction mixture was 
added benzaldehyde (1.38g, 13.0 mmol) the mixture was then heated to reflux under a 
nitrogen atmosphere overnight, 17 h.  The solution was then separated between water (50 
mL) and chloroform (50 mL) and the aqueous layer further extracted with chloroform (2 x 50 
mL), the organic layers were combined, dried over magnesium sulfate and concentrated 
under reduced pressure to give a yellow oil that was shown to contain a large amount of 
compounds by TLC (3:1 light petrol:ethyl acetate v/v), none of which were identified by 1H 
NMR spectroscopy to have characteristics of a new alkene bond being formed. 
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N,3-Dimethyl-5-vinylisoxazole-4-carboxamide (161)79  
Sodium (2.5 eq, 0.185g, 8.11 mmol) was added directly to tert-butanol (25 mL) and the 
mixture heated at reflux with stirring under nitrogen atmosphere for 45 minutes until all the 
sodium had dissolved.  This cloudy mixture was then added to a suspension of N,3,5-
trimethylisoxazole-4-carboxamide (151) (0.5 g, 3.25 mmol) in dry THF (25 mL) and the 
mixture stirred at room temperature for 2 minutes, after which the reaction mixture turned 
red. To this reaction mixture was added paraformaldehyde (0.21g, 7.14 mmol) the mixture 
was then heated to reflux under a nitrogen atmosphere overnight, 18 h.  The red solution 
was then separated between water (50 mL) and ethyl acetate (50 mL) and the aqueous layer 
further extracted with ethyl acetate (2 x 50 mL), the organic layers were combined, dried 
over magnesium sulfate and concentrated under reduced pressure to give a yellow oil that 
was identified as a mixture of starting materials my 1H NMR spectroscopy and TLC (3:1 light 
petrol:ethyl acetate v/v). 
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(E)-N,3-Dimethyl-5-(2-phenylethenyl)isoxazole-4-carboxamide (162)79 
Sodium (2.5 eq, 0.185g, 8.11 mmol) was added in small pieces to tert-butanol (25 mL) and 
the mixture heated at reflux with stirring under a nitrogen atmosphere for 45 minutes until 
all the sodium had dissolved.  This cloudy mixture was then added to a suspension of N,3,5-
trimethylisoxazole-4-carboxamide (151) (0.5 g, 3.25 mmol) in dry THF (20 mL) and stirred at 
room temperature for 2 minutes, after which the reaction mixture turned red. To this 
reaction mixture was added benzaldehyde (0.75g, 7.14 mmol) and the mixture was then 
heated at reflux under a nitrogen atmosphere overnight, 18 h.  The red solution was cooled 
then separated between water (50 mL) and ethyl acetate (50 mL) and the aqueous layer 
extracted with ethyl acetate (2 x 50 mL).  The organic layers were combined, dried over 
magnesium sulfate and concentrated under a reduced pressure to give the crude product as 
a yellow oil that was identified by characteristic peaks in the 1H NMR spectrum 
corresponding to the trans double bond hydrogens.  The product was purified by column 
chromatography using ethyl acetate and light petrol (2:1 v/v) to give the desired product as 
a pale yellow solid (220 mg/ 26%). mp 210-2110C; MS: m/z calculated for C14H14N2O2 (MH+): 
243.1106.  Found 246.1101; IR νmax (CHCl3)/cm-1 3426 (NH), 3032, 3011 (CH2, CH3), 1716 
(CO), 1695 (CC), 1598 (CN); 1H NMR δH (400 MHz; CDCl3) 2.33 (3H, s, NCCH3), 2.91 (3H, d, J 
4.8, NHCH3) 6.59 (1H, br. s, NHCH3), 7.19 (1H, d, J 16.3, OCCHCH), 7.30-7.35 (3H, m, Ar-H), 
7.35 (1H, d, J 16.3, PhCHCH), 7.44-7.48 (2H, m, Ar-H) ; 13C NMR δC (100 MHz; CDCl3) 11.1 
(NCCH3), 26.5 (NHCCH3), 112.1 (OCCH), 128.3 (2ArC), 128.6 (2ArC), 129.1 (ArC), 135.6 (ArC), 
136.9 (PhCH), 110.0 (C(C)4), 158.8 (NCCH3), 162.6 (OCCH3), 167.9 (CO2NHCH3). 
New Routes to Acyltetramic Acids and Analogues – James Bullous 
 
204 
 
N,3-Dimethyl-5-(2-oxo-2-phenylethyl)isoxazole-4-carboxamide (163)79  
To a suspension of N,3,5-trimethylisoxazole-4-carboxamide (151) (100 mg, 0.649 mmol) in 
dry THF (10 mL) was added potassium tert-butoxide (3.0 eq., 218 mg, 1.95 mmol ) and the 
mixture stirred at room temperature for 2 minutes. To this was added benzaldehyde (10 eq., 
0.671 mL, 691 mg, 6.49 mmol) which was then heated at reflux under a nitrogen 
atmosphere overnight, 18 h.  The red solution was then separated between water (50 mL) 
and ethyl acetate (50 mL) and the aqueous layer extracted with ethyl acetate (2 x 50 mL). 
The organic layers were combined, dried over magnesium sulfate and concentrated under a 
reduced pressure to give the crude product as a yellow oil that was determined to be the 
ketone.  The product was purified by column chromatography using ethyl acetate and light 
petrol (1:3 v/v) to give the product as a white solid (55.0 mg/ 33%). mp 198-2020C; MS: m/z 
calculated for C14H14N2O2 (MH+): 258.1004.  Found 258.1005; IR νmax (CHCl3)/cm-1 3256 (NH), 
3012, 2985 (CH2, CH3), 1712 (CO), 1679 (CC), 1601 (CN); 1H NMR δH (400 MHz; CDCl3) 2.50 
(3H, s, NCCH3), 2.97 (3H, d, J 4.8, NHCH3), 4.64 (2H, s, CH2), 7.29 (1H, br. s, NH), 7.50-7.55 
(3H, m, Ar-H), 7.65 (1H, d, J 16.3, PhCHCH), 8.14-8.18 (2H, m, Ar-H); 13C NMR δC (100 MHz; 
CDCl3) 11.3 (NCCH3), 26.5 (NHCCH3), 36.3 (CH2), 115.2 (C(C)3), 129.0 (2ArC), 129.1 (2ArC), 
134.7 (ArC), 135.4 (ArC), 158.8 (NCCH3), 162.6 (OCCH3), 167.9 (CO2NHCH3), 195.1 (C(O)). 
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N,3-Dimethylisoxazole-5-(2-hydroxy-2-phenylethyl)-4-carboxamide (166)79  
Sodium borohydride (1.0 eq., 6.0 mg, 0.161 mmol) was added portionwise to N,3-dimethyl-
5-(2-oxo-2-phenylethyl)isoxazole-4-carboxamide (163) (40.0 mg, 0.161 mmol) suspended in 
ethanol (5 mL).  This reaction was stirred at room temperature and monitored by TLC to 
observe the disappearance of the ketone starting material, which took 1 hour, after which 
the reaction was quenched with the addition of saturated ammonium chloride solution (5 
mL).  The mixture was then concentrated to remove ethanol under reduced pressure and 
separated between water (5 mL) and ethyl acetate (5 mL).  The aqueous layer was extracted 
further with ethyl acetate (5 mL) and the organic fraction washed with saturated brine, 
dried over magnesium sulfate and concentrated under reduced pressure to yield the title 
compound as a white solid (41 mg/ quantitative yield). mp 195-1980C; MS: m/z calculated 
for C14H14N2O2 (MH+): 261.1194.  Found 261.1195; IR νmax (CHCl3)/cm-1 3402 (OH), 3298 
(NH), 3010, 2996 (CH2, CH3), 1713 (CO), 1689 (CC), 1581 (CN); 1H NMR δH (400 MHz; CDCl3) 
2.45 (3H, s, NCCH3), 2.96 (3H, d, J 4.8, NHCH3), 3.19 (1H, dd, Ja 3.6 Hz, Jb 14.4 Hz, CHH), 3.31 
(1H, dd, Ja 10.0 Hz, Jb 14.4 Hz, CHH), 3.55 (1H, br. s, OH), 5.13 (1H, dd Ja 3.6 Hz, Jb 10.0 Hz, 
CH), 7.28-7.36 (1H, m, Ar-H), 7.38-7.41 (4H, m, 4Ar-H),  7.42 (1H, br. s, NH); 13C NMR δC (100 
MHz; CDCl3) 11.2 (NCCH3), 26.4 (NHCCH3), 36.3 (CH2), 73.2 (CH(OH)), 114.8 (C(C)3), 125.4 
(2ArC), 128.5 (ArC), 128.9 (2ArC), 142.6 (ArC), 159.3 (NCCH3), 163.2 (OCCH3), 168.8 
(CO2NHCH3). 
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(E)-N,3-Dimethyl-5-(2-phenylethenyl)isoxazole-4-carboxamide (167)79 
p-Toluenesulfonic acid (1.15 ea., 31.9 mg, 0.185 mmol) was suspended in toluene (10 mL) 
and added dropwise to 5-(2-hydroxy-2-phenylethyl)-N,3-dimethylisoxazole-4-carboxamide 
(166) (40.0 mg, 0.161 mmol) in toluene (30 mL) and the mixture heated under Dean-Stark 
conditions for 17 h with stirring.  The cooled reaction mixture was then partitioned between 
ethyl acetate (30 mL) and saturated sodium carbonate solution (30 mL), followed by a 
washing with saturated brine (30 mL).  The organic fraction was collected, dried over 
magnesium sulfate and concentrated under a reduced pressure.  Upon TLC analysis it was 
shown to contain several products but, after separation via flash column chromatography 
eluting with ethyl acetate and light petroleum (5:1 ratio), no dehydrated product could be 
identified. 
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 N-Butanoyl-N,3-dimethyl-5-(2-oxopentyl)isoxazole-4-carboxamide (167)  
To a suspension of N,3,5-trimethylisoxazole-4-carboxamide (151) (100 mg, 0.649 mmol) in 
dry THF (10 mL) was added potassium tert-butoxide (3.2 eq., 233 mg, 2.08 mmol ) and the 
mixture stirred at room temperature for 2 minutes. To this was added benzaldehyde (10 eq., 
0.671 mL, 691 mg, 6.49 mmol) and the mixture was then heated at reflux under a nitrogen 
atmosphere overnight, 18 h.  The cooled red solution was then separated between water 
(50 mL) and ethyl acetate (50 mL) and the aqueous layer extracted with ethyl acetate (2 x 50 
mL).  The organic layers were combined, dried over magnesium sulfate and concentrated 
under a reduced pressure to give the crude product as a yellow oil that could not be 
confirmed as the containing the diacylated product. After purification it was found that no 
diacylated product was formed. 
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4.10 – Laccarin Analogue Synthesis 
 
Ethyl 2,5-diaminopentanoate dihydrochloride (171)75 
Acetyl chloride (4.2 eq, 9.40 g, 9.49 mL, 124.5 mmol) was added dropwise to a suspension of 
S-ornithine monohydrochloride (5.00 g, 29.7 mmol) in dry ethanol (50 mL, 1.13 mol) at 0°C 
over 4 h.  The reaction mixture was then heated at reflux for 20 h; it was cooled to room 
temperature and then concentrated under reduced pressure to yield a viscous white gel 
which was evaporated further in a high vacuum oven at 100 0C to give a white powdered 
solid that was identified as the title compound (6.51 g, 99%).  mp 60-63 oC; MS: m/z 
calculated for C7H17N2O2Cl2 (MH+): 162.1465  Found 162.1461; IR νmax (CHCl3)/cm-1 3299 
(NH), 2987, 2942 (CH2, CH3), 1706 (CO), 1398 (CN), 1186 (COC); 1H NMR δH (400 MHz; (D2O)) 
1.29 (3H, t, J 7.2 Hz, CH2CH3), 1.61-1.75 (2H, m, NCHCH2CH2), 1.86-1.91 (2H, m, NCHCH2CH2), 
2.78 (2H, br. s, CH2NH3), 3.99 (1H, t, J 6.0 Hz, CHNH3), 4.20 (1H, d, J 7.2 Hz, CH2CH3), 4.24 
(1H, d, Ja 7.2 Hz, CH2CH3), 8.28 (1H, br. s, CH2NH3), 8.78 (1H, br, s, CHNH3); 13C NMR δC (100 
MHz; (CDCl3)) 13.9 (CH3), 22.7 (NCHCH2CH2), 27.0 (NCHCH2CH2), 37.9 (NH3CH2), 51.3 
(NH3CH), 61.8 (OCH2), 169.2 (COO). This was a literature compound and the data agreed 
with that seen earlier. 
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(S)-Ethyl 2,5-bis(tert-butoxycarbonylamino)pentanoate (172)75,980 
Triethylamine (4 eq, 12.0 g, 16.57 mL, 118.8 mmol) was added dropwise to ethyl 2,5-
diaminopentanoate dihydrochloride (171) (5.87 g, 29.7 mmol) in dichloromethane (100 mL) 
over 1 h at 00C.  Di-tert-butyl dicarbonate (2.1 eq, 13.56 g, 67.4 mmol) in dichloromethane 
(50 mL) was added dropwise over 1 h at 0 oC, after which the reaction mixture was stirred 
for a further h at 0 oC.  After this time the clear and colourless reaction mixture was allowed 
to warm to room temperature and continually stirred for 18 h, under a nitrogen 
atmosphere.  The reaction mixture, now a colourless clear solution, was washed with citric 
acid solution (1 M, 200 mL) and saturated brine (2 x 200 mL), then dried using magnesium 
sulfate which was removed by filtration and the excess solvent evaporated under reduced 
pressure to afford the product as a clear colourless oil (7.09 g, 64%); MS: m/z calculated for 
C17H32N2O6 (MH+): 361.2354  Found 361.2359; IR νmax (CHCl3)/cm-1 3301 (NH), 2994, 2936 
(CH2, CH3), 1729 (CO), 1406 (CN), 1197 (COC); 1H NMR δH (400 MHz; (CDCl3)) 1.28 (3H, t, J 
7.2 Hz, CH2CH3), 1.45 (18H, br. s, 2xtBu), 1.58-1.62 (2H, m, NCHCH2CH2), 1.62-1.65 (2H, m, 
NCHCH2CH2), 1.81-1.88 (1H, m, CHNHBoc), 3.12 (2H, br. s, CH2NHBoc), 4.10 (1H, d, J 7.2 Hz, 
CH2CH3), 4.15 (1H, d, J 7.2 Hz, CH2CH3), 4.67 (1H, br. s, CH2NHBoc), 5.21 (1H, br, s, 
CHNHBoc). 13C NMR δC (100 MHz; ((CD3)2SO)) 25.6 (CH2), 26.9 (2x(CH3)3), 38.5 (CH2), 51.6 
(CHNH), 68.9 (CH2NH), 72.3 (C(CH3)3), 125.6 (C(O)), 165.8 (NCOO), 191.6 (NCOO).  This was a 
literature compound and the data agreed with that seen earlier. 
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(S)-tert-Butyl 5-oxopentane-1,4-dicarbamate (173)75 
Diisobutylaluminium hydride (2.5 eq., 1.0M in toluene, 47.87 mL, 47.87 mmol) was added to 
a suspension of (S)-ethyl 2,5-bis(tert-butoxycarbonylamino)pentanoate (172) (7.09 g, 19.15 
mmol) in dry toluene (150 mL) under nitrogen with stirring at -78 °C for 1 h.  The reaction 
mixture was left stirring for a further 30 min at -78 °C.  Methanol (25 mL) was added to the 
mixture which was then poured into a solution of Rochelle salt (60 g) in water (200 mL).  The 
reaction mixture was stirred vigorously for 2 h.  The aqueous phase was separated and 
extracted with ethyl acetate (3 x 50 mL).  The combined organic layers were washed with 
saturated brine (100 mL), then dried over magnesium sulfate, filtered and concentrated 
under reduced pressure to yield the aldehyde as a colourless oil (3.8 g, 61 %).  This was then 
used directly for oxime formation without further purification. MS: m/z calculated for 
C15H27N2O5 (MH+): 316.1998.  Found 316.1998; IR νmax (CHCl3)/cm-1 3265 (NH), 2994, 2923 
(CH2), 1759 (CO), 1621 (Ar), 1421 (CN), 1121 (COC);  1H NMR δH (400 MHz; (CDCl3)) 1.45 
(18H, br. s, 2xtBu), 1.59-1.66 (2H, m, NCHCH2CH2), 1.61-1.69 (2H, m, NCHCH2CH2), 1.80-1.86 
(1H, m, CHNHBoc), 3.22 (2H, br. s, CH2NHBoc), 4.68 (1H, br. s, CH2NHBoc), 5.23 (1H, br, s, 
CHNHBoc), 9.48 (1H, br. s, CHO). 13C NMR δC (100 MHz; ((CD3)2SO)) 26.8 (CH2), 27.9 
(2x(CH3)3), 41.2 (CH2), 54.6 (CHNH), 69.3 (CH2NH), 71.2 (C(CH3)3), 129.9 (CH(O)), 167.8 
(NCOO), 195.6 (NCOO).   
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(S)-tert-Butyl 5-(hydroxyimino)pentane-1,4-dicarbamate (174)75 
The crude aldehyde, (S)-tert-butyl 5-oxopentane-1,4-diyldicarbamate (173) (3.8 g, 11.66 
mmol) in ethanol (50 mL) was added to hydroxylamine hydrochloride (2 eq., 1.62 g, 23.3 
mmol) and sodium acetate (4 eq., 3.8 g, 46.65 mmol) in water (50 mL).  A few drops of 
ethanol were added to dissolve the precipitate and the solution was warmed to 70 °C for 30 
min.  The reaction mixture was then allowed to cool to room temperature and stored in a 
refrigerator (2-50C) for 24 h.  A white precipitate was seen and filtered off.  The remaining 
mixture was extracted with ethyl acetate (3 x 50 mL) and the combined organic layers dried 
over magnesium sulfate, filtered and concentrated under reduced pressure to yield the title 
compound as a white solid (3.7 g, 96%); mp 159-160°C; MS: m/z calculated for C15H28N3O5 
(MH+): 332.2130.  Found 332.2128; IR νmax (CHCl3)/cm-1 3402 (OH), 2995, 2940 (CH2), 1726 
(CO), 1601 (Ar), 1395 (CN), 1251 (COC); 1H NMR δH (400 MHz; ((CD3)2SO)) 1.45 (18H, br. s, 
2xtBu), 1.49-1.51 (2H, m, NCHCH2CH2), 1.55-1.61 (2H, m, NCHCH2CH2). 3.22 (2H, br. s, 
CH2NHBoc), 4.38 (1H, br. s, OH), 4.69 (1H, br. s, CH2NHBoc), 5.25 (1H, br, s, CHNHBoc), 7.43 
(1H, s, CHNOH), 9.46 (1H, br. s, CHO); 13C NMR δC (100 MHz; ((CD3)2SO)) 26.9 (CH2), 27.3 
(2x(CH3)3), 40.8 (CH2), 53.9 (CHNH), 64.2 (CH2NH), 72.2 (C(CH3)3), 129.1 (CN(OH)), 167.2 
(NCOO), 201.6 (NCOO).   
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(S)-tert-Butyl 5-chloro-5-(hydroxyimino)pentane-1,4-dicarbamate (175)75 
N-Chlorosuccinimide (1.1 eq., 4.44 g, 33.2 mmol) was added portionwise to (S)-tert-butyl 5-
(hydroxyimino)pentane-1,4-diyldicarbamate (174) (10.0 g, 30.2 mmol) in chloroform (100 
mL) at 0°C over 30 minutes.  The reaction mixture was then heated at reflux for 16 h.  A 
gradual colour change from pale yellow to dark orange/brown was noted during this time.  
This solution was then washed with water (3x100 mL) and saturated brine (2 x 100 mL) 
before being dried over MgSO4, filtered and concentrated under a reduced pressure to yield 
the chlorinated oxime (S)-tert-butyl 5-chloro-5-(hydroxyimino)pentane-1,4-diyldicarbamate 
as a dark orange thick oil (4.63g, 43%); MS: m/z calculated for C15H28N3O535Cl (MH+): 
365.1717.  Found 365.1717; IR νmax (CHCl3)/cm-1 3456 (OH), 2998 (CH2), 1726 (CO), 1624 
(Ar), 1401 (CN), 1112 (COC); 1H NMR δH (400 MHz; ((CD3)2SO)) 1.48 (18H, br. s, 2xtBu), 1.59-
1.62 (2H, m, NCHCH2CH2), 1.55-1.61 (2H, m, NCHCH2CH2), 3.15 (2H, br. s, CH2NHBoc), 4.38 
(1H, br. s, OH), 4.19-4.23 (1H, m, CHNH), 4.68 (1H, br. s, CH2NHBoc), 5.25 (1H, br, s, 
CHNHBoc); 13C NMR δC (100 MHz; ((CD3)2SO)) 26.4 (CH2), 28.3 (2x(CH3)3), 40.0 (CH2), 53.2 
(CHNH), 61.4 (CH2NH), 72.2 (C(CH3)3), 119.1 (CN(OH)), 165.8 (NCOO), 226.1 (NCOO).   
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(S)-tert-Butyl 5-methyl-3-[1,4-bis(tert-butoxycarbonylamino)butyl]isoxazole-4-carboxylate 
(176)75 
To the refluxing suspension of (S)-tert-butyl 5-chloro-5-(hydroxyimino)pentane-1,4-
diyldicarbamate (175) (4.63 g, 12.65 mmol) in chloroform (150 mL) was added tert-butyl 3-
(pyrrolidin-1-yl)but-2-enoate (72) (2 eq., 5.33 g, 25.22 mmol) in one portion followed by 
triethylamine (1.1 eq., 1.40 g,1.93 mL, 13.87 mmol) dropwise over 1 h.  The mixture was 
heated at reflux for a further 2 h and allowed to cool to room temperature.  The mixture 
was poured into water (200 mL) and the organic layer was separated and washed with citric 
acid solution (2M, 100 mL), sodium hydroxide solution (5 % w/v, 100 mL) and saturated 
brine (100 mL).  The organic layer was dried over magnesium sulfate, filtered and 
concentrated under reduced pressure to provide a dark brown thick oil.  The oil was purified 
by column chromatography eluting with light petroleum:ethyl acetate (3:1 v/v) to yield the 
title compound as a yellow oil (271 mg, 5%); MS: m/z calculated for C29H39N3O7 (MNa+): 
493.7891  Found 493.7886; IR νmax (CHCl3)/cm-1 3402 (NH), 2981, 2939 (CH2), 1726 (CO), 
1601 (Ar), 1395 (CN), 1251, 1167, 1121 (COC); 1H NMR δH (400 MHz; (CDCl3)) 1.31 (27H, s, 
3xC(CH3)3), 1.49-1.51 (2H, m, NCHCH2CH2), 1.55-1.61 (2H, m, NCHCH2CH2),1.65-1.75 (1H, m, 
CH2), 1.75-1.85 (2H, m, NHCH), 1.89 (3H, s, CH3), 2.95-3.06 (2H, m, CH2), 4.97-5.06 (1H, m, 
CH2NH), 5.29-5.36 (1H, m, CHNH); 13C NMR δC (100 MHz; (CDCl3)) 13.9 (5-CH3), 21.6 (CH2), 
27.6 (C(CH3)3), 27.7 (C(CH3)3), 31.5 (CH2), 42.6 (CH2), 50.1 (CHNH), 60.1 (C(CH3)3), 66.5 
(C(CH3)3), 69.5 (C(CH3)3), 155.1 (CO), 156.2 (CN), 170.2 (NCOO), 172.5 (NCOO), 173.6(COO). 
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(S)-Ethyl 5-methyl-3-[1,4-bis(tert-butoxycarbonylamino)butyl]isoxazole-4-carboxylate 
(176)75 
To the refluxing suspension of (S)-tert-butyl 5-chloro-5-(hydroxyimino)pentane-1,4-
diyldicarbamate (175) (2.00 g, 5.47 mmol) in chloroform (100 mL) was added ethyl 3-
(pyrrolidin-1-yl)but-2-enoate (72) (2.0 eq., 1.853 g, 10.9 mmol) in one portion followed by 
triethylamine (1.1 eq., 0.60 g, 0.840 mL, 6.02 mmol) dropwise over 1 h.  The mixture was 
heated to reflux for a further 2 h and allowed to cool to room temperature.  The mixture 
was poured into water (200 mL) and the organic layer was washed with citric acid solution 
(2M, 100 mL), sodium hydroxide solution (5 % w/v, 100 mL) and saturated brine (100 mL).  
The organic layer was dried over magnesium sulfate, filtered and concentrated under 
reduced pressure to provide a dark brown thick oil.  The oil was subjected to purification by 
column chromatography eluting with light petroleum:ethyl acetate (3:1 v/v) to yield a 
yellow oil which was shown to contain a mixture of compounds, from which none could be 
identified by 1H NMR spectroscopy. 
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(S)-tert-Butyl 5-methyl-3-[1,4-bis(tert-butoxycarbonylamino)butyl]isoxazole-4-carboxylic 
acid dihydrochloride (177)75,57 
To S-tert-Butyl 5-methyl-3-[1,4-bis(tert-butoxycarbonylamino)butyl]isoxazole-4-carboxylate 
(176) (271 mg, 0.577 mmol) was added trifluoroacetic acid (30 eq., 1.33 mL, 17.3 mmol).  
The reaction mixture was stirred at room temperature for 4 h, and then concentrated under 
a reduced pressure, after which hydrochloric acid (30 eq., 2M, 8.65 mL, 17.3 mmol) was 
added to the residue and the reaction mixture was stirred at room temperature for a 
further 17 h.  After this time the reaction mixture was again concentrated under reduced 
pressure.  The residue was dissolved in water (50 mL) and washed with ethyl acetate (3 x 50 
mL).  The aqueous phase was evaporated to dryness in a vacuum oven set to 800C to yield a 
light brown solid (200 mg, quantitative %).  MS: m/z calculated for C9H17N3O3Cl2 (MH+) 
215.1367: Found 215.1369; 13C NMR δC (100 MHz; CDCl3) 13.9 (5-CH3), 22.9 (CH2), 28.1 
(C(CH3)3), 28.6 (C(CH3)3), 30.5 (CH2), 45.1 (CH2), 51.3 (CHNH), 156.9 (CO), 158.6 (CN), 175.1 
(COOH). 
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(S)-6-(3-Aminopropyl)-3-methyl-5,6-dihydro-4H-pyrrolo[3,4-c]isoxazol-4-one (178)75,57 
1-[3-(Dimethylamino)propyl]-3-ethylcarbodiimide hydrochloride  (EDCI) (123) (1.1 eq., 119.4 
g, 0.77 mmol) was added to a suspension of 3-(1,4-diaminobutyl)-5-methylisoxazole-4-
carboxylic acid dihydrochloride (177) (200 mg, 0.70 mmol) and N-hydroxysuccinimide (1.1 
eq., 88.5 mg, 0.77 mmol) in dry dimethylformamide (30 mL) at 0 0C.  The reaction mixture 
was stirred at room temperature for 17 h.  Triethylamine (3.2 eq., 0.226 g, 0.31 mL, 2.24 
mmol, 2.2 eq) was added to the mixture and it was left to stir for a further 17 h and then 
concentrated under reduced pressure.  The residue was dissolved in ethyl acetate (60 mL) 
and washed with water (60 mL), hydrochloric acid (2M, 60 mL), saturated sodium 
bicarbonate solution (60 mL) and saturated brine (60 mL).  The organic layer was dried over 
magnesium sulfate, filtered and concentrated under reduced pressure to yield a beige solid 
(0.125 g, 99%).  The solid was analysed by NMR spectroscopy, which showed no peaks that 
could be associated with the product.  The initial aqueous layer was then basified with 
sodium bicarbonate (7.0 g) to pH 12 and the aqueous phase now extracted with ethyl 
acetate (60 mL) and washed with water (60 mL) and saturated brine (60 mL).  The organic 
layer was dried over magnesium sulfate, filtered and concentrated under a reduced 
pressure to yield a yellow solid (99.6 mg) which was shown by 1H NMR spectroscopy to 
contain none of the relevant peaks. 
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4.11 – X-Ray Crystal Data 
4.11.1 – 6-(1-methylethyl)-3-methyl-5,6-dihydro-4H-pyrrolo[3,4-c]isoxazol-4-one 
(125a) X-Ray Data 
X-Ray data has been identified for 6-(1-methylethyl)-3-methyl-5,6-dihydro-4H-pyrrolo[3,4-
c]isoxazol-4-one (125a), Figure 28, as prepared by the PS-CDI route as described above. 
 
Figure 28. Structural illustration of 6-(1-methylethyl)-3-methyl-5,6-dihydro-4H-pyrrolo[3,4-
c]isoxazol-4-one (125a) 
rcfj40.figs 
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Table 13.  Crystal data and structure refinement for 6-(1-methylethyl)-3-methyl-5,6-
dihydro-4H-pyrrolo[3,4-c]isoxazol-4-one (125a). 
 
Identification code  rcfj40  
Chemical formula  C9H12N2O2  
Formula weight  180.21  
Temperature  150(2) K  
Radiation, wavelength  MoK, 0.71073 Å  
Crystal system, space group  Monoclinic, P21  
Unit cell parameters a = 5.5512(4) Å  = 90° 
 b = 8.7805(7) Å  = 
95.4252(12)° 
 c = 18.5613(15) Å  = 90° 
Cell volume 900.67(12) Å3  
Z 4  
Calculated density  1.329 g/cm3  
Absorption coefficient  0.096 mm1  
F(000) 384  
Crystal colour and size colourless, 0.72  0.17 
 0.14 mm3 
 
Reflections for cell refinement 4955 (  range 2.20 to 
30.55°) 
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Data collection method Bruker APEX 2 CCD 
diffractometer 
 
  rotation with narrow 
frames 
 
 range for data collection 1.10 to 30.56°  
Index ranges h 7 to 7, k 12 to 12, l 
25 to 26 
 
Completeness to  = 30.56° 99.3 %   
Intensity decay 0%  
Reflections collected 10700  
Independent reflections 5424 (Rint = 0.0189)  
Reflections with F2>2  4950  
Absorption correction semi-empirical from 
equivalents 
 
Min. and max. transmission 0.934 and 0.987  
Structure solution direct methods  
Refinement method Full-matrix least-
squares on F2 
 
Weighting parameters a, b 0.0707, 0.0133  
Data / restraints / parameters 5424 / 1 / 331  
Final R indices [F2>2 ] R1 = 0.0385, wR2 = 
0.0990 
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R indices (all data) R1 = 0.0429, wR2 = 
0.1029 
 
Goodness-of-fit on F2 1.025  
Absolute structure parameter  0.7(7)  
Largest and mean shift/su 0.000 and 0.000  
Largest diff. peak and hole 0.386 and 0.164 e Å3  
 
Table 14.  Atomic coordinates and equivalent isotropic displacement parameters (Å2) for 
6-(1-methylethyl)-3-methyl-5,6-dihydro-4H-pyrrolo[3,4-c]isoxazol-4-one (125a).  Ueq is 
defined as one third of the trace of the orthogonalized Uij tensor. 
 
      x                           y      z                  Ueq 
N(1) 1.6350(2) 0.11416(13) 0.13835(6) 0.0279(2) 
O(1) 1.75696(18) 0.06367(12) 0.20609(5) 0.0287(2) 
C(1) 1.6411(2) 0.11762(14) 0.26202(6) 0.0233(2) 
C(2) 1.4491(2) 0.20206(13) 0.23411(6) 0.0207(2) 
C(3) 1.4557(2) 0.19480(13) 0.15846(6) 0.0214(2) 
C(4) 1.2430(2) 0.27965(14) 0.12084(6) 0.0212(2) 
N(2) 1.14016(19) 0.34402(13) 0.18484(5) 0.0230(2) 
C(5) 1.2442(2) 0.29806(14) 0.25040(6) 0.0204(2) 
O(2) 1.17821(16) 0.33258(11) 0.30988(5) 0.02568(19) 
C(6) 1.7425(3) 0.07619(18) 0.33616(7) 0.0303(3) 
C(7) 1.3039(2) 0.39857(15) 0.06492(6) 0.0239(2) 
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C(8) 1.4203(3) 0.32018(19) 0.00329(7) 0.0322(3) 
C(9) 1.0752(3) 0.48259(18) 0.03473(7) 0.0324(3) 
N(3) 0.2631(2) 0.75585(14) 0.36071(6) 0.0290(2) 
O(3) 0.16064(17) 0.82211(12) 0.29363(5) 0.0302(2) 
C(10) 0.2802(2) 0.77101(14) 0.23783(7) 0.0238(2) 
C(11) 0.4588(2) 0.67594(13) 0.26543(6) 0.0217(2) 
C(12) 0.4364(2) 0.66976(14) 0.34033(6) 0.0225(2) 
C(13) 0.6165(2) 0.55956(14) 0.37699(6) 0.0214(2) 
N(4) 0.74898(19) 0.51830(13) 0.31417(5) 0.0227(2) 
C(14) 0.6623(2) 0.57864(14) 0.24934(6) 0.0215(2) 
O(4) 0.74328(16) 0.55436(12) 0.19058(5) 0.0269(2) 
C(15) 0.1888(3) 0.82215(17) 0.16413(8) 0.0300(3) 
C(16) 0.7785(2) 0.62062(16) 0.44194(6) 0.0243(2) 
C(17) 0.6228(3) 0.6617(2) 0.50271(8) 0.0336(3) 
C(18) 0.9673(3) 0.5019(2) 0.46789(7) 0.0323(3) 
 
Table 15.   Bond lengths [Å] and angles [°] for 6-(1-methylethyl)-3-methyl-5,6-dihydro-4H-
pyrrolo[3,4-c]isoxazol-4-one (125a). 
 
N(1)–C(3)  1.3047(16) N(1)–O(1)  1.4402(14) 
O(1)–C(1)  1.3574(14) C(1)–C(2)  1.3600(17) 
C(1)–C(6)  1.4821(18) C(2)–C(3)  1.4097(15) 
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C(2)–C(5)  1.4700(16) C(3)–C(4)  1.5103(16) 
C(4)–N(2)  1.4781(15) C(4)–C(7)  1.5324(16) 
N(2)–C(5)  1.3579(14) C(5)–O(2)  1.2335(14) 
C(7)–C(9)  1.5282(18) C(7)–C(8)  1.5298(18) 
N(3)–C(12)  1.3071(16) N(3)–O(3)  1.4416(15) 
O(3)–C(10)  1.3582(14) C(10)–C(11)  1.3589(17) 
C(10)–C(15)  1.4829(18) C(11)–C(12)  1.4086(16) 
C(11)–C(14)  1.4693(17) C(12)–C(13)  1.5068(17) 
C(13)–N(4)  1.4811(15) C(13)–C(16)  1.5312(17) 
N(4)–C(14)  1.3604(15) C(14)–O(4)  1.2368(14) 
C(16)–C(18)  1.524(2) C(16)–C(17)  1.5278(17) 
 
C(3)–N(1)–O(1) 103.04(9) C(1)–O(1)–N(1) 110.04(9) 
O(1)–C(1)–C(2) 108.05(10) O(1)–C(1)–C(6) 117.30(11) 
C(2)–C(1)–C(6) 134.65(12) C(1)–C(2)–C(3) 105.16(10) 
C(1)–C(2)–C(5) 145.90(11) C(3)–C(2)–C(5) 108.92(10) 
N(1)–C(3)–C(2) 113.69(11) N(1)–C(3)–C(4) 136.05(10) 
C(2)–C(3)–C(4) 110.21(10) N(2)–C(4)–C(3) 99.29(9) 
N(2)–C(4)–C(7) 114.24(10) C(3)–C(4)–C(7) 115.87(10) 
C(5)–N(2)–C(4) 116.28(10) O(2)–C(5)–N(2) 126.30(11) 
O(2)–C(5)–C(2) 128.75(11) N(2)–C(5)–C(2) 104.95(9) 
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C(9)–C(7)–C(8) 109.76(10) C(9)–C(7)–C(4) 110.39(10) 
C(8)–C(7)–C(4) 109.62(11) C(12)–N(3)–O(3) 102.97(9) 
C(10)–O(3)–N(3) 110.12(9) O(3)–C(10)–C(11) 107.89(11) 
O(3)–C(10)–C(15) 117.02(11) C(11)–C(10)–C(15) 135.04(12) 
C(10)–C(11)–C(12) 105.44(10) C(10)–C(11)–C(14) 145.91(12) 
C(12)–C(11)–C(14) 108.65(10) N(3)–C(12)–C(11) 113.56(11) 
N(3)–C(12)–C(13) 135.71(11) C(11)–C(12)–C(13) 110.70(10) 
N(4)–C(13)–C(12) 99.17(9) N(4)–C(13)–C(16) 114.03(9) 
C(12)–C(13)–C(16) 116.48(10) C(14)–N(4)–C(13) 116.15(10) 
O(4)–C(14)–N(4) 125.83(11) O(4)–C(14)–C(11) 129.04(11) 
N(4)–C(14)–C(11) 105.13(10) C(18)–C(16)–C(17) 110.40(12) 
C(18)–C(16)–C(13) 110.16(11) C(17)–C(16)–C(13) 109.45(10) 
 
 
Table 16. Hydrogen coordinates and isotropic displacement parameters (Å2) for 6-(1-
methylethyl)-3-methyl-5,6-dihydro-4H-pyrrolo[3,4-c]isoxazol-4-one (125a). 
 
      x                            y        z                       U 
H(4A) 1.120(3) 0.2048(18) 0.0959(8) 0.020(4) 
H(2) 1.007(3) 0.395(2) 0.1814(9) 0.033(4) 
H(6A) 1.676(5) 0.136(3) 0.3670(14) 0.069(7) 
H(6B) 1.915(5) 0.088(3) 0.3408(12) 0.067(7) 
H(6C) 1.742(6)  0.028(5) 0.3447(16) 0.099(10) 
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H(7) 1.418(3) 0.473(2) 0.0879(8) 0.023(4) 
H(8A) 1.298(4) 0.253(3)  0.0222(11) 0.047(5) 
H(8B) 1.568(4) 0.264(2) 0.0201(10) 0.038(5) 
H(8C) 1.453(3) 0.396(2)  0.0306(11) 0.041(5) 
H(9A) 0.963(3) 0.412(2) 0.0084(10) 0.036(5) 
H(9B) 1.113(4) 0.562(3)  0.0016(11) 0.045(5) 
H(9C) 0.992(3) 0.531(2) 0.0723(10) 0.033(4) 
H(13) 0.523(3) 0.470(2) 0.3887(8) 0.026(4) 
H(4) 0.875(4) 0.455(3) 0.3195(11) 0.047(5) 
H(15A) 0.290(4) 0.795(3) 0.1310(12) 0.054(6) 
H(15B) 0.165(4) 0.929(3) 0.1624(10) 0.041(5) 
H(15C) 0.031(4) 0.784(3) 0.1493(13) 0.065(7) 
H(16) 0.869(4) 0.712(2) 0.4276(10) 0.038(5) 
H(17A) 0.548(3) 0.568(3) 0.5222(10) 0.039(5) 
H(17B) 0.516(4) 0.732(3) 0.4893(12) 0.048(6) 
H(17C) 0.726(4) 0.703(3) 0.5458(11) 0.048(6) 
H(18A) 0.900(3) 0.406(2) 0.4828(10) 0.036(5) 
H(18B) 1.075(4) 0.546(3) 0.5101(11) 0.046(5) 
H(18C) 1.070(3) 0.485(3) 0.4299(10) 0.041(5) 
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Table 17.  Torsion angles [°] for 6-(1-methylethyl)-3-methyl-5,6-dihydro-4H-pyrrolo[3,4-
c]isoxazol-4-one (125a). 
 
C(3)–N(1)–O(1)–C(1) 0.14(14) N(1)–O(1)–C(1)–C(2)  0.33(15) 
N(1)–O(1)–C(1)–C(6) 179.91(11) O(1)–C(1)–C(2)–C(3) 0.37(14) 
C(6)–C(1)–C(2)–C(3)  179.92(15) O(1)–C(1)–C(2)–C(5)  178.02(16) 
C(6)–C(1)–C(2)–C(5) 1.7(3) O(1)–N(1)–C(3)–C(2) 0.10(14) 
O(1)–N(1)–C(3)–C(4)  177.05(13) C(1)–C(2)–C(3)–N(1)  0.30(14) 
C(5)–C(2)–C(3)–N(1) 178.74(11) C(1)–C(2)–C(3)–C(4) 177.59(10) 
C(5)–C(2)–C(3)–C(4)  3.37(13) N(1)–C(3)–C(4)–N(2)  177.45(15) 
C(2)–C(3)–C(4)–N(2) 5.33(12) N(1)–C(3)–C(4)–C(7)  54.65(19) 
C(2)–C(3)–C(4)–C(7) 128.13(11) C(3)–C(4)–N(2)–C(5)  6.02(13) 
C(7)–C(4)–N(2)–C(5)  129.98(11) C(4)–N(2)–C(5)–O(2)  176.34(11) 
C(4)–N(2)–C(5)–C(2) 4.31(14) C(1)–C(2)–C(5)–O(2)  1.4(3) 
C(3)–C(2)–C(5)–O(2)  179.74(12) C(1)–C(2)–C(5)–N(2) 177.94(18) 
C(3)–C(2)–C(5)–N(2)  0.41(13) N(2)–C(4)–C(7)–C(9)  61.83(13) 
C(3)–C(4)–C(7)–C(9)  176.36(11) N(2)–C(4)–C(7)–C(8) 177.14(11) 
C(3)–C(4)–C(7)–C(8) 62.61(13) C(12)–N(3)–O(3)–
C(10) 
 0.06(14) 
N(3)–O(3)–C(10)–
C(11) 
 0.89(14) N(3)–O(3)–C(10)–
C(15) 
176.88(11) 
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O(3)–C(10)–C(11)–
C(12) 
1.41(14) C(15)–C(10)–C(11)–
C(12) 
 175.77(15) 
O(3)–C(10)–C(11)–
C(14) 
 178.59(17) C(15)–C(10)–C(11)–
C(14) 
4.2(3) 
O(3)–N(3)–C(12)–
C(11) 
0.99(14) O(3)–N(3)–C(12)–
C(13) 
 176.53(13) 
C(10)–C(11)–C(12)–
N(3) 
 1.56(14) C(14)–C(11)–C(12)–
N(3) 
178.44(11) 
C(10)–C(11)–C(12)–
C(13) 
176.58(10) C(14)–C(11)–C(12)–
C(13) 
 3.41(13) 
N(3)–C(12)–C(13)–
N(4) 
 178.03(14) C(11)–C(12)–C(13)–
N(4) 
4.40(12) 
N(3)–C(12)–C(13)–
C(16) 
 55.27(19) C(11)–C(12)–C(13)–
C(16) 
127.16(11) 
C(12)–C(13)–N(4)–
C(14) 
 4.22(13) C(16)–C(13)–N(4)–
C(14) 
 128.72(12) 
C(13)–N(4)–C(14)–
O(4) 
 177.81(12) C(13)–N(4)–C(14)–
C(11) 
2.43(14) 
C(10)–C(11)–C(14)–
O(4) 
0.9(3) C(12)–C(11)–C(14)–
O(4) 
 179.06(12) 
C(10)–C(11)–C(14)–
N(4) 
 179.31(18) C(12)–C(11)–C(14)–
N(4) 
0.69(13) 
N(4)–C(13)–C(16)–
C(18) 
 59.38(14) C(12)–C(13)–C(16)–
C(18) 
 174.02(10) 
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N(4)–C(13)–C(16)–
C(17) 
179.06(12) C(12)–C(13)–C(16)–
C(17) 
64.41(15) 
 
Table 18. Hydrogen bonds for 6-(1-methylethyl)-3-methyl-5,6-dihydro-4H-pyrrolo[3,4-
c]isoxazol-4-one (125a). [Å and °]. 
D–H...A d(D–H) d(H...A) d(D...A) <(DHA) 
N(2)–H(2)...O(4) 0.862(19) 2.04(2) 2.8846(14) 165.1(17) 
N(4)–H(4)...O(2) 0.89(2) 2.02(2) 2.8946(14) 167.0(19) 
 
 
4.11.2 – 6-(2-methylpropyl)-3-methyl-5,6-dihydro-4H-pyrrolo[3,4-c]isoxazol-4-one 
(125b) X-Ray Data 
X-Ray data has also been identified for 6-(1-methylethyl)-3-methyl-5,6-dihydro-4H-
pyrrolo[3,4-c]isoxazol-4-one (125b), Figure 29, as prepared by the T3P route described 
above. 
 
Figure 29. Structural illustration of 6-(2-methylpropyl)-3-methyl-5,6-dihydro-4H-
pyrrolo[3,4-c]isoxazol-4-one (125b) 
rcfj49.figs 
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Table 19.  Crystal data for 6-(1-methylethyl)-3-methyl-5,6-dihydro-4H-pyrrolo[3,4-
c]isoxazol-4-one (125b) 
C10H14N2O2 F(000) = 416 
Mr = 194.23 Dx = 1.253 Mg m-3 
Monoclinic, P21  
a = 5.558 (1) Å Cell parameters from 6151 reflections 
b = 10.6051 (19) Å –28.3° 
c = 17.647 (3) Å -1 
 T = 150 K 
V = 1030.0 (3)  Å3 Rod, colourless 
Z = 4 1.10 × 0.23 × 0.10 mm 
 
Table 20. Data collection for 125b 
Bruker APEX 2 CCD diffractometer  
Radiation source: fine-focus sealed tube Rint = 0.040 
  
Absorption correction: multi-scan  
TWINABS v20012/1, Sheldrick, G.M., (2012) h = -  
Tmin = 0.909, Tmax = 0.991 k = -  
18525 measured reflections l = -  
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5115 independent reflections  
 
Table 21. Refinement for 125b 
Refinement on F2 Secondary atom site location: All non-H atoms found by direct 
methods 
Least-squares matrix: full Hydrogen site location: difference Fourier map 
 All H-atom parameters refined 
wR(F2) = 0.089  
where P = (Fo2 + 2Fc2)/3 
S = 1.04  
5115 reflections -3 
365 parameters -0.17 e Å-3 
16 restraints Absolute structure:  Flack x determined using 1971 quotients [(I+)-(I-
)]/[(I+)+(I-)]   (Parsons and Flack (2004), Acta Cryst. A60, s61). 
Primary atom site location: structure-invariant direct methods Flack parameter: -0.3 (6) 
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Table 22. Fractional atomic coordinates and isotropic or equivalent isotropic displacement 
parameters (Å2) for 6-(1-methylethyl)-3-methyl-5,6-dihydro-4H-pyrrolo[3,4-c]isoxazol-4-
one (125b) 
 x y z Uiso*/Ueq 
N1 0.5354 (3) 0.37681 (16) 0.66552 (9) 0.0258 (3) 
H1 0.682 (5) 0.349 (3) 0.6918 (15) 0.041 (7)* 
C1 0.4480 (3) 0.49305 (18) 0.67757 (10) 0.0229 (4) 
O1 0.5438 (2) 0.57230 (13) 0.72354 (7) 0.0268 (3) 
C2 0.2171 (3) 0.50300 (18) 0.62533 (10) 0.0241 (4) 
O2 -0.1300 (3) 0.50612 (14) 0.54890 (8) 0.0315 (3) 
N2 -0.0221 (3) 0.38518 (17) 0.53771 (9) 0.0316 (4) 
C3 0.0178 (3) 0.57315 (19) 0.60207 (10) 0.0267 (4) 
N3 1.0190 (3) 0.50850 (15) 0.80497 (9) 0.0233 (3) 
H3 0.876 (4) 0.537 (2) 0.7802 (12) 0.029 (6)* 
O3 0.9641 (3) 0.30199 (13) 0.76370 (8) 0.0302 (3) 
C4 0.1813 (3) 0.38949 (18) 0.58396 (10) 0.0258 (4) 
O4 1.6529 (3) 0.36342 (13) 0.93243 (8) 0.0280 (3) 
N4 1.5748 (3) 0.49293 (15) 0.93334 (9) 0.0262 (3) 
C5 0.3938 (3) 0.30169 (19) 0.60419 (10) 0.0254 (4) 
H5 0.489 (4) 0.297 (2) 0.5620 (12) 0.023 (5)* 
C6 -0.0653 (4) 0.7008 (2) 0.62054 (14) 0.0349 (5) 
H6A -0.054 (6) 0.755 (3) 0.5799 (18) 0.067 (10)* 
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H6B -0.224 (7) 0.696 (4) 0.6250 (19) 0.074 (10)* 
H6C 0.036 (6) 0.739 (3) 0.6677 (17) 0.060 (9)* 
C7 0.3248 (4) 0.17108 (19) 0.63002 (12) 0.0274 (4) 
H7A 0.218 (4) 0.134 (2) 0.5864 (11) 0.018 (5)* 
H7B 0.236 (4) 0.183 (2) 0.6737 (13) 0.025 (5)* 
C8 0.5389 (4) 0.08160 (19) 0.65233 (12) 0.0310 (4) 
H8 0.651 (4) 0.115 (2) 0.6949 (13) 0.027 (6)* 
C9 0.4441 (5) -0.0434 (2) 0.67883 (16) 0.0465 (6) 
H9A 0.337 (5) -0.084 (3) 0.6359 (13) 0.053 (8)* 
H9B 0.356 (6) -0.032 (4) 0.7243 (15) 0.088 (12)* 
H9C 0.581 (5) -0.103 (3) 0.6947 (19) 0.067 (10)* 
C10 0.6833 (4) 0.0587 (3) 0.58620 (16) 0.0423 (5) 
H10A 0.572 (5) 0.025 (3) 0.5408 (17) 0.060 (9)* 
H10B 0.813 (5) -0.002 (3) 0.6030 (15) 0.050 (8)* 
H10C 0.760 (5) 0.137 (3) 0.5682 (16) 0.055 (8)* 
C11 1.0814 (3) 0.38468 (17) 0.80155 (10) 0.0225 (4) 
C12 1.3142 (3) 0.37371 (17) 0.85237 (10) 0.0218 (3) 
C13 1.4936 (3) 0.29570 (18) 0.88356 (10) 0.0245 (4) 
C14 1.3761 (3) 0.49291 (17) 0.88452 (9) 0.0211 (3) 
C15 1.1931 (3) 0.59071 (16) 0.85327 (10) 0.0213 (4) 
H15 1.272 (4) 0.648 (2) 0.8232 (12) 0.021 (5)* 
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C16 1.5480 (5) 0.1600 (2) 0.87611 (14) 0.0358 (5) 
H16A 1.715 (8) 0.154 (4) 0.860 (2) 0.099 (13)* 
H16B 1.546 (6) 0.117 (3) 0.9242 (18) 0.069 (10)* 
H16C 1.441 (5) 0.126 (3) 0.8392 (16) 0.051 (8)* 
C17 1.0788 (3) 0.66370 (17) 0.91327 (10) 0.0216 (4) 
H17A 1.009 (4) 0.600 (2) 0.9439 (12) 0.024 (5)* 
H17B 1.207 (4) 0.704 (2) 0.9485 (12) 0.027 (6)* 
C18 0.8962 (4) 0.76490 (18) 0.88012 (11) 0.0274 (4) 
H18 0.771 (5) 0.724 (2) 0.8404 (14) 0.041 (7)* 
C19 1.0196 (5) 0.8719 (2) 0.84346 (15) 0.0454 (6) 
H19A 0.909 (5) 0.937 (2) 0.8189 (16) 0.055 (8)* 
H19B 1.112 (5) 0.848 (4) 0.8027 (16) 0.078 (11)* 
H19C 1.144 (5) 0.915 (3) 0.8815 (16) 0.061 (9)* 
C20 0.7611 (4) 0.8155 (2) 0.94284 (15) 0.0389 (5) 
H20A 0.687 (6) 0.746 (3) 0.9632 (16) 0.052 (8)* 
H20B 0.648 (6) 0.880 (3) 0.9233 (17) 0.060 (9)* 
H20C 0.879 (5) 0.860 (3) 0.9791 (14) 0.042 (7)* 
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Table 23. Geometric parameters (Å, º) for 6-(1-methylethyl)-3-methyl-5,6-dihydro-4H-
pyrrolo[3,4-c]isoxazol-4-one (125b) 
N1—C1 1.353 (3) C8—H8 0.97 (2) 
N1—C5 1.479 (2) C9—H9A 0.993 (19) 
N1—H1 0.93 (3) C9—H9B 1.00 (2) 
C1—O1 1.236 (2) C9—H9C 0.99 (2) 
C1—C2 1.475 (3) C10—H10A 1.01 (3) 
C2—C3 1.350 (3) C10—H10B 0.98 (3) 
C2—C4 1.407 (3) C10—H10C 1.00 (3) 
O2—C3 1.359 (2) C11—C12 1.472 (2) 
O2—N2 1.441 (2) C12—C13 1.352 (3) 
N2—C4 1.299 (3) C12—C14 1.408 (2) 
C3—C6 1.481 (3) C13—C16 1.481 (3) 
N3—C11 1.362 (2) C14—C15 1.502 (2) 
N3—C15 1.481 (2) C15—C17 1.520 (2) 
N3—H3 0.90 (2) C15—H15 0.95 (2) 
O3—C11 1.232 (2) C16—H16A 1.01 (4) 
C4—C5 1.507 (3) C16—H16B 0.96 (3) 
O4—C13 1.353 (2) C16—H16C 0.89 (3) 
O4—N4 1.441 (2) C17—C18 1.535 (3) 
N4—C14 1.302 (2) C17—H17A 0.98 (2) 
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C5—C7 1.524 (3) C17—H17B 0.98 (2) 
C5—H5 0.97 (2) C18—C19 1.517 (3) 
C6—H6A 0.93 (3) C18—C20 1.520 (3) 
C6—H6B 0.90 (4) C18—H18 1.01 (3) 
C6—H6C 1.02 (3) C19—H19A 0.99 (2) 
C7—C8 1.530 (3) C19—H19B 0.97 (2) 
C7—H7A 0.99 (2) C19—H19C 1.00 (2) 
C7—H7B 0.98 (2) C20—H20A 0.94 (3) 
C8—C9 1.524 (3) C20—H20B 0.96 (3) 
C8—C10 1.525 (3) C20—H20C 0.97 (3) 
C1—N1—C5 116.08 (16) C8—C10—H10B 108.5 (16) 
C1—N1—H1 121.2 (17) H10A—C10—H10B 111 (2) 
C5—N1—H1 122.5 (17) C8—C10—H10C 113.8 (18) 
O1—C1—N1 126.27 (17) H10A—C10—H10C 106 (2) 
O1—C1—C2 128.23 (18) H10B—C10—H10C 108 (2) 
N1—C1—C2 105.49 (16) O3—C11—N3 126.27 (17) 
C3—C2—C4 105.25 (17) O3—C11—C12 128.85 (17) 
C3—C2—C1 146.56 (19) N3—C11—C12 104.88 (16) 
C4—C2—C1 108.10 (17) C13—C12—C14 105.11 (16) 
C3—O2—N2 109.70 (14) C13—C12—C11 146.26 (18) 
C4—N2—O2 102.99 (16) C14—C12—C11 108.59 (16) 
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C2—C3—O2 108.25 (18) C12—C13—O4 108.33 (17) 
C2—C3—C6 134.82 (19) C12—C13—C16 135.00 (19) 
O2—C3—C6 116.92 (18) O4—C13—C16 116.67 (17) 
C11—N3—C15 116.31 (15) N4—C14—C12 113.79 (16) 
C11—N3—H3 120.7 (15) N4—C14—C15 135.29 (17) 
C15—N3—H3 123.0 (15) C12—C14—C15 110.93 (15) 
N2—C4—C2 113.80 (18) N3—C15—C14 99.16 (14) 
N2—C4—C5 135.33 (18) N3—C15—C17 113.42 (14) 
C2—C4—C5 110.86 (16) C14—C15—C17 115.03 (14) 
C13—O4—N4 109.97 (14) N3—C15—H15 111.7 (12) 
C14—N4—O4 102.80 (14) C14—C15—H15 107.7 (13) 
N1—C5—C4 99.20 (15) C17—C15—H15 109.4 (13) 
N1—C5—C7 113.65 (16) C13—C16—H16A 107 (3) 
C4—C5—C7 114.25 (16) C13—C16—H16B 110 (2) 
N1—C5—H5 107.3 (12) H16A—C16—H16B 110 (3) 
C4—C5—H5 110.1 (13) C13—C16—H16C 109.4 (18) 
C7—C5—H5 111.5 (14) H16A—C16—H16C 109 (3) 
C3—C6—H6A 110 (2) H16B—C16—H16C 111 (3) 
C3—C6—H6B 108 (3) C15—C17—C18 114.13 (14) 
H6A—C6—H6B 106 (3) C15—C17—H17A 105.8 (13) 
C3—C6—H6C 112.9 (17) C18—C17—H17A 113.5 (12) 
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H6A—C6—H6C 107 (3) C15—C17—H17B 109.1 (13) 
H6B—C6—H6C 113 (3) C18—C17—H17B 108.6 (13) 
C5—C7—C8 114.93 (17) H17A—C17—H17B 105.3 (17) 
C5—C7—H7A 106.2 (12) C19—C18—C20 110.19 (18) 
C8—C7—H7A 108.2 (12) C19—C18—C17 111.81 (17) 
C5—C7—H7B 107.3 (14) C20—C18—C17 109.69 (17) 
C8—C7—H7B 109.6 (13) C19—C18—H18 109.5 (15) 
H7A—C7—H7B 110.5 (17) C20—C18—H18 107.0 (15) 
C9—C8—C10 109.8 (2) C17—C18—H18 108.5 (15) 
C9—C8—C7 109.17 (18) C18—C19—H19A 114.9 (18) 
C10—C8—C7 112.04 (19) C18—C19—H19B 116 (2) 
C9—C8—H8 107.0 (13) H19A—C19—H19B 103 (3) 
C10—C8—H8 107.6 (13) C18—C19—H19C 111.4 (18) 
C7—C8—H8 111.1 (13) H19A—C19—H19C 108 (3) 
C8—C9—H9A 109.7 (17) H19B—C19—H19C 103 (3) 
C8—C9—H9B 111 (2) C18—C20—H20A 106.6 (18) 
H9A—C9—H9B 111 (3) C18—C20—H20B 110.9 (19) 
C8—C9—H9C 110.6 (19) H20A—C20—H20B 113 (3) 
H9A—C9—H9C 107 (3) C18—C20—H20C 107.2 (16) 
H9B—C9—H9C 107 (3) H20A—C20—H20C 115 (2) 
C8—C10—H10A 109.7 (17) H20B—C20—H20C 104 (3) 
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C5—N1—C1—O1 -176.78 (17) C5—C7—C8—C10 -59.7 (2) 
C5—N1—C1—C2 3.8 (2) C15—N3—C11—O3 -178.58 (17) 
O1—C1—C2—C3 -4.2 (4) C15—N3—C11—C12 1.6 (2) 
N1—C1—C2—C3 175.3 (3) O3—C11—C12—C13 -1.9 (4) 
O1—C1—C2—C4 -179.85 (18) N3—C11—C12—C13 177.9 (3) 
N1—C1—C2—C4 -0.40 (19) O3—C11—C12—C14 -178.91 (18) 
C3—O2—N2—C4 -0.65 (19) N3—C11—C12—C14 0.91 (19) 
C4—C2—C3—O2 -0.5 (2) C14—C12—C13—O4 0.7 (2) 
C1—C2—C3—O2 -176.2 (3) C11—C12—C13—O4 -176.3 (2) 
C4—C2—C3—C6 -179.4 (2) C14—C12—C13—
C16 
-179.6 (2) 
C1—C2—C3—C6 4.9 (5) C11—C12—C13—
C16 
3.4 (5) 
N2—O2—C3—C2 0.7 (2) N4—O4—C13—C12 -0.2 (2) 
N2—O2—C3—C6 179.83 (16) N4—O4—C13—C16 -179.92 (17) 
O2—N2—C4—C2 0.3 (2) O4—N4—C14—C12 1.00 (19) 
O2—N2—C4—C5 -179.0 (2) O4—N4—C14—C15 -178.84 (18) 
C3—C2—C4—N2 0.1 (2) C13—C12—C14—N4 -1.1 (2) 
C1—C2—C4—N2 177.61 (16) C11—C12—C14—N4 177.12 (15) 
C3—C2—C4—C5 179.57 (15) C13—C12—C14—
C15 
178.75 (15) 
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C1—C2—C4—C5 -2.9 (2) C11—C12—C14—
C15 
-3.00 (19) 
C13—O4—N4—C14 -0.52 (19) C11—N3—C15—C14 -3.19 (19) 
C1—N1—C5—C4 -5.2 (2) C11—N3—C15—C17 -125.67 (17) 
C1—N1—C5—C7 -126.89 (17) N4—C14—C15—N3 -176.6 (2) 
N2—C4—C5—N1 -176.0 (2) C12—C14—C15—N3 3.59 (18) 
C2—C4—C5—N1 4.63 (19) N4—C14—C15—C17 -55.3 (3) 
N2—C4—C5—C7 -54.8 (3) C12—C14—C15—
C17 
124.89 (16) 
C2—C4—C5—C7 125.87 (17) N3—C15—C17—C18 -68.0 (2) 
N1—C5—C7—C8 -65.9 (2) C14—C15—C17—
C18 
178.84 (16) 
C4—C5—C7—C8 -178.82 (16) C15—C17—C18—
C19 
-67.4 (2) 
C5—C7—C8—C9 178.48 (18) C15—C17—C18—
C20 
170.04 (16) 
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Table 24.  Hydrogen-bond geometry (Å, º)for 6-(1-methylethyl)-3-methyl-5,6-dihydro-4H-
pyrrolo[3,4-c]isoxazol-4-one (125b) 
   
D—H•••A D—H H•••A D•••A D—H•••A 
N1—H1•••O3 0.93 (3) 1.94 (3) 2.855 (2) 169 (2) 
N3—H3•••O1 0.90 (2) 2.01 (2) 2.905 (2) 171 (2) 
 
Computing details 
Data collection: Bruker APEX 2; cell refinement: Bruker SAINT; data reduction: Bruker SAINT; 
program(s) used to solve structure: SHELXS97 (Sheldrick, 2008); program(s) used to refine 
structure: SHELXL2012 (Sheldrick, 2012); molecular graphics: Bruker SHELXTL; software used 
to prepare material for publication: Bruker SHELXTL. 
Special details 
Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are 
estimated using the full covariance matrix. The cell esds are taken into account individually 
in the estimation of esds in distances, angles and torsion angles; correlations between esds 
in cell parameters are only used when they are defined by crystal symmetry. An 
approximate (isotropic) treatment of cell esds is used for estimating esds involving l.s. 
planes. 
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4.11.3 – (S,E)-5-(But-2-enoyl)-6-isopropyl-3-methyl-5,6-dihydro-4H-pyrrolo[3,4-
c]isoxazol-4-one (139a) X-Ray Data 
X-Ray data has also been identified for (S,E)-5-(But-2-enoyl)-6-isopropyl-3-methyl-5,6-
dihydro-4H-pyrrolo[3,4-c]isoxazol-4-one (139a), Figure 29, as prepared by the T3P route 
described above. 
 
Figure 30. Structural illustration of (S,E)-5-(But-2-enoyl)-6-isopropyl-3-methyl-5,6-dihydro-
4H-pyrrolo[3,4-c]isoxazol-4-one (139a) 
Rcfj51.figs 
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Table 25. Crystal Data for (S,E)-5-(But-2-enoyl)-6-isopropyl-3-methyl-5,6-dihydro-4H-
pyrrolo[3,4-c]isoxazol-4-one (139a) 
C13H16N2O3 Dx = 1.294 Mg m-3 
Mr = 248.28 Mo Ka radiation, l = 0.71073 Å 
Orthorhombic, P212121 Cell parameters from 3130 reflections 
a = 6.9698 (12) Å q = 2.4–23.3° 
b = 9.5108 (16) Å m = 0.09 mm-1 
c = 19.233 (3) Å T = 150 K 
V = 1274.9 (4)  Å3 Lath, colourless 
Z = 4 1.70 × 0.28 × 0.07 mm 
F(000) = 528  
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Table 26. Data collection for (S,E)-5-(But-2-enoyl)-6-isopropyl-3-methyl-5,6-dihydro-4H-
pyrrolo[3,4-c]isoxazol-4-one (139a) 
Bruker APEX 2 CCD diffractometer 2390 reflections with I > 2s(I) 
Radiation source: fine-focus sealed 
tube 
Rint = 0.034 
w rotation with narrow frames scans qmax = 26.4°, qmin = 2.1° 
Absorption correction: multi-scan  
SADABS v2012/1, Sheldrick, G.M., 
(2012) 
h = -8®8 
Tmin = 0.858, Tmax = 0.994 k = -11®11 
11350 measured reflections l = -24®23 
2618 independent reflections  
 
Table 27. Refinement for (S,E)-5-(But-2-enoyl)-6-isopropyl-3-methyl-5,6-dihydro-4H-
pyrrolo[3,4-c]isoxazol-4-one (139a) 
Refinement on F2 Secondary atom site location: all non-
H atoms found by direct methods 
Least-squares matrix: full Hydrogen site location: difference 
Fourier map 
R[F2 > 2s(F2)] = 0.032 All H-atom parameters refined 
wR(F2) = 0.078 w = 1/[s2(Fo2) + (0.0451P)2 + 0.0725P]   
where P = (Fo2 + 2Fc2)/3 
S = 1.03 (D/s)max < 0.001 
2618 reflections Dñmax = 0.16 e Å-3 
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227 parameters Dñmin = -0.15 e Å-3 
0 restraints Absolute structure:  Flack x 
determined using 939 quotients [(I+)-
(I-)]/[(I+)+(I-)]   (Parsons and Flack 
(2004), Acta Cryst. A60, s61). 
Primary atom site location: structure-
invariant direct methods 
Flack parameter: 0.0 (6) 
 
Table 28. Fractional atomic coordinates and isotropic or equivalent isotropic displacement 
parameters (Å2) for (S,E)-5-(But-2-enoyl)-6-isopropyl-3-methyl-5,6-dihydro-4H-pyrrolo[3,4-
c]isoxazol-4-one (139a) 
 x y z Uiso*/Ueq 
N1 0.6760 (3) 0.47667 (18) 0.17030 (8) 0.0289 (4) 
O1 0.6596 (2) 0.34386 (15) 0.20662 (7) 0.0294 (4) 
C1 0.5953 (3) 0.2431 (2) 0.16305 (10) 0.0251 (4) 
C2 0.5658 (3) 0.3043 (2) 0.09976 (10) 0.0227 (4) 
C3 0.6192 (3) 0.4450 (2) 0.10789 (10) 0.0231 (4) 
C4 0.5887 (3) 0.5260 (2) 0.04159 (9) 0.0225 (4) 
H4 0.704 (3) 0.563 (2) 0.0234 (11) 0.020 (5)* 
N2 0.5322 (2) 0.40813 (16) -0.00600 (8) 0.0219 (4) 
C5 0.5092 (3) 0.2767 (2) 0.02828 (9) 0.0215 (4) 
O2 0.4512 (2) 0.16826 (13) 0.00244 (7) 0.0276 (3) 
C6 0.5773 (4) 0.0993 (2) 0.19076 (12) 0.0341 (5) 
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H6A 0.491 (5) 0.044 (3) 0.1630 (16) 0.068 (9)* 
H6B 0.690 (7) 0.052 (4) 0.191 (2) 0.100 (13)* 
H6C 0.506 (4) 0.092 (3) 0.2330 (14) 0.055 (8)* 
C7 0.4362 (3) 0.6423 (2) 0.04790 (11) 0.0273 (5) 
H7 0.416 (3) 0.679 (2) 0.0018 (11) 0.025 (5)* 
C8 0.5136 (4) 0.7610 (2) 0.09322 (13) 0.0359 (5) 
H8A 0.644 (4) 0.802 (2) 0.0798 (14) 0.039 (7)* 
H8B 0.419 (4) 0.842 (3) 0.0956 (14) 0.058 (8)* 
H8C 0.536 (4) 0.731 (2) 0.1422 (14) 0.041 (7)* 
C9 0.2457 (3) 0.5881 (3) 0.07569 (14) 0.0353 (5) 
H9A 0.196 (4) 0.512 (3) 0.0474 (13) 0.037 (6)* 
H9B 0.257 (4) 0.549 (3) 0.1259 (14) 0.046 (7)* 
H9C 0.147 (4) 0.667 (3) 0.0803 (15) 0.052 (8)* 
C10 0.5543 (3) 0.4308 (2) -0.07795 (10) 0.0245 (4) 
O3 0.5795 (3) 0.55123 (15) -0.09796 (7) 0.0363 (4) 
C11 0.5554 (3) 0.3089 (2) -0.12532 (10) 0.0253 (4) 
H11 0.532 (3) 0.216 (2) -0.1071 (11) 0.029 (6)* 
C12 0.5902 (3) 0.3271 (2) -0.19257 (10) 0.0284 (5) 
H12 0.610 (4) 0.422 (3) -0.2100 (12) 0.036 (6)* 
C13 0.6051 (4) 0.2113 (3) -0.24419 (13) 0.0388 (6) 
H13A 0.517 (4) 0.226 (3) -0.2797 (14) 0.047 (8)* 
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H13B 0.736 (5) 0.208 (3) -0.2643 (14) 0.054 (8)* 
H13C 0.582 (4) 0.116 (3) -0.2224 (14) 0.056 (8)* 
 
Table 29. Geometric parameters (Å, º) for (S,E)-5-(But-2-enoyl)-6-isopropyl-3-methyl-5,6-
dihydro-4H-pyrrolo[3,4-c]isoxazol-4-one (139a) 
N1—C3 1.299 (3) C7—C8 1.525 (3) 
N1—O1 1.448 (2) C7—H7 0.96 (2) 
O1—C1 1.350 (2) C8—H8A 1.02 (3) 
C1—C2 1.365 (3) C8—H8B 1.02 (3) 
C1—C6 1.473 (3) C8—H8C 1.00 (3) 
C2—C3 1.397 (3) C9—H9A 0.97 (3) 
C2—C5 1.454 (3) C9—H9B 1.04 (3) 
C3—C4 1.505 (3) C9—H9C 1.02 (3) 
C4—N2 1.500 (2) C10—O3 1.221 (2) 
C4—C7 1.539 (3) C10—C11 1.475 (3) 
C4—H4 0.95 (2) C11—C12 1.327 (3) 
N2—C10 1.409 (2) C11—H11 0.97 (2) 
N2—C5 1.422 (2) C12—C13 1.486 (3) 
C5—O2 1.214 (2) C12—H12 0.97 (2) 
C6—H6A 0.96 (3) C13—H13A 0.93 (3) 
C6—H6B 0.91 (4) C13—H13B 0.99 (3) 
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C6—H6C 0.95 (3) C13—H13C 1.01 (3) 
C7—C9 1.521 (3)   
    
C3—N1—O1 102.66 (15) C8—C7—C4 109.44 (19) 
C1—O1—N1 110.25 (14) C9—C7—H7 108.7 (13) 
O1—C1—C2 107.52 (17) C8—C7—H7 108.1 (12) 
O1—C1—C6 117.57 (17) C4—C7—H7 106.6 (12) 
C2—C1—C6 134.88 (19) C7—C8—H8A 117.0 (14) 
C1—C2—C3 105.56 (17) C7—C8—H8B 110.9 (16) 
C1—C2—C5 143.81 (19) H8A—C8—H8B 107 (2) 
C3—C2—C5 110.54 (16) C7—C8—H8C 112.3 (14) 
N1—C3—C2 114.00 (18) H8A—C8—H8C 102 (2) 
N1—C3—C4 134.98 (18) H8B—C8—H8C 106 (2) 
C2—C3—C4 110.96 (16) C7—C9—H9A 111.5 (15) 
N2—C4—C3 99.88 (14) C7—C9—H9B 112.6 (15) 
N2—C4—C7 113.83 (16) H9A—C9—H9B 106.4 (19) 
C3—C4—C7 113.49 (16) C7—C9—H9C 111.5 (15) 
N2—C4—H4 106.1 (13) H9A—C9—H9C 111 (2) 
C3—C4—H4 112.7 (13) H9B—C9—H9C 103 (2) 
C7—C4—H4 110.3 (13) O3—C10—N2 117.98 (17) 
C10—N2—C5 127.03 (15) O3—C10—C11 122.82 (17) 
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C10—N2—C4 117.15 (15) N2—C10—C11 119.13 (16) 
C5—N2—C4 113.81 (14) C12—C11—C10 120.02 (19) 
O2—C5—N2 126.48 (17) C12—C11—H11 120.3 (12) 
O2—C5—C2 129.10 (18) C10—C11—H11 119.7 (13) 
N2—C5—C2 104.41 (15) C11—C12—C13 124.5 (2) 
C1—C6—H6A 111.2 (17) C11—C12—H12 118.9 (14) 
C1—C6—H6B 113 (3) C13—C12—H12 116.6 (14) 
H6A—C6—H6B 106 (3) C12—C13—H13A 109.7 (16) 
C1—C6—H6C 115.0 (17) C12—C13—H13B 110.3 (16) 
H6A—C6—H6C 96 (2) H13A—C13—H13B 109 (2) 
H6B—C6—H6C 114 (3) C12—C13—H13C 112.1 (15) 
C9—C7—C8 111.03 (19) H13A—C13—H13C 109 (2) 
C9—C7—C4 112.79 (17) H13B—C13—H13C 106 (2) 
    
C3—N1—O1—C1 0.3 (2) C7—C4—N2—C5 -115.02 (18) 
N1—O1—C1—C2 -0.9 (2) C10—N2—C5—O2 -22.4 (3) 
N1—O1—C1—C6 177.61 (19) C4—N2—C5—O2 174.39 (19) 
O1—C1—C2—C3 1.1 (2) C10—N2—C5—C2 158.92 (19) 
C6—C1—C2—C3 -177.0 (2) C4—N2—C5—C2 -4.3 (2) 
O1—C1—C2—C5 177.2 (3) C1—C2—C5—O2 5.6 (5) 
C6—C1—C2—C5 -1.0 (5) C3—C2—C5—O2 -178.4 (2) 
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O1—N1—C3—C2 0.4 (2) C1—C2—C5—N2 -175.7 (3) 
O1—N1—C3—C4 177.3 (2) C3—C2—C5—N2 0.2 (2) 
C1—C2—C3—N1 -0.9 (2) N2—C4—C7—C9 59.8 (2) 
C5—C2—C3—N1 -178.48 (18) C3—C4—C7—C9 -53.6 (2) 
C1—C2—C3—C4 -178.61 (17) N2—C4—C7—C8 -176.08 (16) 
C5—C2—C3—C4 3.9 (2) C3—C4—C7—C8 70.6 (2) 
N1—C3—C4—N2 177.1 (2) C5—N2—C10—O3 -177.35 (19) 
C2—C3—C4—N2 -5.9 (2) C4—N2—C10—O3 -14.6 (3) 
N1—C3—C4—C7 -61.4 (3) C5—N2—C10—C11 -0.3 (3) 
C2—C3—C4—C7 115.6 (2) C4—N2—C10—C11 162.47 (17) 
C3—C4—N2—
C10 
-158.75 (16) O3—C10—C11—
C12 
1.9 (3) 
C7—C4—N2—
C10 
80.0 (2) N2—C10—C11—
C12 
-175.02 (19) 
C3—C4—N2—C5 6.3 (2) C10—C11—C12—
C13 
176.6 (2) 
Computing details 
Data collection: Bruker APEX 2; cell refinement: Bruker SAINT; data reduction: Bruker SAINT; 
program(s) used to solve structure: SHELXS97 (Sheldrick, 2008); program(s) used to refine 
structure: SHELXL2013 (Sheldrick, 2013); molecular graphics: Bruker SHELXTL; software used 
to prepare material for publication: Bruker SHELXTL. 
Special details 
Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are 
estimated using the full covariance matrix. The cell esds are taken into account individually 
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in the estimation of esds in distances, angles and torsion angles; correlations between esds 
in cell parameters are only used when they are defined by crystal symmetry. An 
approximate (isotropic) treatment of cell esds is used for estimating esds involving l.s. 
planes. 
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